2024 ESC Guidelines for the management of peripheral arterial and aortic diseases.

Acute aortic syndrome; Aortic aneurysm; Aortic atherosclerosis; Aortic dissection; Aortic surgery; Carotid artery disease; Chronic limb-threatening ischaemia; Endovascular repair; Exercise; Genetic aortic diseases; Guidelines; Intramural haematoma; Lower extremity artery disease; Penetrating atherosclerotic ulcer; Peripheral arterial disease; Polyvascular disease; Renal artery disease; Humans; Practice Guidelines as Topic; Europe; Aortic Diseases/therapy; Aortic Diseases/diagnosis; Peripheral Arterial Disease/therapy; Peripheral Arterial Disease/diagnosis

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Mazzolai, Lucia ; (Switzerland

Teixido-Tura, Gisela ; (Spain

Lanzi, Stefano ; (Switzerland

Boc, Vinko ; (Slovenia

Bossone, Eduardo ; (Italy

Brodmann, Marianne ; (Austria

Bura-Rivière, Alessandra ; (France

De Backer, Julie ; (Belgium

Deglise, Sebastien ; (Switzerland

Della Corte, Alessandro ; (Italy

More authors (18 more)

Language :

English

Title :

2024 ESC Guidelines for the management of peripheral arterial and aortic diseases.

Publication date :

29 September 2024

Journal title :

European Heart Journal

ISSN :

0195-668X

eISSN :

1522-9645

Publisher :

Oxford University Press, England

Volume :

Issue :

Pages :

3538 - 3700

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://academic.oup.com/eurheartj/article-pdf/45/36/3538/59561327/ehae179.pdf

Available on ORBi :

since 20 May 2025

Statistics

Number of views

1782 (0 by ULiège)

Number of downloads

1499 (0 by ULiège)

More statistics

Scopus citations^®

449

Scopus citations^®
without self-citations

392

OpenCitations

OpenAlex citations

473

Bibliography

van Kuijk JP, Flu WJ, Welten GM, Hoeks SE, Chonchol M, Vidakovic R, et al. Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease. Eur Heart J 2010;31:992–9. https://doi.org/10.1093/eurheartj/ ehp553
Dolmaci OB, El Mathari S, Driessen AHG, Klautz RJM, Poelmann RE, Lindeman JHN, et al. Are thoracic aortic aneurysm patients at increased risk for cardiovascular diseases? J Clin Med 2023;12:272. https://doi.org/10.3390/jcm12010272
Tully L, Gianos E, Vani A, Guo Y, Balakrishnan R, Schwartzbard A, et al. Suboptimal risk factor control in patients undergoing elective coronary or peripheral percutaneous intervention. Am Heart J 2014;168:310–6.e3. https://doi.org/10.1016/j.ahj.2014.05.011
Saratzis A, Jaspers NEM, Gwilym B, Thomas O, Tsui A, Lefroy R, et al. Observational study of the medical management of patients with peripheral artery disease. Br J Surg 2019;106:1168–77. https://doi.org/10.1002/bjs.11214
McDermott MM, Mandapat AL, Moates A, Albay M, Chiou E, Celic L, et al. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med 2003;163:2157–62. https://doi.org/10.1001/archinte.163.18.2157
Grayson PC, Ponte C, Suppiah R, Robson JC, Gribbons KB, Judge A, et al. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis 2022;81:1654–60. https://doi.org/10.1136/ard-2022-223482
Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2020;79:19–30. https://doi.org/10.1136/annrheumdis-2019-215672
Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, et al. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis 2022;81:1647–53. https://doi.org/10.1136/ard-2022-223480
Stone JR, Bruneval P, Angelini A, Bartoloni G, Basso C, Batoroeva L, et al. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc Pathol 2015;24:267–78. https://doi.org/10.1016/j.carpath.2015.05.001
Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019. Lancet 2020;396:1204–22. https://doi.org/10.1016/S0140-6736(20)30925-9
Lin J, Chen Y, Jiang N, Li Z, Xu S. Burden of peripheral artery disease and its attributable risk factors in 204 countries and territories from 1990 to 2019. Front Cardiovasc Med 2022;9:868370. https://doi.org/10.3389/fcvm.2022.868370
GBD 2019 Peripheral Artery Disease Collaborators. Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019. Lancet Glob Health 2023;11:e1553–65. https://doi.org/10.1016/ S2214-109X(23)00355-8
Liu W, Yang C, Chen, Lei F, Qin J-J, Liu H, et al. Global death burden and attributable risk factors of peripheral artery disease by age, sex, SDI regions, and countries from 1990 to 2030: results from the Global Burden of Disease study 2019. Atherosclerosis 2022;347:17–27. https://doi.org/10.1016/j.atherosclerosis.2022.03.002
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 2020;76:2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010
Pu L, Wang L, Zhang R, Zhao T, Jiang Y, Han L. Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030. Stroke 2023;54:1330–9. https://doi.org/10.1161/STROKEAHA.122.040073
Summers KL, Kerut EK, Sheahan CM, Sheahan MG, III. Evaluating the prevalence of abdominal aortic aneurysms in the United States through a national screening database. J Vasc Surg 2021;73:61–8. https://doi.org10.1016/j.jvs.2020.03.046
Behrendt CA, Thomalla G, Rimmele DL, Petersen EL, Twerenbold R, Debus ES, et al. Editor’s choice—prevalence of peripheral arterial disease, abdominal aortic aneurysm, and risk factors in the Hamburg city health study: a cross sectional analysis. Eur J Vasc Endovasc Surg 2023;65:590–8. https://doi.org/10.1016/j.ejvs.2023.01.002
Rossello X, Dorresteijn JA, Janssen A, Lambrinou E, Scherrenberg M, Bonnefoy-Cudraz E, et al. Risk prediction tools in cardiovascular disease prevention: a report from the ESC Prevention of CVD programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). Eur Heart J Acute Cardiovasc Care 2020;9: 522–32. https://doi.org/10.1177/2048872619858285
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42:3227–337. https://doi.org/10.1093/eurheartj/ehab484
Aday AW, Matsushita K. Epidemiology of peripheral artery disease and polyvascular disease. Circ Res 2021;128:1818–32. https://doi.org/10.1161/CIRCRESAHA.121. 318535
Pabon M, Cheng S, Altin SE, Sethi SS, Nelson MD, Moreau KL, et al. Sex differences in peripheral artery disease. Circ Res 2022;130:496–511. https://doi.org/10.1161/CIRCRESAHA.121.320702
Khawaja T, Janus SE, Tashtish N, Janko M, Baeza C, Gilkeson R, et al. Prevalence of thoracic aortic aneurysm in patients referred for no/low-charge coronary artery calcium scoring: insights from the CLARIFY registry. Am J Prev Cardiol 2022;12:100378. https://doi.org/10.1016/j.ajpc.2022.100378
Obel LM, Diederichsen AC, Steffensen FH, Frost L, Lambrechtsen J, Busk M, et al. Population-based risk factors for ascending, arch, descending, and abdominal aortic dilations for 60-74-year-old individuals. J Am Coll Cardiol 2021;78:201–11. https://doi.org/10.1016/j.jacc.2021.04.094
Bossone E, Eagle KA. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes. Nat Rev Cardiol 2021;18:331–48. https://doi.org/10.1038/s41569-020-00472-6
Verhagen JMA, Kempers M, Cozijnsen L, Bouma BJ, Duijnhouwer AL, Post JG, et al. Expert consensus recommendations on the cardiogenetic care for patients with thoracic aortic disease and their first-degree relatives. Int J Cardiol 2018;258:243–8. https://doi.org/10.1016/j.ijcard.2018.01.145
Burger PM, Pradhan AD, Dorresteijn JAN, Koudstaal S, Teraa M, de Borst GJ, et al. C-reactive protein and risk of cardiovascular events and mortality in patients with various cardiovascular disease locations. Am J Cardiol 2023;197:13–23. https://doi.org/10.1016/j.amjcard.2023.03.025
Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, et al. Colchicine in patients with chronic coronary disease. N Engl J Med 2020;383:1838–47. https://doi.org/10.1056/NEJMoa2021372
Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 2019;381: 2497–505. https://doi.org/10.1056/NEJMoa1912388
Parkkila K, Kiviniemi A, Tulppo M, Perkiömäki J, Kesäniemi YA, Ukkola O. Carotid and femoral bruits as cardiovascular risk indicators in a middle-aged Finnish population: a 20-year prospective study. PLoS One 2022;17:e0278901. https://doi.org/10.1371/journal.pone.0278901
Pickett CA, Jackson JL, Hemann BA, Atwood JE. Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis. Lancet 2008; 371:1587–94. https://doi.org/10.1016/s0140-6736(08)60691-1
Charry D, Gouskova N, Meyer ML, Ring K, Nambi V, Heiss G, et al. Arterial stiffness and contralateral differences in blood pressure: the Atherosclerosis Risk in Communities (ARIC) study. J Clin Hypertens (Greenwich) 2022;24:878–84. https://doi.org/10.1111/jch.14493
Aboyans V, Criqui MH, McDermott MM, Allison MA, Denenberg JO, Shadman R, et al. The vital prognosis of subclavian stenosis. J Am Coll Cardiol 2007;49:1540–5. https://doi.org/10.1016/j.jacc.2006.09.055
Marcovina SM, Shapiro MD. Measurement of lipoprotein(a): a once in a lifetime opportunity. J Am Coll Cardiol 2022;79:629–31. https://doi.org/10.1016/j.jacc.2021.11. 053
Arndt H, Nordanstig J, Bertges DJ, Budtz-Lilly J, Venermo M, Espada CL, et al. A Delphi consensus on patient reported outcomes for registries and trials including patients with intermittent claudication: recommendations and reporting standard. Eur J Vasc Endovasc Surg 2022;64:526–33. https://doi.org/10.1016/j.ejvs.2022.08.011
Rymer JA, Narcisse D, Cosiano M, Tanaka J, McDermott MM, Treat-Jacobson DJ, et al. Patient-reported outcome measures in symptomatic, non-limb-threatening peripheral artery disease: a state-of-the-art review. Circ Cardiovasc Interv 2022;15:e011320. https://doi.org/10.1161/circinterventions.121.011320
Raja A, Spertus J, Yeh RW, Secemsky EA. Assessing health-related quality of life among patients with peripheral artery disease: a review of the literature and focus on patient-reported outcome measures. Vasc Med 2021;26:317–25. https://doi.org/10.1177/ 1358863x20977016
Treat-Jacobson D, McDermott MM, Bronas UG, Campia U, Collins TC, Criqui MH, et al. Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association. Circulation 2019;139:e10–33. https://doi.org/10.1161/cir.0000000000000623
Poku E, Duncan R, Keetharuth A, Essat M, Phillips P, Woods HB, et al. Patient-reported outcome measures in patients with peripheral arterial disease: a systematic review of psychometric properties. Health Qual Life Outcomes 2016;14:161. https://doi.org/10. 1186/s12955-016-0563-y
Mays RJ, Casserly IP, Kohrt WM, Ho PM, Hiatt WR, Nehler MR, et al. Assessment of functional status and quality of life in claudication. J Vasc Surg 2011;53:1410–21. https://doi.org/10.1016/j.jvs.2010.11.092
Regensteiner JG, Hiatt WR, Coll JR, Criqui MH, Treat-Jacobson D, McDermott MM, et al. The impact of peripheral arterial disease on health-related quality of life in the peripheral arterial disease awareness, risk, and treatment: new resources for survival (PARTNERS) program. Vasc Med 2008;13:15–24. https://doi.org/10.1177/ 1358863x07084911
Harwood AE, King S, Totty J, Smith GE, Vanicek N, Chetter IC. A systematic review of muscle morphology and function in intermittent claudication. J Vasc Surg 2017;66: 1241–57. https://doi.org/10.1016/j.jvs.2017.05.106
Schieber MN, Hasenkamp RM, Pipinos II, Johanning JM, Stergiou N, DeSpiegelaere HK, et al. Muscle strength and control characteristics are altered by peripheral artery disease. J Vasc Surg 2017;66:178–86.e12. https://doi.org/10.1016/j.jvs.2017.01.051
Gohil RA, Mockford KA, Mazari F, Khan J, Vanicek N, Chetter IC, et al. Balance impairment, physical ability, and its link with disease severity in patients with intermittent claudication. Ann Vasc Surg 2013;27:68–74. https://doi.org/10.1016/j.avsg.2012.05.005
Mockford KA, Mazari FA, Jordan AR, Vanicek N, Chetter IC, Coughlin PA. Computerized dynamic posturography in the objective assessment of balance in patients with intermittent claudication. Ann Vasc Surg 2011;25:182–90. https://doi.org/10.1016/j.avsg.2010.07.021
Gardner AW, Montgomery PS. Impaired balance and higher prevalence of falls in subjects with intermittent claudication. J Gerontol A Biol Sci Med Sci 2001;56:M454–8. https://doi.org/10.1093/gerona/56.7.m454
McDermott MM, Ferrucci L, Liu K, Guralnik JM, Tian Lu, Liao Y, et al. Leg symptom categories and rates of mobility decline in peripheral arterial disease. J Am Geriatr Soc 2010;58:1256–62. https://doi.org/10.1111/j.1532-5415.2010.02941.x
McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 2004;292:453–61. https://doi.org/10.1001/jama.292.4.453
McDermott MM, Greenland P, Guralnik JM, Guralnik JM, Criqui MH, Chan C, et al. Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med 2003;18:461–7. https://doi.org/10.1046/j.1525-1497.2003.20527.x
Ramirez JL, Drudi LM, Grenon SM. Review of biologic and behavioral risk factors linking depression and peripheral artery disease. Vasc Med 2018;23:478–88. https://doi.org/10.1177/1358863X18773161
Golledge J, Leicht AS, Yip L, Rowbotham SE, Pinchbeck J, Jenkins JS, et al. Relationship between disease specific quality of life measures, physical performance, and activity in people with intermittent claudication caused by peripheral artery disease. Eur J Vasc Endovasc Surg 2020;59:957–64. https://doi.org/10.1016/j.ejvs.2020.02.006
Gardner AW, Montgomery PS, Wang M, Xu C. Predictors of health-related quality of life in patients with symptomatic peripheral artery disease. J Vasc Surg 2018;68: 1126–34. https://doi.org/10.1016/j.jvs.2017.12.074
McDermott MM, Tian L, Liu K, Guralnik JM, Ferrucci L, Tan J, et al. Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol 2008;51:1482–9. https://doi.org/10.1016/j.jacc.2007.12.034
McDermott MM, Guralnik JM, Tian L, Ferrucci L, Liu K, Liao Y, et al. Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol 2007;50:974–82. https://doi.org/10.1016/j.jacc.2007.05.030
Sprengers RW, Teraa M, Moll FL, de Wit GA, van der Graaf Y, Verhaar MC. Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment. J Vasc Surg 2010;52:843–9.e1. https://doi.org/10.1016/j.jvs.2010.04.057
Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:645–58 .
Leng GC, Fowkes FG. The Edinburgh claudication questionnaire: an improved version of the WHO/Rose questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992;45:1101–9. https://doi.org/10.1016/0895-4356(92)90150-l
Birkett ST, Harwood AE, Caldow E, Ibeggazene S, Ingle L, Pymer S. A systematic review of exercise testing in patients with intermittent claudication: a focus on test standardisation and reporting quality in randomised controlled trials of exercise interventions. PLoS One 2021;16:e0249277. https://doi.org/10.1371/journal.pone.0249277
Harwood AE, Pymer S, Ingle L, Doherty P, Chetter IC, Parmenter B. Exercise training for intermittent claudication: a narrative review and summary of guidelines for practitioners. BMJ Open Sport Exerc Med 2020;6:e000897. https://doi.org/10.1136/bmjsem-2020-000897
Treat-Jacobson D, McDermott MM, Beckman JA, Burt MA, Creager MA, Ehrman JK, et al. Implementation of supervised exercise therapy for patients with symptomatic peripheral artery disease: a science advisory from the American Heart Association. Circulation 2019;140:e700–10. https://doi.org/10.1161/cir.0000000000000727
Hiatt WR, Rogers RK, Brass EP. The treadmill is a better functional test than the 6-mi-nute walk test in therapeutic trials of patients with peripheral artery disease. Circulation 2014;130:69–78. https://doi.org/10.1161/circulationaha.113.007003
Nicolaï SP, Viechtbauer W, Kruidenier LM, Candel MJJM, Prins MH, Teijink JAW. Reliability of treadmill testing in peripheral arterial disease: a meta-regression analysis. J Vasc Surg 2009;50:322–9. https://doi.org/10.1016/j.jvs.2009.01.042
Mazzolai L, Belch J, Venermo M, Aboyans V, Brodmann M, Bura-Rivière A, et al. Exercise therapy for chronic symptomatic peripheral artery disease. Eur Heart J 2024;45:1303–21. https://doi.org/10.1093/eurheartj/ehad734
McDermott MM, Guralnik JM, Criqui MH, Liu K, Kibbe MR, Ferrucci L. Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation 2014;130:61–8. https://doi.org/10.1161/circulationaha.114.007002
McDermott MM, Ades PA, Dyer A, Guralnik JM, Kibbe M, Criqui MH. Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg 2008; 48:1231–7.e1. https://doi.org/10.1016/j.jvs.2008.06.050
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111–7. https://doi.org/10.1164/ajrccm.166.1.at1102
Verdijk LB, van Loon L, Meijer K, Savelberg HH. One-repetition maximum strength test represents a valid means to assess leg strength in vivo in humans. J Sports Sci 2009;27:59–68. https://doi.org/10.1080/02640410802428089
Ritti-Dias RM, Basyches M, Câmara L, Puech-Leao P, Battistella L, Wolosker N. Test-retest reliability of isokinetic strength and endurance tests in patients with intermittent claudication. Vasc Med 2010;15:275–8. https://doi.org/10.1177/ 1358863x10371415
Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85–94. https://doi.org/10.1093/geronj/49.2.m85
Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332:556–62. https://doi.org/10.1056/nejm199503023320902
Isselbacher EM, Preventza O, Hamilton Black J III, Augoustides JG, Beck AW, Bolen MA, et al. 2022 ACC/AHA Guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on clinical practice guidelines. J Am Coll Cardiol 2022;80:e223–393. https://doi.org/10.1016/j.jacc.2022.08.004
Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, Caselli S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J 2021;42:17–96. https://doi.org/10.1093/eurheartj/ehaa605
de Heer F, Gökalp AL, Kluin J, Takkenberg JJM. Measuring what matters to the patient: health related quality of life after aortic valve and thoracic aortic surgery. Gen Thorac Cardiovasc Surg 2019;67:37–43. https://doi.org/10.1007/s11748-017-0830-9
Chaddha A, Kline-Rogers E, Braverman AC, Erickson SR, Jackson EA, Franklin BA, et al. Survivors of aortic dissection: activity, mental health, and sexual function. Clin Cardiol 2015;38:652–9. https://doi.org/10.1002/clc.22418
Andonian C, Freilinger S, Achenbach S, Ewert P, Gundlach U, Kaemmerer H, et al. Quality of life in patients with Marfan syndrome: a cross-sectional study of 102 adult patients. Cardiovasc Diagn Ther 2021;11:602–10. https://doi.org/10.21037/cdt-20-692
Vanem TT, Rand-Hendriksen S, Brunborg C, Geiran OR, Røe C. Health-related quality of life in Marfan syndrome: a 10-year follow-up. Health Qual Life Outcomes 2020;18: 376. https://doi.org/10.1186/s12955-020-01633-4
Cervin A, Wanhainen A, Björck M. Popliteal aneurysms are common among men with screening detected abdominal aortic aneurysms, and prevalence correlates with the diameters of the common iliac arteries. Eur J Vasc Endovasc Surg 2020;59:67–72. https://doi.org/10.1016/j.ejvs.2019.07.042
Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO), the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018;39:763–816. https://doi.org/10.1093/eurheartj/ehx095
Ichihashi S, Desormais I, Hashimoto T, Magne J, Kichikawa K, Aboyans V. Accuracy and reliability of the ankle brachial index measurement using a multicuff oscillometric device versus the Doppler method. Eur J Vasc Endovasc Surg 2020;60:462–8. https://doi.org/10.1016/j.ejvs.2020.06.013
Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 2012;126:2890–909. https://doi.org/10.1161/CIR.0b013e318276fbcb
Høyer C, Strandberg J, Overvad Jordansen MK, Zacho HD. The ability of the toe-brachial index to predict the outcome of treadmill exercise testing in patients with a normal resting ankle-brachial index. Ann Vasc Surg 2020;64:263–9. https://doi.org/10.1016/j.avsg.2019.10.041
Godet R, Bruneau A, Vielle B, Vincent F, Le Tourneau T, Carre F, et al. Post-exercise ankle blood pressure and ankle to brachial index after heavy load bicycle exercise. Scand J Med Sci Sports 2018;28:2144–52. https://doi.org/10.1111/sms.13234
van Langen H, van Gurp J, Rubbens L. Interobserver variability of ankle-brachial index measurements at rest and post exercise in patients with intermittent claudication. Vasc Med 2009;14:221–6. https://doi.org/10.1177/1358863x08101017
Stein R, Hriljac I, Halperin JL, Gustavson SM, Teodorescu V, Olin JW, Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease. Vasc Med 2006;11:29–33. https://doi.org/10.1191/1358863x06vm663oa
Abraham P, Desvaux B, Saumet JL. Ankle-brachial index after maximum exercise in treadmill and cycle ergometers in athletes. Clin Physiol 1998;18:321–6. https://doi.org/10.1046/j.1365-2281.1998.00100.x
Stoffers HE, Kester AD, Kaiser V, Rinkens PELM, Kitslaar PJEHM, Knottnerus JA, The diagnostic value of the measurement of the ankle-brachial systolic pressure index in primary health care. J Clin Epidemiol 1996;49:1401–5. https://doi.org/10.1016/s0895-4356(96)00275-2
Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 1982;91:686–93 .
Laing S, Greenhalgh RM. The detection and progression of asymptomatic peripheral arterial disease. Br J Surg 2005;70:628–30. https://doi.org/10.1002/bjs.1800701017
Ankle Brachial Index Collaboration; Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, et al. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300:197–208. https://doi.org/10.1001/jama.300.2.197
Criqui MH, McClelland RL, McDermott MM, McDermott MM, Allison MA, Blumenthal RS, et al. The ankle-brachial index and incident cardiovascular events in the MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol 2010;56:1506–12. https://doi.org/10.1016/j.jacc.2010.04.060
Herraiz-Adillo Á, Cavero-Redondo I, Álvarez-Bueno C, Pozuelo-Carrascosa DP, Solera-Martínez M. The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: a systematic review and meta-analysis. Atherosclerosis 2020;315:81–92. https://doi.org/10.1016/j.atherosclerosis.2020.09.026
Tehan PE, Santos D, Chuter VH. A systematic review of the sensitivity and specificity of the toe-brachial index for detecting peripheral artery disease. Vasc Med 2016;21: 382–9. https://doi.org/10.1177/1358863x16645854
Fukui M, Tanaka M, Hamaguchi M, Senmaru T, Sakabe K, Asano M, et al. Toe-brachial index is associated more strongly with albuminuria or glomerular filtration rate than ankle-brachial index in patients with type 2 diabetes. Hypertens Res 2012;35:745–9. https://doi.org/10.1038/hr.2012.16
Dachun X, Jue L, Liling Z, Xu Y, Hu D, Pagoto SL, et al. Sensitivity and specificity of the ankle—brachial index to diagnose peripheral artery disease: a structured review. Vasc Med 2010;15:361–9. https://doi.org/10.1177/1358863x10378376
Morimoto S, Nakajima F, Yurugi T, Morita T, Jo F, Nishikawa M, et al. Risk factors of normal ankle-brachial index and low toe-brachial index in hemodialysis patients. Ther Apher Dial 2009;13:103–7. https://doi.org/10.1111/j.1744-9987.2009.00663.x
Young MJ, Adams JE, Anderson GF, Boulton AJ, Cavanagh PR. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 1993;36:615–21. https://doi.org/10.1007/bf00404070
Carter SA, Lezack JD. Digital systolic pressures in the lower limb in arterial disease. Circulation 1971;43:905–14. https://doi.org/10.1161/01.cir.43.6.905
Watanabe Y, Masaki H, Kojima K, Tanemoto K. Toe-brachial index in the second toe: substitutability to toe-brachial index in the great toe and ankle-brachial index. Ann Vasc Dis 2016;9:300–6. https://doi.org/10.3400/avd.oa.16-00078
Pérez-Martin A, Meyer G, Demattei C, Böge G, Laroche J-P, Quéré I, et al. Validation of a fully automatic photoplethysmographic device for toe blood pressure measurement. Eur J Vasc Endovasc Surg 2010;40:515–20. https://doi.org/10.1016/j.ejvs.2010.06.008
Hoyer C, Sandermann J, Petersen LJ. The toe-brachial index in the diagnosis of peripheral arterial disease. J Vasc Surg 2013;58:231–8. https://doi.org/10.1016/j.jvs.2013.03. 044
Monti M, Calanca L, Alatri A, Mazzolai L. Accuracy of in-patients ankle-brachial index measurement by medical students. Vasa 2016;45:43–8. https://doi.org/10.1024/03011526/a000494
Kaiser V, Kester AD, Stoffers HE, Kitslaar PJ, Knottnerus JA. The influence of experience on the reproducibility of the ankle-brachial systolic pressure ratio in peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg 1999;18:25–9. https://doi.org/10.1053/ejvs.1999.0843
Ray SA, Srodon PD, Taylor RS, Dormandy JA. Reliability of ankle:brachial pressure index measurement by junior doctors. Br J Surg 1994;81:188–90. https://doi.org/10.1002/bjs.1800810208
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/ American Heart Association task force on clinical practice guidelines. Circulation 2017;135:e726–79. https://doi.org/10.1161/CIR.0000000000000471
Stivalet O, Paisant A, Belabbas D, Omarjee L, Le Faucheur A, Landreau P, et al. Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography. PLoS One 2019;14:e0219082. https://doi.org/10.1371/journal.pone.0219082
Abraham P, Picquet J, Vielle B, Sigaudo-Roussel D, Paisant-Thouveny F, Enon B, et al. Transcutaneous oxygen pressure measurements on the buttocks during exercise to detect proximal arterial ischemia: comparison with arteriography. Circulation 2003; 107:1896–900. https://doi.org/10.1161/01.Cir.0000060500.60646.E0
Yamamoto K, Miyata T, Onozuka A, Koyama H, Ohtsu H, Nagawa H. Plantar flexion as an alternative to treadmill exercise for evaluating patients with intermittent claudication. Eur J Vasc Endovasc Surg 2007;33:325–9. https://doi.org/10.1016/j.ejvs.2006.10.012
Maufus M, Sevestre-Pietri MA, Sessa C, Pignon B, Egelhofer H, Dupas S, et al. Critical limb ischaemia and the response to bone marrow-derived cell therapy according to tcPO(2) measurement. Vasa 2017;46:23–8. https://doi.org/10.1024/0301-1526/ a000590
Leenstra B, Wijnand J, Verhoeven B, Koning O, Teraa M, Verhaar MC, et al. Applicability of transcutaneous oxygen tension measurement in the assessment of chronic limb-threatening ischemia. Angiology 2020;71:208–16. https://doi.org/10.1177/0003319719866958
Ott A. Inflammation and transcutaneous measurement of oxygen pressure in dermatology. Adv Exp Med Biol 1987;220:79–82. https://doi.org/10.1007/978-1-4613-1927-6_14
Woo Y, Suh YJ, Lee H, Jeong E, Park SC, Yun SS, et al. TcPO2 value can predict wound healing time in clinical practice of CLTI patients. Ann Vasc Surg 2023;91:249–56. https://doi.org/10.1016/j.avsg.2022.11.020
Wang Z, Hasan R, Firwana B, Elraiyah T, Tsapas A, Prokop L, et al. A systematic review and meta-analysis of tests to predict wound healing in diabetic foot. J Vasc Surg 2016; 63:29S–36S.e2. https://doi.org/10.1016/j.jvs.2015.10.004
Yamada T, Ohta T, Ishibashi H, Sugimoto I, Iwata H, Takahashi M, et al. Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs—comparison with other noninvasive diagnostic methods. J Vasc Surg 2008;47:318–23. https://doi.org/10.1016/j.jvs.2007.10.045
Noori N, Haruno L, Schroeder I, Vrahas M, Little M, Moon C, et al. Preoperative transcutaneous oxygen perfusion measurements in predicting atraumatic wound healing after major lower extremity amputation. Orthopedics 2022;45:174–80. https://doi.org/10.3928/01477447-20220128-05
Nishio H, Minakata K, Kawaguchi A, Kumagai M, Ikeda T, Shimizu A, et al. Transcutaneous oxygen pressure as a surrogate index of lower limb amputation. Int Angiol 2016;35:565–72.
Sarin S, Shami S, Shields DA, Scurr JH, Smith PD. Selection of amputation level: a review. Eur J Vasc Surg 1991;5:611–20. https://doi.org/10.1016/s0950-821x(05)80894-1
Abraham P, Ramondou P, Hersant J, Sempore WY, Feuilloy M, Henni S. Investigation of arterial claudication with transcutaneous oxygen pressure at exercise: interests and limits. Trends Cardiovasc Med 2021;31:218–23. https://doi.org/10.1016/j.tcm.2020.03.003
Abraham P, Gu Y, Guo L, Kroeger K, Ouedraogo N, Wennberg P, et al. Clinical application of transcutaneous oxygen pressure measurements during exercise. Atherosclerosis 2018;276:117–23. https://doi.org/10.1016/j.atherosclerosis.2018.07.023
Colas-Ribas C, Signolet I, Henni S, Feuillloy M, Gagnadoux F, Abraham P. High prevalence of known and unknown pulmonary diseases in patients with claudication during exercise oximetry: a retrospective analysis. Medicine (Baltimore) 2016;95:e4888. https://doi.org/10.1097/md.0000000000004888
Frank U, Nikol S, Belch J, Boc V, Brodmann M, Carpentier PH, et al. ESVM guideline on peripheral arterial disease. Vasa 2019;48:1–79. https://doi.org/10.1024/0301-1526/ a000834
Schlager O, Francesconi M, Haumer M, Dick P, Sabeti S, Amighi J, et al. Duplex sonography versus angiography for assessment of femoropopliteal arterial disease in a ‘real-world’ setting. J Endovasc Ther 2007;14:452–9. https://doi.org/10.1177/ 152660280701400404
Collins R, Burch J, Cranny G, Aguiar-Ibáñez R, Craig D, Wright K, et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ 2007;334:1257. https://doi.org/10.1136/bmj.39217.473275.55
Sprynger M, Rigo F, Moonen M, Aboyans V, Edvardsen T, de Alcantara ML, et al. Focus on echovascular imaging assessment of arterial disease: complement to the ESC Guidelines (PARTIM 1) in collaboration with the working group on aorta and peripheral vascular diseases. Eur Heart J Cardiovasc Imaging 2018;19:1195–221. https://doi.org/10.1093/ehjci/jey103
Collins R, Cranny G, Burch J, Aguiar-Ibáñez R, Craig D, Wright K, et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess 2007;11:iii–iv, xi-xiii, 1–184. https://doi.org/10.3310/hta11200
Rodway AD, Cheal D, Allan C, Pazos-Casal F, Hanna L, Field BCT, et al. Ankle Doppler for cuffless ankle brachial index estimation and peripheral artery disease diagnosis independent of diabetes. J Clin Med 2022;12:97. https://doi.org/10.3390/ jcm12010097
Katsanos K, Tepe G, Tsetis D, Fanelli F. Standards of practice for superficial femoral and popliteal artery angioplasty and stenting. Cardiovasc Intervent Radiol 2014;37: 592–603. https://doi.org/10.1007/s00270-014-0876-3
Coffi SB, Ubbink DT, Zwiers I, van Gurp JA, Legemate DA. Improved assessment of the hemodynamic significance of borderline iliac stenoses with use of hyperemic duplex scanning. J Vasc Surg 2002;36:575–80. https://doi.org/10.1067/mva.2002.126086
Elsman BH, Legemate DA, de Vos HJ, Mali WP, Eikelboom BC. Hyperaemic colour duplex scanning for the detection of aortoiliac stenoses. a comparative study with intra-arterial pressure measurement. Eur J Vasc Endovasc Surg 1997;14:462–7. https://doi.org/10.1016/s1078-5884(97)80125-6
Venermo M, Sprynger M, Desormais I, Björck M, Brodmann M, Cohnert T, et al. Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology working group on aorta and peripheral vascular diseases and the European Society for Vascular Surgery. Eur J Prev Cardiol 2019;26:1971–84. https://doi.org/10.1177/2047487319846999
Golemati S, Cokkinos DD. Recent advances in vascular ultrasound imaging technology and their clinical implications. Ultrasonics 2022;119:106599. https://doi.org/10.1016/j.ultras.2021.106599
Itoga NK, Minami HR, Chelvakumar M, Pearson K, Mell MM, Bendavid E, et al. Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test. Vasc Med 2018;23:97–106. https://doi.org/10.1177/1358863X17745371
Xu D, Zou L, Xing Y, Hou L, Wei Y, Zhang J, et al. Diagnostic value of ankle-brachial index in peripheral arterial disease: a meta-analysis. Can J Cardiol 2013;29:492–8. https://doi.org/10.1016/j.cjca.2012.06.014
Hashimoto T, Ichihashi S, Iwakoshi S, Kichikawa K. Combination of pulse volume recording (PVR) parameters and ankle-brachial index (ABI) improves diagnostic accuracy for peripheral arterial disease compared with ABI alone. Hypertens Res 2016;39:430–4. https://doi.org/10.1038/hr.2016.13
Tehan PE, Bray A, Chuter VH. Non-invasive vascular assessment in the foot with diabetes: sensitivity and specificity of the ankle brachial index, toe brachial index and continuous wave Doppler for detecting peripheral arterial disease. J Diabetes Complications 2016;30:155–60. https://doi.org/10.1016/j.jdiacomp.2015.07.019
Loukas M, Bilinsky E, Bilinsky S, Blaak C, Tubbs RS, Anderson RH. The anatomy of the aortic root. Clin Anat 2014;27:748–56. https://doi.org/10.1002/ca.22295
Dagenais F. Anatomy of the thoracic aorta and of its branches. Thorac Surg Clin 2011; 21:219–27, viii. https://doi.org/10.1016/j.thorsurg.2010.12.004
Lombardi JV, Hughes GC, Appoo JJ, Bavaria JE, Beck AW, Cambria RP, et al. Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) reporting standards for type B aortic dissections. Ann Thorac Surg 2020;109:959–81. https://doi.org/10.1016/j.athoracsur.2019.10.005
Rodríguez-Palomares JF, Teixidó-Tura G, Galuppo V, Cuéllar H, Laynez A, Gutiérrez L, et al. Multimodality assessment of ascending aortic diameters: comparison of different measurement methods. J Am Soc Echocardiogr 2016;29:819–26.e4. https://doi.org/10.1016/j.echo.2016.04.006
Saura D, Dulgheru R, Caballero L, Bernard A, Kou S, Gonjilashvili N, et al. Two-dimensional transthoracic echocardiographic normal reference ranges for proximal aorta dimensions: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging 2017;18:167–79. https://doi.org/10.1093/ehjci/jew053
Bons LR, Duijnhouwer AL, Boccalini S, van den Hoven AT, van der Vlugt MJ, Chelu RG, et al. Intermodality variation of aortic dimensions: how, where and when to measure the ascending aorta. Int J Cardiol 2019;276:230–5. https://doi.org/10.1016/j.ijcard.2018.08.067
Amsallem M, Ou P, Milleron O, Henry-Feugeas M-C, Detaint D, Arnoult F, et al. Comparative assessment of ascending aortic aneurysms in Marfan patients using ECG-gated computerized tomographic angiography versus trans-thoracic echocardiography. Int J Cardiol 2015;184:22–7. https://doi.org/10.1016/j.ijcard.2015.01.086
Matthews EO, Pinchbeck J, Elmore K, Jones RE, Moxon JV, Golledge J. The reproducibility of measuring maximum abdominal aortic aneurysm diameter from ultrasound images. Ultrasound J 2021;13:13. https://doi.org/10.1186/s13089-021-00211-z
Bonnafy T, Lacroix P, Desormais I, Labrunie A, Marin B, Leclerc A, et al. Reliability of the measurement of the abdominal aortic diameter by novice operators using a pocket-sized ultrasound system. Arch Cardiovasc Dis 2013;106:644–50. https://doi.org/10.1016/j.acvd.2013.08.004
Fitzgerald BT, Kwon A, Scalia GM. The new dimension in aortic measurements—use of the inner edge measurement for the thoracic aorta in Australian patients. Heart Lung Circ 2015;24:1104–10. https://doi.org/10.1016/j.hlc.2015.05.001
Burman ED, Keegan J, Kilner PJ. Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values. Circ Cardiovasc Imaging 2008;1:104–13. https://doi.org/10.1161/circimaging.108.768911
Muraru D, Maffessanti F, Kocabay G, Peluso D, Bianco LD, Piasentini E, et al. Ascending aorta diameters measured by echocardiography using both leading edge-to-leading edge and inner edge-to-inner edge conventions in healthy volunteers. Eur Heart J Cardiovasc Imaging 2014;15:415–22. https://doi.org/10.1093/ehjci/jet173
Vis JC, Rodríguez-Palomares JF, Teixidó-Tura G, Galian-Gay L, Granato C, Guala A, et al. Implications of asymmetry and valvular morphotype on echocardiographic measurements of the aortic root in bicuspid aortic valve. J Am Soc Echocardiogr 2019;32: 105–12. https://doi.org/10.1016/j.echo.2018.08.004
Ghulam Ali S, Fusini L, Dalla Cia A, Tamborini G, Gripari P, Muratori M, et al. Technological advancements in echocardiographic assessment of thoracic aortic dilatation: head to head comparison among multidetector computed tomography, 2-di-mensional, and 3-dimensional echocardiography measurements. J Thorac Imaging 2018;33:232–9. https://doi.org/10.1097/rti.0000000000000330
Mendoza DD, Kochar M, Devereux RB, Basson CT, Min JK, Holmes K, et al. Impact of image analysis methodology on diagnostic and surgical classification of patients with thoracic aortic aneurysms. Ann Thorac Surg 2011;92:904–12. https://doi.org/10.1016/j.athoracsur.2011.03.130
Campens L, Demulier L, De Groote K, Vandekerckhove K, De Wolf D, Roman MJ, et al. Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories. Am J Cardiol 2014;114:914–20. https://doi.org/10.1016/j.amjcard.2014.06.024
Pedersen OM, Aslaksen A, Vik-Mo H. Ultrasound measurement of the luminal diameter of the abdominal aorta and iliac arteries in patients without vascular disease. J Vasc Surg 1993;17:596–601. https://doi.org/10.1067/mva.1993.39525
Kim H, Kwon TW, Choi E, Jeong S, Kim H-K, Han Y, et al. Aortoiliac diameter and length in a healthy cohort. PLoS One 2022;17:e0268077. https://doi.org/10.1371/journal.pone.0268077
Evangelista A, Flachskampf FA, Erbel R, Antonini-Canterin F, Vlachopoulos C, Rocchi G, et al. Echocardiography in aortic diseases: EAE recommendations for clinical practice. Eur J Echocardiogr 2010;11:645–58. https://doi.org/10.1093/ejechocard/jeq056
Zafar MA, Li Y, Rizzo JA, Charilaou P, Saeyeldin A, Velasquez CA, et al. Height alone, rather than body surface area, suffices for risk estimation in ascending aortic aneurysm. J Thorac Cardiovasc Surg 2018;155:1938–50. https://doi.org/10.1016/j.jtcvs.2017.10.140
Masri A, Kalahasti V, Svensson LG, Roselli EE, Johnston D, Hammer D, et al. Aortic cross-sectional area/height ratio and outcomes in patients with a trileaflet aortic valve and a dilated aorta. Circulation 2016;134:1724–37. https://doi.org/10.1161/circulationaha.116.022995
Wu J, Zafar MA, Li Y, Saeyeldin A, Huang Y, Zhao R, et al. Ascending aortic length and risk of aortic adverse events: the neglected dimension. J Am Coll Cardiol 2019;74: 1883–94. https://doi.org/10.1016/j.jacc.2019.07.078
Pham MHC, Ballegaard C, de Knegt MC, Sigvardsen PE, Sørgaard MH, Fuchs A, et al. Normal values of aortic dimensions assessed by multidetector computed tomography in the Copenhagen general population study. Eur Heart J Cardiovasc Imaging 2019;20: 939–48. https://doi.org/10.1093/ehjci/jez012
Davis AE, Lewandowski AJ, Holloway CJ, Ntusi NAB, Banerjee R, Nethononda R, et al. Observational study of regional aortic size referenced to body size: production of a cardiovascular magnetic resonance nomogram. J Cardiovasc Magn Reson 2014;16:9. https://doi.org/10.1186/1532-429x-16-9
Braley KT, Tang X, Makil ES, Borroughs-Ray D, Collins RT. The impact of body weight on the diagnosis of aortic dilation—misdiagnosis in overweight and underweight groups. Echocardiography 2017;34:1029–34. https://doi.org/10.1111/echo.13565
Evangelista A, Sitges M, Jondeau G, Nijveldt R, Pepi M, Cuellar H, et al. Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases. Eur Heart J Cardiovasc Imaging 2023;24:e65–85. https://doi.org/10.1093/ehjci/jead024
Macdonald DB, Hurrell C, Costa AF, McInnes MDF, O’Malley ME, Barrett B, et al. Canadian Association of Radiologists Guidance on contrast associated acute kidney injury. Can Assoc Radiol J 2022;73:499–514. https://doi.org/10.1177/ 08465371221083970
Committee opinion no. 723: guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 2017;130:e210–6. https://doi.org/10.1097/AOG.000000000 0002355
von Kodolitsch Y, Nienaber CA, Dieckmann C, Schwartz AG, Hofmann T, Brekenfeld C, et al. Chest radiography for the diagnosis of acute aortic syndrome. Am J Med 2004; 116:73–7. https://doi.org/10.1016/j.amjmed.2003.08.030
Nazerian P, Pivetta E, Veglia S, Cavigli E, Mueller C, de Matos Soeiro A, et al. Integrated use of conventional chest radiography cannot rule out acute aortic syndromes in emergency department patients at low clinical probability. Acad Emerg Med 2019; 26:1255–65. https://doi.org/10.1111/acem.13819
Hartnell GG, Wakeley CJ, Tottle A, Papouchado M, Wilde RP. Limitations of chest radiography in discriminating between aortic dissection and myocardial infarction: implications for thrombolysis. J Thorac Imaging 1993;8:152–5. https://doi.org/10.1097/ 00005382-199321000-00008
Evangelista A, Avegliano G, Aguilar R, Cuellar H, Igual A, Gonzalez-Alujas T, et al. Impact of contrast-enhanced echocardiography on the diagnostic algorithm of acute aortic dissection. Eur Heart J 2010;31:472–9. https://doi.org/10.1093/eurheartj/ehp505
Litmanovich D, Bankier AA, Cantin L, Raptopoulos V, Boiselle PM. CT and MRI in diseases of the aorta. AJR Am J Roentgenol 2009;193:928–40. https://doi.org/10.2214/ajr.08.2166
Pennell DJ, Sechtem UP, Higgins CB, Manning W, Pohost G, Rademakers F, et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. J Cardiovasc Magn Reson 2004;6:727–65. https://doi.org/10.1081/jcmr-200038581
Yoshioka K, Tanaka R. MRI and MRA of aortic disease. Ann Vasc Dis 2010;3:196–201. https://doi.org/10.3400/avd.sasdi10003
Fadel BM, Mohty D, Kazzi BE, Alamro B, Arshi F, Mustafa M, et al. Ultrasound imaging of the abdominal aorta: a comprehensive review. J Am Soc Echocardiogr 2021;34:1119–36. https://doi.org/10.1016/j.echo.2021.06.012
Bhave NM, Nienaber CA, Clough RE, Eagle KA. Multimodality imaging of thoracic aortic diseases in adults. JACC Cardiovasc Imaging 2018;11:902–19. https://doi.org/10.1016/j.jcmg.2018.03.009
Goldstein SA, Evangelista A, Abbara S, Arai A, Asch FM, Badano LP, et al. Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2015;28:119–82. https://doi.org/10.1016/j.echo.2014.11.015
Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2873–926. https://doi.org/10.1093/eurheartj/ ehu281
Bossone E, Czerny M, Lerakis S, Rodríguez-Palomares J, Kukar N, Ranieri B, et al. Imaging and biomarkers in acute aortic syndromes: diagnostic and prognostic implications. Curr Probl Cardiol 2021;46:100654. https://doi.org/10.1016/j.cpcardiol.2020. 100654
Bossone E, LaBounty TM, Eagle KA. Acute aortic syndromes: diagnosis and management, an update. Eur Heart J 2018;39:739–49d. https://doi.org/10.1093/eurheartj/ ehx319
Vardhanabhuti V, Nicol E, Morgan-Hughes G, Roobottom CA, Roditi G, Hamilton MCK, et al. Recommendations for accurate CT diagnosis of suspected acute aortic syndrome (AAS)—on behalf of the British Society of Cardiovascular Imaging (BSCI)/ British Society of Cardiovascular CT (BSCCT). Br J Radiol 2016;89:20150705. https://doi.org/10.1259/bjr.20150705
Carstensen M, Keer D, Rempel J, Jeon P, Barrett B. Prevalence of risk factors for contrast-induced nephrotoxicity in outpatients undergoing intravenous contrast-enhanced computed tomography studies. Can Assoc Radiol J 2012;63: 177–82. https://doi.org/10.1016/j.carj.2010.12.004
Brenner DJ, Hall EJ. Computed tomography—an increasing source of radiation exposure. N Engl J Med 2007;357:2277–84. https://doi.org/10.1056/NEJMra072149
Barra L, Kanji T, Malette J, Pagnoux C. Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: a systematic review and meta-analysis. Autoimmun Rev 2018;17:175–87. https://doi.org/10.1016/j.autrev.2017.11.021
Dyverfeldt P, Bissell M, Barker AJ, Bolger AF, Carlhäll C-J, Ebbers T, et al. 4D flow cardiovascular magnetic resonance consensus statement. J Cardiovasc Magn Reson 2015; 17:72. https://doi.org/10.1186/s12968-015-0174-5
Rodriguez-Palomares JF. Genetics of bicuspid aortic valve: ready for clinical use? Heart 2022;108:1078–9. https://doi.org/10.1136/heartjnl-2021-320742
Guala A, Teixido-Tura G, Dux-Santoy L, Granato C, Ruiz-Muñoz A, Valente F, et al. Decreased rotational flow and circumferential wall shear stress as early markers of descending aorta dilation in Marfan syndrome: a 4D flow CMR study. J Cardiovasc Magn Reson 2019;21:63. https://doi.org/10.1186/s12968-019-0572-1
Horowitz MJ, Kupsky DF, El-Said HG, Alshawabkeh L, Kligerman SJ, Hsiao A. 4D flow MRI quantification of congenital shunts: comparison to invasive catheterization. Radiol Cardiothorac Imaging 2021;3:e200446. https://doi.org/10.1148/ryct.2021200446
Rizk J. 4D flow MRI applications in congenital heart disease. Eur Radiol 2021;31: 1160–74. https://doi.org/10.1007/s00330-020-07210-z
Gupta SK, Ya’qoub L, Wimmer AP, Fisher S, Saeed IM. Safety and clinical impact of MRI in patients with non-MRI-conditional cardiac devices. Radiol Cardiothorac Imaging 2020; 2:e200086. https://doi.org/10.1148/ryct.2020200086
Munawar DA, Chan JEZ, Emami M, Kadhim K, Khokhar K, O’Shea C, et al. Magnetic resonance imaging in non-conditional pacemakers and implantable cardioverter-defibrillators: a systematic review and meta-analysis. Europace 2020;22:288–98. https://doi.org/10.1093/europace/euz343
Nienaber CA. The role of imaging in acute aortic syndromes. Eur Heart J Cardiovasc Imaging 2013;14:15–23. https://doi.org/10.1093/ehjci/jes215
van der Geest KSM, Treglia G, Glaudemans A, Brouwer E, Sandovici M, Jamar F, et al. Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2021;48: 3886–902. https://doi.org/10.1007/s00259-021-05362-8
Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018;77:636–43. https://doi.org/10.1136/annrheumdis-2017-212649
Forsythe RO, Dweck MR, McBride OMB, Vesey AT, Semple SI, Shah ASV, et al. (18) F-sodium fluoride uptake in abdominal aortic aneurysms: the SoFIA(3) study. J Am Coll Cardiol 2018;71:513–23. https://doi.org/10.1016/j.jacc.2017.11.053
Roque A, Pizzi MN. (18)F-FDG PET/CT: not only a promise for complex scenarios-let’s talk about aortic grafts. J Nucl Cardiol 2022;29:2949–51. https://doi.org/10.1007/ s12350-021-02888-0
Roque A, Pizzi MN, Fernández-Hidalgo N, Permanyer E, Cuellar-Calabria H, Romero-Farina G, et al. Morpho-metabolic post-surgical patterns of non-infected prosthetic heart valves by [18F]FDG PET/CTA: ‘normality’ is a possible diagnosis. Eur Heart J Cardiovasc Imaging 2020;21:24–33. https://doi.org/10.1093/ehjci/jez222
Pizzi MN, Roque A, Cuéllar-Calabria H, Fernández-Hidalgo N, Ferreira-González I, González-Alujas MT, et al. (18)F-FDG-PET/CTA of prosthetic cardiac valves and valve-tube grafts: infective versus inflammatory patterns. JACC Cardiovasc Imaging 2016;9: 1224–7. https://doi.org/10.1016/j.jcmg.2016.05.013
Pizzi MN, Roque A, Fernández-Hidalgo N, Cuéllar-Calabria H, Ferreira-González I, Gonzàlez-Alujas MT, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation 2015;132:1113–26. https://doi.org/10.1161/circulationaha.115.015316
Teraa M, Hazenberg CE, Houben IB, Trimarchi S, van Herwaarden JA. Important issues regarding planning and sizing for emergent TEVAR. J Cardiovasc Surg (Torino) 2020;61: 708–12. https://doi.org/10.23736/S0021-9509.20.11571-4
Lindholt JS, Sogaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet 2017;390:2256–65. https://doi.org/10.1016/S0140-6736(17)32250-X
Lin JS, Evans CV, Johnson E, Redmond N, Coppola EL, Smith N. Nontraditional risk factors in cardiovascular disease risk assessment: updated evidence report and systematic review for the US preventive services task force. JAMA 2018;320:281–97. https://doi.org/10.1001/jama.2018.4242
Normahani P, Burgess L, Norrie J, Epstein DM, Kandiyil N, Saratzis A, et al. Study protocol for a multicentre comparative diagnostic accuracy study of tools to establish the presence and severity of peripheral arterial disease in people with diabetes mellitus: the DM PAD study. BMJ Open 2022;12:e066950. https://doi.org/10.1136/ bmjopen-2022-066950
Ueshima D, Barioli A, Nai Fovino L, D’Amico G, Fabris T, Brener SJ, et al. The impact of pre-existing peripheral artery disease on transcatheter aortic valve implantation outcomes: a systematic review and meta-analysis. Catheter Cardiovasc Interv 2020;95: 993–1000. https://doi.org/10.1002/ccd.28335
de Weerd M, Greving JP, Hedblad B, Lorenz MW, Mathiesen EB, O’Leary DH, et al. Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke 2010;41:1294–7. https://doi.org/10.1161/STROKEAHA.110.581058
Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, et al. Screening for asymptomatic carotid artery stenosis: US preventive services task force recommendation statement. JAMA 2021;325:476–81. https://doi.org/10.1001/jama.2020.26988
AbuRahma AF, Avgerinos ED, Chang RW, Darling RC, Duncan AA, Forbes TL, et al. Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease. J Vasc Surg 2022;75:4S–22S. https://doi.org/10.1016/j.jvs.2021.04.073
Howard DPJ, Gaziano L, Rothwell PM. Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol 2021;20:193–202. https://doi.org/10.1016/s1474-4422(20)30484-1
Paraskevas KI, Spence JD, Mikhailidis DP, Antignani PL, Gloviczki P, Eckstein H-H, et al. Why do guidelines recommend screening for abdominal aortic aneurysms, but not for asymptomatic carotid stenosis? A plea for a randomized controlled trial. Int J Cardiol 2023;371:406–12. https://doi.org/10.1016/j.ijcard.2022.09.045
Kobo O, Saada M, von Birgelen C, Tonino PAL, Íñiguez-Romo A, Fröbert O, et al. Impact of multisite artery disease on clinical outcomes after percutaneous coronary intervention: an analysis from the e-Ultimaster registry. Eur Heart J Qual Care Clin Outcomes 2023;9:417–26. https://doi.org/10.1093/ehjqcco/qcac043
Steffel J, Eikelboom JW, Anand SS, Shestakovska O, Yusuf S, Fox KAA. The COMPASS trial: net clinical benefit of low-dose rivaroxaban plus aspirin as compared with aspirin in patients with chronic vascular disease. Circulation 2020;142:40–8. https://doi.org/10.1161/CIRCULATIONAHA.120.046048
Del Giorno R, Reveilhac M, Stauffer I, Berthoud M, Mazzolai L, Depairon M, et al. A new score for improving cardiovascular risk prediction and prevention. Nutr Metab Cardiovasc Dis 2023;33:1546–55. https://doi.org/10.1016/j.numecd.2023.04.019
Mehta A, Rigdon J, Tattersall MC, German CA, Barringer TA, Joshi PH, et al. Association of carotid artery plaque with cardiovascular events and incident coronary artery calcium in individuals with absent coronary calcification: the MESA. Circ Cardiovasc Imaging 2021;14:e011701. https://doi.org/10.1161/circimaging.120.011701
Gepner AD, Young R, Delaney JA, Budoff MJ, Polak JF, Blaha MJ, et al. Comparison of carotid plaque score and coronary artery calcium score for predicting cardiovascular disease events: the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2017;6: e005179. https://doi.org/10.1161/jaha.116.005179
Laclaustra M, Casasnovas JA, Fernández-Ortiz A, Fuster V, León-Latre M, Jiménez-Borreguero LJ, et al. Femoral and carotid subclinical atherosclerosis association with risk factors and coronary calcium: the AWHS study. J Am Coll Cardiol 2016;67:1263–74. https://doi.org/10.1016/j.jacc.2015.12.056
Jacobowitz GR, Rockman CB, Gagne PJ, Adelman MA, Lamparello PJ, Landis R, et al. A model for predicting occult carotid artery stenosis: screening is justified in a selected population. J Vasc Surg 2003;38:705–9. https://doi.org/10.1016/s0741-5214(03)00730-4
Rockman CB, Jacobowitz GR, Gagne PJ, Adelman MA, Lamparello PJ, Landis R, et al. Focused screening for occult carotid artery disease: patients with known heart disease are at high risk. J Vasc Surg 2004;39:44–50. https://doi.org/10.1016/j.jvs.2003.07.008
Yuo TH, Sidaoui J, Marone LK, Makaroun MS, Chaer RA. Revascularization of asymptomatic carotid stenosis is not appropriate in patients on dialysis. J Vasc Surg 2015;61: 670–4. https://doi.org/10.1016/j.jvs.2014.10.002
Ramos MJ, González-Fajardo JA, Vaquero-Puerta C, Vallina-Victorero M, Vicente-Santiago M, Vaquero-Lorenzo F, et al. Asymptomatic carotid stenosis in patients with intermittent claudication: epidemiological study. J Cardiovasc Surg (Torino) 2011;52:761–8 .
Aboyans V, Lacroix P, Guilloux J, Rollé F, Le Guyader A, Cautrès M, et al. A predictive model for screening cerebrovascular disease in patient undergoing coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2005;4:90–5. https://doi.org/10.1510/icvts.2004.092262
Cornily JC, Le Saux D, Vinsonneau U, Bezon E, Le Ven F, Le Gal G, et al. Assessment of carotid artery stenosis before coronary artery bypass surgery. Is it always necessary? Arch Cardiovasc Dis 2011;104:77–83. https://doi.org/10.1016/j.acvd.2010.11.008
Johansson EP, Wester P. Carotid bruits as predictor for carotid stenoses detected by ultrasonography: an observational study. BMC Neurol 2008;8:23. https://doi.org/10.1186/1471-2377-8-23
Carmody BJ, Arora S, Avena R, Curry KM, Simpkins J, Cosby K, et al. Accelerated carotid artery disease after high-dose head and neck radiotherapy: is there a role for routine carotid duplex surveillance? J Vasc Surg 1999;30:1045–51. https://doi.org/10.1016/ s0741-5214(99)70042-x
Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 2019;7:e1020–30. https://doi.org/10.1016/s2214-109x(19)30255-4
Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ. Peripheral artery disease: past, present, and future. Am J Med 2019;132:1133–41. https://doi.org/10.1016/j.amjmed.2019.04.043
Søgaard R, Lindholt JS. Cost-effectiveness of population-based vascular disease screening and intervention in men from the Viborg Vascular (VIVA) trial. Br J Surg 2018;105: 1283–93. https://doi.org/10.1002/bjs.10872
Lindholt JS, Juul S, Fasting H, Henneberg EW. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ 2005;330:750. https://doi.org/10.1136/bmj.38369.620162.82
Norman PE, Jamrozik K, Lawrence-Brown MM, Le MT, Spencer CA, Tuohy RJ, et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ 2004;329:1259. https://doi.org/10.1136/bmj.38272.478438.55
Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, et al. The multicentre aneurysm screening study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002;360: 1531–9. https://doi.org/10.1016/s0140-6736(02)11522-4
Scott RA, Wilson NM, Ashton HA, Kay DN. Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. Br J Surg 1995;82:1066–70. https://doi.org/10.1002/bjs.1800820821
Duncan A, Maslen C, Gibson C, Hartshorne T, Farooqi A, Saratzis A, et al. Ultrasound screening for abdominal aortic aneurysm in high-risk women. Br J Surg 2021;108: 1192–8. https://doi.org/10.1093/bjs/znab220
Lindholt JS, Sogaard R, Rasmussen LM, Mejldal A, Lambrechtsen J, Steffensen FH, et al. Five-year outcomes of the Danish cardiovascular screening (DANCAVAS) trial. N Engl J Med 2022;387:1385–94. https://doi.org/10.1056/NEJMoa2208681
Howard DP, Banerjee A, Fairhead JF, Handa A, Silver LE, Rothwell PM. Population-based study of incidence of acute abdominal aortic aneurysms with projected impact of screening strategy. J Am Heart Assoc 2015;4:e001926. https://doi.org/10.1161/JAHA.115.001926
Howard DP, Banerjee A, Fairhead JF, Handa A, Silver LE, Rothwell PM. Age-specific incidence, risk factors and outcome of acute abdominal aortic aneurysms in a defined population. Br J Surg 2015;102:907–15. https://doi.org/10.1002/bjs.9838
Sprynger M, Willems M, Van Damme H, Drieghe B, Wautrecht JC, Moonen M. Screening program of abdominal aortic aneurysm. Angiology 2019;70:407–13. https://doi.org/10.1177/0003319718824940
Larsson E, Granath F, Swedenborg J, Hultgren R. A population-based case-control study of the familial risk of abdominal aortic aneurysm. J Vasc Surg 2009;49:47–50; discussion 51. https://doi.org/10.1016/j.jvs.2008.08.012
Linné A, Forsberg J, Lindström D, Ideskog E, Hultgren R. Age at detection of abdominal aortic aneurysms in siblings of patients with abdominal aortic aneurysms. J Vasc Surg 2016;63:883–7. https://doi.org/10.1016/j.jvs.2015.10.057
Aboyans V, Bataille V, Bliscaux P, Ederhy S, Filliol D, Honton B, et al. Effectiveness of screening for abdominal aortic aneurysm during echocardiography. Am J Cardiol 2014;114:1100–4. https://doi.org/10.1016/j.amjcard.2014.07.024
Hicks CW, Al-Qunaibet A, Ding N, Kwak L, Folsom AR, Tanaka H, et al. Symptomatic and asymptomatic peripheral artery disease and the risk of abdominal aortic aneurysm: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2021;333:32–8. https://doi.org/10.1016/j.atherosclerosis.2021.08.016
Benson RA, Poole R, Murray S, Moxey P, Loftus IM. Screening results from a large United Kingdom abdominal aortic aneurysm screening center in the context of optimizing United Kingdom National Abdominal Aortic Aneurysm Screening Programme protocols. J Vasc Surg 2016;63:301–4. https://doi.org/10.1016/j.jvs.2015.08.091
Sciria CT, Osorio B, Wang J, Lu DY, Amin N, Vohra A, et al. Sex-based disparities in outcomes with abdominal aortic aneurysms. Am J Cardiol 2021;155:135–48. https://doi.org/10.1016/j.amjcard.2021.06.023
Carter JL, Morris DR, Sherliker P, Clack R, Lam KBH, Halliday A, et al. Sex-specific associations of vascular risk factors with abdominal aortic aneurysm: findings from 1.5 million women and 0.8 million men in the United States and United Kingdom. J Am Heart Assoc 2020;9:e014748. https://doi.org/10.1161/JAHA.119.014748
Wanhainen A, Lundkvist J, Bergqvist D, Bjorck M. Cost-effectiveness of screening women for abdominal aortic aneurysm. J Vasc Surg 2006;43:908–14; discussion 914. https://doi.org/10.1016/j.jvs.2005.12.064
Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010;92:1189–96. https://doi.org/10.3945/ajcn.2010.29673
Mente A, Dehghan M, Rangarajan S, O’Donnell M, Hu W, Dagenais G, et al. Diet, cardiovascular disease, and mortality in 80 countries. Eur Heart J 2023;44:2560–79. https://doi.org/10.1093/eurheartj/ehad269
Wan D, Dehghan M, de Souza RJ, Ramasundarahettige C, Eikelboom JW, Bosch J, et al. Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort. Eur J Prev Cardiol 2023;30:709–18. https://doi.org/10.1093/eurjpc/zwad062
Adegbola A, Behrendt CA, Zyriax BC, Windler E, Kreutzburg T. The impact of nutrition on the development and progression of peripheral artery disease: a systematic review. Clin Nutr 2022;41:49–70. https://doi.org/10.1016/j.clnu.2021.11.005
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/ EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111–88. https://doi.org/10.1093/eurheartj/ehz455
Amarenco P, Kim JS, Labreuche J, Charles H, Giroud M, Lee B-C, et al. Benefit of targeting a LDL (low-density lipoprotein) cholesterol <70 mg/dL during 5 years after ischemic stroke. Stroke 2020;51:1231–9. https://doi.org/10.1161/strokeaha.119.028718
Aung PP, Maxwell HG, Jepson RG, Price JF, Leng GC. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev 2007;4:CD000123. https://doi.org/10.1002/14651858.CD000123.pub2
Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 2007;45:645–54; discussion 653–644. https://doi.org/10.1016/j.jvs.2006.12.054
Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–78. https://doi.org/10.1016/S0140-6736(05)67394-1
Bonaca MP, Gutierrez JA, Cannon C, Giugliano R, Blazing M, Park J-G, et al. Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial. Lancet Diabetes Endocrinol 2018;6:934–43. https://doi.org/10.1016/s2213-8587(18)30290-0
Yu E, Malik VS, Hu FB. Cardiovascular disease prevention by diet modification: JACC health promotion series. J Am Coll Cardiol 2018;72:914–26. https://doi.org/10.1016/j.jacc.2018.02.085
López-Laguna N, Martínez-González MA, Toledo E, Babio N, Sorlí JV, Ros E, et al. Risk of peripheral artery disease according to a healthy lifestyle score: the PREDIMED study. Atherosclerosis 2018;275:133–40. https://doi.org/10.1016/j.atherosclerosis.2018.05.049
Kaluza J, Stackelberg O, Harris HR, Akesson A, Björck M, Wolk A. Mediterranean diet is associated with reduced risk of abdominal aortic aneurysm in smokers: results of two prospective cohort studies. Eur J Vasc Endovasc Surg 2021;62:284–93. https://doi.org/10.1016/j.ejvs.2021.04.017
Liu L, Yang Y. Nutritional management mode of early cardiac rehabilitation in patients with Stanford type A aortic dissection. Comput Math Methods Med 2022;2022: 2124636. https://doi.org/10.1155/2022/2124636
Lauret GJ, Fokkenrood HJ, Bendermacher BL, Scheltinga MR, Teijink JA. Physical activity monitoring in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2014; 47:656–63. https://doi.org/10.1016/j.ejvs.2014.03.001
Gardner AW, Addison O, Katzel LI, Montgomery PS, Prior SJ, Serra MC, et al. Association between physical activity and mortality in patients with claudication. Med Sci Sports Exerc 2021;53:732–9. https://doi.org/10.1249/mss.0000000000002526
Gardner AW, Montgomery PS, Parker DE. Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. J Vasc Surg 2008;47:117–22. https://doi.org/10.1016/j.jvs.2007.09.033
Gardner AW, Montgomery PS, Wang M, Shen B, Zhang S, Pomilla WA. Association between meeting physical activity time-intensity guidelines with ambulation, quality of life, and inflammation in claudication. J Cardiopulm Rehabil Prev 2022;42:E82–9. https://doi.org/10.1097/hcr.0000000000000686
Thijssen CGE, Bons LR, Gökalp AL, Van Kimmenade RRJ, Mokhles MM, Pelliccia A, et al. Exercise and sports participation in patients with thoracic aortic disease: a review. Expert Rev Cardiovasc Ther 2019;17:251–66. https://doi.org/10.1080/14779072.2019. 1585807
Delsart P, Maldonado-Kauffmann P, Bic M, Boudghene-Stambouli F, Sobocinski J, Juthier F, et al. Post aortic dissection: gap between activity recommendation and real life patients aerobic capacities. Int J Cardiol 2016;219:271–6. https://doi.org/10.1016/j.ijcard.2016.06.026
Chaddha A, Eagle KA, Braverman AC, Kline-Rogers E, Hirsch AT, Brook R, et al. Exercise and physical activity for the post-aortic dissection patient: the clinician’s conundrum. Clin Cardiol 2015;38:647–51. https://doi.org/10.1002/clc.22481
Chaddha A, Kline-Rogers E, Woznicki EM, Brook R, Housholder-Hughes S, Braverman AC, et al. Cardiology patient page. Activity recommendations for postaortic dissection patients. Circulation 2014;130:e140–2. https://doi.org/10.1161/circulationaha.113. 005819
Katsiki N, Papadopoulou SK, Fachantidou AI, Mikhailidis DP. Smoking and vascular risk: are all forms of smoking harmful to all types of vascular disease? Public Health 2013; 127:435–41. https://doi.org/10.1016/j.puhe.2012.12.021
Wu CW, Chuang HY, Watanabe K, Wu P-S, Pan H-C, Wang C-L, et al. Association between secondhand smoke and peripheral arterial disease: a meta-analysis of cross-sectional studies. Int Arch Occup Environ Health 2022;95:1091–101. https://doi.org/10.1007/s00420-022-01837-9
Sode BF, Nordestgaard BG, Gronbaek M, Dahl M. Tobacco smoking and aortic aneurysm: two population-based studies. Int J Cardiol 2013;167:2271–7. https://doi.org/10.1016/j.ijcard.2012.06.003
Altobelli E, Rapacchietta L, Profeta VF, Fagnano R. Risk factors for abdominal aortic aneurysm in population-based studies: a systematic review and meta-analysis. Int J Environ Res Public Health 2018;15:2805. https://doi.org/10.3390/ijerph15122805
Lederle FA, Nelson DB, Joseph AM. Smokers’ relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review. J Vasc Surg 2003;38: 329–34. https://doi.org/10.1016/s0741-5214(03)00136-8
Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006;368:647–58. https://doi.org/10.1016/S0140-6736(06)69249-0
Mahtta D, Ramsey D, Krittanawong C, Al Rifai M, Khurram N, Samad Z, et al. Recreational substance use among patients with premature atherosclerotic cardiovascular disease. Heart 2021;107:650–6. https://doi.org/10.1136/heartjnl-2020-318119
Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233–9. https://doi.org/10.7326/0003-4819-142-4-200502150-00005
Suissa K, Lariviere J, Eisenberg MJ, Eberg M, Gore GC, Grad R, et al. Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials. Circ Cardiovasc Qual Outcomes 2017;10: e002458. https://doi.org/10.1161/CIRCOUTCOMES.115.002458
Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2023;5:CD006103. https://doi.org/10.1002/14651858.CD006103.pub8
Rose JJ, Krishnan-Sarin S, Exil VJ, Hamburg NM, Fetterman JL, Ichinose F, et al. Cardiopulmonary impact of electronic cigarettes and vaping products: a scientific statement from the American Heart Association. Circulation 2023;148:703–28. https://doi.org/10.1161/CIR.0000000000001160
Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Begh R, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2024;1:CD010216. https://doi.org/10.1002/14651858.CD010216.pub8
Travis N, Knoll M, Cadham CJ, Cook S, Warner KE, Fleischer NL, et al. Health effects of electronic cigarettes: an umbrella review and methodological considerations. Int J Environ Res Public Health 2022;19:9054. https://doi.org/10.3390/ijerph19159054
Abbott AJ, Reibel YG, Arnett MC, Marka N, Drake MA. Oral and systemic health implications of electronic cigarette usage as compared to conventional tobacco cigarettes: a review of the literature. J Dent Hyg 2023;97:21–35.
Hamann SL, Kungskulniti N, Charoenca N, Kasemsup V, Ruangkanchanasetr S, Jongkhajornpong P. Electronic cigarette harms: aggregate evidence shows damage to biological systems. Int J Environ Res Public Health 2023;20:6808. https://doi.org/10.3390/ijerph20196808
Kavousi M, Pisinger C, Barthelemy JC, De Smedt D, Koskinas K, Marques-Vidal P, et al. Electronic cigarettes and health with special focus on cardiovascular effects: position paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2021;28:1552–66. https://doi.org/10.1177/2047487320941993
Goldman RE, Parker DR, Eaton CB, Borkan JM, Gramling R, Cover RT, et al. Patients’ perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med 2006;4:205–12. https://doi.org/10.1370/afm.534
Howarth M, Lister C. Social prescribing in cardiology: rediscovering the nature within us. Br J Card Nurs 2019;14:1–9. https://doi.org/10.12968/bjca.2019.0036
Nichols LO, Martindale-Adams J, Burns R, Graney MJ, Zuber J. Translation of a dementia caregiver support program in a health care system—REACH VA. Arch Intern Med 2011;171:353–9. https://doi.org/10.1001/archinternmed.2010.548
Martire LM, Schulz R, Keefe FJ, Rudy TE, Starz TW. Couple-oriented education and support intervention for osteoarthritis: effects on spouses’ support and responses to patient pain. Fam Syst Health 2008;26:185–95. https://doi.org/10.1037/1091-7527.26.2.185
Morris SM, King C, Turner M, Payne S. Family carers providing support to a person dying in the home setting: a narrative literature review. Palliat Med 2015;29:487–95. https://doi.org/10.1177/0269216314565706
Ventura AD, Burney S, Brooker J, Fletcher J, Ricciardelli L. Home-based palliative care: a systematic literature review of the self-reported unmet needs of patients and carers. Palliat Med 2014;28:391–402. https://doi.org/10.1177/0269216313511141
Reynolds CF, III, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry 2022;21:336–63. https://doi.org/10.1002/wps.20996
Katch H. The role of self-efficacy in cardiovascular disease self-management: a review of effective programs. Patient Intelligence 2010;2:33–4. doi: https://doi.org/10.2147/PI. S12624]
Ohman EM, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau C-S, et al. The REduction of Atherothrombosis for Continued Health (REACH) registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events–study design. Am Heart J 2006;151:786.e1–10. https://doi.org/10.1016/j.ahj.2005.11. 004
Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999;15: 773–81. https://doi.org/10.1023/a:1007621514757
Dorresteijn JA, Visseren FL, Wassink AM, Gondrie MJA, Steyerberg EW, Ridker PM, et al. Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score. Heart 2013;99:866–72. https://doi.org/10.1136/heartjnl-2013-303640
Kaasenbrood L, Bhatt DL, Dorresteijn JAN, Wilson PWF, D’Agostino RB, Massaro JM, et al. Estimated life expectancy without recurrent cardiovascular events in patients with vascular disease: the SMART-REACH model. J Am Heart Assoc 2018;7: e009217. https://doi.org/10.1161/JAHA.118.009217
Hageman SHJ, McKay AJ, Ueda P, Gunn LH, Jernberg T, Hagström E, et al. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm. Eur Heart J 2022;43:1715–27. https://doi.org/10.1093/eurheartj/ehac056
van Trier TJ, Snaterse M, Boekholdt SM, Scholte Op Reimer WJM, Hageman SHJ, Visseren FLJ, et al. Validation of systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in the EPIC Norfolk prospective population cohort. Eur J Prev Cardiol 2024;31:182–9. https://doi.org/10.1093/eurjpc/zwad318
Wan D, Li V, Banfield L, Azab S, de Souza RJ, Anand SS, et al. Diet and nutrition in peripheral artery disease: a systematic review. Can J Cardiol 2022;38:672–80. https://doi.org/10.1016/j.cjca.2022.01.021
Sesso HD, Rist PM, Aragaki AK, Rautiainen S, Johnson LG, Friedenberg G, et al. Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. Am J Clin Nutr 2022;115:1501–10. https://doi.org/10.1093/ajcn/nqac056
Bondonno NP, Murray K, Cassidy A, Bondonno CP, Lewis JR, Croft KD, et al. Higher habitual flavonoid intakes are associated with a lower risk of peripheral artery disease hospitalizations. Am J Clin Nutr 2021;113:187–99. https://doi.org/10.1093/ajcn/ nqaa300
Bapir M, Untracht GR, Cooke D, McVey JH, Skene SS, Campagnolo P, et al. Cocoa flavanol consumption improves lower extremity endothelial function in healthy individuals and people with type 2 diabetes. Food Funct 2022;13:10439–48. https://doi.org/10.1039/d2fo02017c
Fassora M, Calanca L, Jaques C, Mazzolai L, Kayser B, Lanzi S. Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in symptomatic patients with lower-extremity peripheral artery disease: a systematic review and meta-analysis. Vasc Med 2022;27:158–70. https://doi.org/10.1177/ 1358863x211034577
O’Connor EA, Evans CV, Rushkin MC, Redmond N, Lin JS. Behavioral counseling to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: updated evidence report and systematic review for the US preventive services task force. JAMA 2020;324:2076–94. https://doi.org/10.1001/jama.2020.17108
Hartmann-Boyce J, McRobbie H, Lindson N, Bullen C, Begh R, Theodoulou A, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2021;4: CD010216. https://doi.org/10.1002/14651858.CD010216.pub5
Krabbe B, Espinola-Klein C, Malyar N, Brodmann M, Mazzolai L, Belch JJF, et al. Health effects of e-cigarettes and their use for smoking cessation from a vascular perspective. Vasa 2023;52:81–5. https://doi.org/10.1024/0301-1526/a001056
Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee I-M, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011;43:1334–59. https://doi.org/10.1249/MSS.0b013e318213fefb
Twine CP, Kakkos SK, Aboyans V, Baumgartner I, Behrendt C-A, Bellmunt-Montoya S, et al. Editor’s choice—European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases. Eur J Vasc Endovasc Surg 2023;65:627–89. https://doi.org/10.1016/j.ejvs.2023.03.042
McEvoy JW, Touyz RM, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 2024. https://doi.org/10.1093/eurheartj/ehae178
Blood Pressure Lowering Treatment Trialists’ Collaboration. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. Lancet 2021;398:1053–64. https://doi.org/10.1016/S0140-6736(21)01921-8
Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957–67. https://doi.org/10.1016/s0140-6736(15)01225-8
Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA 2016;315:2673–82. https://doi.org/10.1001/jama.2016.7050
Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, et al. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med 2021;385:1268–79. https://doi.org/10.1056/NEJMoa2111437
Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens 2014;32:2285–95. https://doi.org/10.1097/hjh.0000000000000378
Wright JT, Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373:2103–16. https://doi.org/10.1056/NEJMoa1511939
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145–53. https://doi.org/10.1056/ nejm200001203420301
Bavry AA, Anderson RD, Gong Y, Denardo SJ, Cooper-DeHoff RM, Handberg EM, et al. Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy. Hypertension 2010;55:48–53. https://doi.org/10.1161/hypertensionaha.109.142240
Fudim M, Hopley CW, Huang Z, Kavanagh S, Rockhold FW, Baumgartner I, et al. Association of hypertension and arterial blood pressure on limb and cardiovascular outcomes in symptomatic peripheral artery disease: the EUCLID trial. Circ Cardiovasc Qual Outcomes 2020;13:e006512. https://doi.org/10.1161/circoutcomes.120.006512
Thomas Manapurathe D, Krishna SM, Dewdney B, Moxon JV, Biros E, Golledge J, Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: a meta-analysis of randomised controlled trials. PLoS One 2017;12: e0178713. https://doi.org/10.1371/journal.pone.0178713
Lu Y, Ballew SH, Tanaka H, Szklo M, Heiss G, Coresh J, et al. 2017 ACC/AHA blood pressure classification and incident peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Prev Cardiol 2020;27:51–9. https://doi.org/10.1177/ 2047487319865378
Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547–59. https://doi.org/10.1056/NEJMoa0801317
Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 2004;25:17–24. https://doi.org/10.1016/j.ehj.2003.10.033
Paravastu SC, Mendonca DA, Da Silva A. Beta blockers for peripheral arterial disease. Cochrane Database Syst Rev 2013;9:CD005508. https://doi.org/10.1002/14651858.CD005508.pub3
Kray JE, Dombrovskiy VY, Vogel TR. Use of angiotensin-converting enzyme inhibitors and freedom from amputation after lower extremity revascularization. Vasc Health Risk Manag 2017;13:269–74. https://doi.org/10.2147/vhrm.S137698
Høgh A, Lindholt JS, Nielsen H, Jensen LP, Johnsen SP. Use of angiotensin-converting enzyme inhibitors and cardiovascular outcomes following primary vascular surgery: a nationwide propensity score matched follow-up study. Vasc Endovascular Surg 2012; 46:515–23. https://doi.org/10.1177/1538574412455229
Armstrong EJ, Chen DC, Singh GD, Amsterdam EA, Laird JR. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia. Vasc Med 2015;20:237–44. https://doi.org/10.1177/1358863x15574321
Aronow WS, Ahn C. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. Am J Cardiol 2001;87:1284–6. https://doi.org/10.1016/s0002-9149(01) 01521-1
Soga Y, Iida O, Takahara M, Hirano K, Suzuki K, Kawasaki D. Beta-blocker treatment does not worsen critical limb ischemia in patients receiving endovascular therapy. J Atheroscler Thromb 2015;22:481–9. https://doi.org/10.5551/jat.27359
Carey RM, Wright JT, Jr, Taler SJ, Whelton PK. Guideline-driven management of hypertension: an evidence-based update. Circ Res 2021;128:827–46. https://doi.org/10.1161/circresaha.121.318083
Evans KL, Tuttle KR, Folt DA, Dawson T, Haller ST, Brewster PS, et al. Use of renin-angiotensin inhibitors in people with renal artery stenosis. Clin J Am Soc Nephrol 2014;9:1199–206. https://doi.org/10.2215/cjn.11611113
Hackam DG, Duong-Hua ML, Mamdani M, Li Ping, Tobe SW, Spence JD, et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J 2008;156:549–55. https://doi.org/10.1016/j.ahj.2008.05.013
Solomon SD, Rice MM, Jablonski KA, Jose P, Domanski M, Sabatine M, et al. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation 2006;114:26–31. https://doi.org/10.1161/circulationaha.105. 592733
Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2014;370: 13–22. https://doi.org/10.1056/NEJMoa1310753
Mayr NP, Hapfelmeier A, Martin K, Kurz A, van der Starre P, Babik B, et al. Comparison of sedation and general anaesthesia for transcatheter aortic valve implantation on cerebral oxygen saturation and neurocognitive outcomedagger. Br J Anaesth 2016; 116:90–9. https://doi.org/10.1093/bja/aev294
Singh K, Bønaa KH, Jacobsen BK, Bjørk L, Solberg S. Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: the Tromsø study. Am J Epidemiol 2001;154:236–44. https://doi.org/10.1093/aje/154.3.236
Vogel TR, Dombrovskiy VY, Galiñanes EL, Kruse RL. Preoperative statins and limb salvage after lower extremity revascularization in the Medicare population. Circ Cardiovasc Interv 2013;6:694–700. https://doi.org/10.1161/circinterventions.113. 000274
Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC, Goto S, et al. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J 2014;35:2864–72. https://doi.org/10.1093/eurheartj/ehu080
Pastori D, Farcomeni A, Milanese A, Del Sole F, Menichelli D, Hiatt WR, et al. Statins and major adverse limb events in patients with peripheral artery disease: a systematic review and meta-analysis. Thromb Haemost 2020;120:866–75. https://doi.org/10.1055/ s-0040-1709711
Su Z, Guo J, Gu Y. Pharmacotherapy in clinical trials for abdominal aortic aneurysms: a systematic review and meta-analysis. Clin Appl Thromb Hemost 2022;28: 10760296221120423. https://doi.org/10.1177/10760296221120423
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015;372:2387–97. https://doi.org/10.1056/NEJMoa1410489
Kaasenbrood L, Boekholdt SM, van der Graaf Y, Ray KK, Peters RJG, Kastelein JJP, et al. Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population. Circulation 2016;134:1419–29. https://doi.org/10.1161/CIRCULATIONAHA.116.021314
Clavijo LC, Caro J, Choi J, Caro JA, Tun H, Rowe V, et al. The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study). Cardiovasc Revasc Med 2023;55:1–5. https://doi.org/10.1016/j.carrev.2023.04.020
Cholesterol Treatment Trialists Collaboration; Fulcher J, O’Connell R, Voysey M, Emberson J, Blackwell L, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet 2015;385:1397–405. https://doi.org/10.1016/S0140-6736(14) 61368-4
Murphy SA, Cannon CP, Blazing MA, Giugliano RP, White JA, Lokhnygina Y, et al. Reduction in total cardiovascular events with ezetimibe/simvastatin post-acute coronary syndrome: the IMPROVE-IT trial. J Am Coll Cardiol 2016;67:353–61. https://doi.org/10.1016/j.jacc.2015.10.077
Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 2017;376:1713–22. https://doi.org/10.1056/NEJMoa1615664
Westin GG, Armstrong EJ, Bang H, Yeo K-K, Anderson D, Dawson DL, et al. Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia. J Am Coll Cardiol 2014;63:682–90. https://doi.org/10.1016/j.jacc.2013.09.073
Belch JJF, Brodmann M, Baumgartner I, Binder CJ, Casula M, Heiss C, et al. Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease. Vasa 2021;50:401–11. https://doi.org/10.1024/0301-1526/a000969
Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen T, Lindholt JS. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg 2009;38:463–74. https://doi.org/10.1016/j.ejvs.2009.06.002
Flint AC, Conell C, Ren X, Kamel H, Chan SL, Rao VA, et al. Statin adherence is associated with reduced recurrent stroke risk in patients with or without atrial fibrillation. Stroke 2017;48:1788–94. https://doi.org/10.1161/strokeaha.117.017343
Merwick Á, Albers GW, Arsava EM, Ay H, Calvet D, Coutts SB, et al. Reduction in early stroke risk in carotid stenosis with transient ischemic attack associated with statin treatment. Stroke 2013;44:2814–20. https://doi.org/10.1161/strokeaha.113.001576
Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009;8:453–63. https://doi.org/10.1016/s1474-4422(09)70058-4
Amarenco P, Bogousslavsky J, Callahan A, III, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549–59. https://doi.org/10.1056/NEJMoa061894
Hackam DG, Wu F, Li P, Austin PC, Tobe SW, Mamdani MM, et al. Statins and renovascular disease in the elderly: a population-based cohort study. Eur Heart J 2011;32: 598–610. https://doi.org/10.1093/eurheartj/ehq452
Peng M, Dong H, Jiang X, Che W, Zou Y, Zhang Y, et al. A randomized unblinded trial to compare effects of intensive versus conventional lipid-lowering therapy in patients undergoing renal artery stenting. J Cardiol 2019;74:443–50. https://doi.org/10.1016/j.jjcc.2019.04.010
Vashist A, Heller EN, Brown EJ, Jr, Alhaddad IA. Renal artery stenosis: a cardiovascular perspective. Am Heart J 2002;143:559–64. https://doi.org/10.1067/mhj.2002.120769
Pan Z, Cui H, Wu N, Zhang H. Effect of statin therapy on abdominal aortic aneurysm growth rate and mortality: a systematic review and meta-analysis. Ann Vasc Surg 2020; 67:503–10. https://doi.org/10.1016/j.avsg.2020.03.036
Salata K, Syed M, Hussain MA, de Mestral C, Greco E, Mamdani M, et al. Statins reduce abdominal aortic aneurysm growth, rupture, and perioperative mortality: a systematic review and meta-analysis. J Am Heart Assoc 2018;7:e008657. https://doi.org/10.1161/jaha.118.008657
Takagi H, Yamamoto H, Iwata K, Goto S, Umemoto T. Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational comparative studies. Eur J Vasc Endovasc Surg 2012;44:287–92. https://doi.org/10.1016/j.ejvs.2012.06.021
Stein LH, Berger J, Tranquilli M, Elefteraides JA. Effect of statin drugs on thoracic aortic aneurysms. Am J Cardiol 2013;112:1240–5. https://doi.org/10.1016/j.amjcard.2013.05. 081
Jovin IS, Duggal M, Ebisu K, Paek H, Oprea AD, Tranquilli M, et al. Comparison of the effect on long-term outcomes in patients with thoracic aortic aneurysms of taking versus not taking a statin drug. Am J Cardiol 2012;109:1050–4. https://doi.org/10.1016/j.amjcard.2011.11.038
Skovbo Kristensen JS, Krasniqi L, Obel LM, Kavaliunaite E, Liisberg M, Lindholt JS. Exploring drug repurposing for treatment of abdominal aortic aneurysms: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2024;67:570–82. https://doi.org/10.1016/j.ejvs.2023.11.037
Rahman MN, Khan JA, Mazari FA, Mockford K, McCollum PT, Chetter IC. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Ann Vasc Surg 2011;25:32–8. https://doi.org/10.1016/j.avsg.2010.06.006
Periard D, Guessous I, Mazzolai L, Haesler E, Monney P, Hayoz D. Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins. Vasa 2012;41:35–42. https://doi.org/10.1024/0301-1526/a000161
Angeloni E, Vitaterna A, Pirelli M, Refice S. Effects of statin therapy on ascending aorta aneurysms growth: a propensity-matched analysis. Int J Cardiol 2015;191:52–5. https://doi.org/10.1016/j.ijcard.2015.05.001
Rowbotham SE, Krishna SM, Moran CS, Golledge J. Fenofibrate and telmisartan in the management of abdominal aortic aneurysm. Curr Drug Targets 2018;19:1241–6. https://doi.org/10.2174/1389450119666171227224655
Pinchbeck JL, Moxon JV, Rowbotham SE, Bourke M, Lazzaroni S, Morton SK, et al. Randomized placebo-controlled trial assessing the effect of 24-week fenofibrate therapy on circulating markers of abdominal aortic aneurysm: outcomes from the FAME-2 trial. J Am Heart Assoc 2018;7:e009866. https://doi.org/10.1161/JAHA.118.009866
Lamb YN. Inclisiran: first approval. Drugs 2021;81:389–95. https://doi.org/10.1007/ s40265-021-01473-6
Ray KK, Bays HE, Catapano AL, Lalwani ND, Bloedon LT, Sterling LR, et al. Safety and efficacy of bempedoic acid to reduce LDL cholesterol. N Engl J Med 2019;380: 1022–32. https://doi.org/10.1056/NEJMoa1803917
Ballantyne CM, Banach M, Mancini GBJ, Lepor NE, Hanselman JC, Zhao X, et al. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: a randomized, placebo-controlled study. Atherosclerosis 2018; 277:195–203. https://doi.org/10.1016/j.atherosclerosis.2018.06.002
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, et al. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med 2023; 388:1353–64. https://doi.org/10.1056/NEJMoa2215024
Balling M, Afzal S, Davey Smith G, Varbo A, Langsted A, Kamstrup PR, et al. Elevated LDL triglycerides and atherosclerotic risk. J Am Coll Cardiol 2023;81:136–52. https://doi.org/10.1016/j.jacc.2022.10.019
Gao JW, Hao QY, Gao M, Zhang K, Li X-Z, Wang J-F, et al. Triglyceride-glucose index in the development of peripheral artery disease: findings from the Atherosclerosis Risk in Communities (ARIC) study. Cardiovasc Diabetol 2021;20:126. https://doi.org/10.1186/s12933-021-01319-1
Britton KA, Mukamal KJ, Ix JH, Siscovick DS, Newman AB, de Boer IH, et al. Insulin resistance and incident peripheral artery disease in the cardiovascular health study. Vasc Med 2012;17:85–93. https://doi.org/10.1177/1358863X11436195
Pande RL, Perlstein TS, Beckman JA, Creager MA. Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004. Circulation 2008;118:33–41. https://doi.org/10.1161/CIRCULATIONAHA.107.721878
Wang D, Liu B, Tao W, Hao Z, Liu M. Fibrates for secondary prevention of cardiovascular disease and stroke. Cochrane Database Syst Rev 2015;10:CD009580. https://doi.org/10.1002/14651858.CD009580.pub2
Meade T, Zuhrie R, Cook C, Cooper J. Bezafibrate in men with lower extremity arterial disease: randomised controlled trial. BMJ 2002;325:1139. https://doi.org/10.1136/bmj.325.7373.1139
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 2019;380:11–22. https://doi.org/10.1056/NEJMoa1812792
Bhatt DS, Steg PG, Miller M, Brinton E, Jacobson T, Tardif J-C, et al. Abstract 10627: benefits of icosapent ethyl in patients with prior peripheral artery disease: REDUCE-IT PAD. Circulation 2021;144:A10627. https://doi.org/10.1161/circ.144.suppl_1.10627
Kobayashi Y, Fujikawa T, Haruna A, Kawano R, Ozawa M, Haze T, et al. Omega-3 fatty acids reduce remnant-like lipoprotein cholesterol and improve the ankle-brachial index of hemodialysis patients with dyslipidemia: a pilot study. Medicina (Kaunas) 2024;60:75. https://doi.org/10.3390/medicina60010075
Dopheide JF, Veit J, Ramadani H, Adam L, Papac L, Vonbank A, et al. Adherence to statin therapy favours survival of patients with symptomatic peripheral artery disease. Eur Heart J Cardiovasc Pharmacother 2021;7:263–70. https://doi.org/10.1093/ehjcvp/ pvz081
Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk). Circulation 2018;137:338–50. https://doi.org/10.1161/circulationaha.117.032235
Oyama K, Giugliano RP, Tang M, Bonaca MP, Saver JL, Murphy SA, et al. Effect of evolocumab on acute arterial events across all vascular territories: results from the FOURIER trial. Eur Heart J 2021;42:4821–9. https://doi.org/10.1093/eurheartj/ ehab604
Marx N, Federici M, Schutt K, Müller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J 2023;44:4043–140. https://doi.org/10.1093/eurheartj/ehad192
Lazzarini PA, Cramb SM, Golledge J, Morton JI, Magliano DJ, Van Netten JJ. Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century. Diabetologia 2023;66:267–87. https://doi.org/10.1007/s00125-022-05845-9
Armstrong PA. Visceral duplex scanning: evaluation before and after artery intervention for chronic mesenteric ischemia. Perspect Vasc Surg Endovasc Ther 2007;19: 386–92; discussion 393–384. https://doi.org/10.1177/1531003507311802
Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res 2015;116: 1509–26. https://doi.org/10.1161/CIRCRESAHA.116.303849
McGurnaghan SJ, McKeigue PM, Read SH, Franzen S, Svensson A-M, Colombo M, et al. Development and validation of a cardiovascular risk prediction model in type 1 diabetes. Diabetologia 2021;64:2001–11. https://doi.org/10.1007/s00125-021-05478-4
Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017;376:2367–75. https://doi.org/10.1056/NEJMra1615439
Malyar NM, Freisinger E, Meyborg M, Lüders F, Gebauer K, Reinecke H, et al. Amputations and mortality in in-hospital treated patients with peripheral artery disease and diabetic foot syndrome. J Diabetes Complications 2016;30:1117–22. https://doi.org/10.1016/j.jdiacomp.2016.03.033
Verma S, Al-Omran M, Leiter LA, Mazer CD, Rasmussen S, Saevereid HA, et al. Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease. Diabetes Obes Metab 2022;24:1288–99. https://doi.org/10.1111/dom.14700
Verma S, Mazer CD, Al-Omran M, Inzucchi SE, Fitchett D, Hehnke U, et al. Cardiovascular outcomes and safety of empagliflozin in patients with type 2 diabetes mellitus and peripheral artery disease: a subanalysis of EMPA-REG OUTCOME. Circulation 2018;137:405–7. https://doi.org/10.1161/circulationaha.117.032031
American Diabetes Association. Standards of care in diabetes–2023 abridged for primary care providers. Clin Diabetes 2022;41:4–31. https://doi.org/10.2337/cd23-as01
Sattar N, McGuire DK. Prevention of CV outcomes in antihyperglycaemic drug-naive patients with type 2 diabetes with, or at elevated risk of, ASCVD: to start or not to start with metformin. Eur Heart J 2021;42:2574–6. https://doi.org/10.1093/eurheartj/ehaa879
Mahaffey KW, Neal B, Perkovic V, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (canagliflozin cardiovascular assessment study). Circulation 2018;137:323–34. https://doi.org/10.1161/CIRCULATIONAHA.117. 032038
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 2017;377:644–57. https://doi.org/10.1056/NEJMoa1611925
Goldenberg RM, Cheng AYY, Fitzpatrick T, Gilbert JD, Verma S, Hopyan JJ. Benefits of GLP-1 (glucagon-like peptide 1) receptor agonists for stroke reduction in type 2 diabetes: a call to action for neurologists. Stroke 2022;53:1813–22. https://doi.org/10.1161/STROKEAHA.121.038151
Malhotra K, Katsanos AH, Lambadiari V, Goyal N, Palaiodimou L, Kosmidou M, et al. GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis. J Neurol 2020;267:2117–22. https://doi.org/10.1007/s00415-020-09813-4
Tsai WH, Chuang SM, Liu SC, Lee C-C, Chien M-N, Leung C-H, et al. Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis. Sci Rep 2021;11:15364. https://doi.org/10.1038/ s41598-021-94945-4
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854–65 .
Kooy A, de Jager J, Lehert P, Bets D, Wulffelé MG, Donker AJM, et al. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med 2009;169:616–25. https://doi.org/10.1001/archinternmed.2009.20
Tan S, Goudot G, Arnoux A, Tran Y, Maissoro H, Poenou G, et al. Occurrence of major local lower limb events in type 2 diabetic patients with lower extremity arterial disease: impact of metformin. Ann Vasc Surg 2023;90:153–61. https://doi.org/10.1016/j.avsg.2022.09.064
Ferrannini G, Gerstein H, Colhoun HM, Dagenais GR, Diaz R, Dyal L, et al. Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin. Eur Heart J 2021;42:2565–73. https://doi.org/10.1093/eurheartj/ehaa777
Zoungas S, Arima H, Gerstein HC, Holman RR, Woodward M, Reaven P, et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol 2017;5:431–7. https://doi.org/10.1016/S2213-8587(17) 30104-3
Group AC, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560–72. https://doi.org/10.1056/NEJMoa0802987
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53. https://doi.org/10.1016/S0140-6736(98)07019-6
Diabetes Control and Complications Trial Research Group; Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86. https://doi.org/10.1056/ NEJM199309303291401
McGuire DK, Shih WJ, Cosentino F, Charbonnel B, Cherney DZI, Dagogo-Jack S, et al. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis. JAMA Cardiol 2021;6:148–58. https://doi.org/10.1001/jamacardio.2020.4511
Bhatt DL, Szarek M, Steg PG, Cannon CP, Leiter LA, McGuire DK, et al. Sotagliflozin in patients with diabetes and recent worsening heart failure. N Engl J Med 2021;384: 117–28. https://doi.org/10.1056/NEJMoa2030183
Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, et al. Sotagliflozin in patients with diabetes and chronic kidney disease. N Engl J Med 2021;384:129–39. https://doi.org/10.1056/NEJMoa2030186
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2019;380:347–57. https://doi.org/10.1056/NEJMoa1812389
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015;373: 2117–28. https://doi.org/10.1056/NEJMoa1504720
Sattar N, Lee MMY, Kristensen SL, Branch KRH, Del Prato S, Khurmi NS, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol 2021;9:653–62. https://doi.org/10.1016/S2213-8587(21) 00203-5
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, et al. Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes. N Engl J Med 2021;385:896–907. https://doi.org/10.1056/NEJMoa2108269
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet 2019;394:121–30. https://doi.org/10.1016/S0140-6736(19)31149-3
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2016;375: 311–22. https://doi.org/10.1056/NEJMoa1603827
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 2016; 375:1834–44. https://doi.org/10.1056/NEJMoa1607141
International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol 2019;7:385–96. https://doi.org/10.1016/S2213-8587(18)30315-2
Zoungas S, Chalmers J, Ninomiya T, Li Q, Cooper ME, Colagiuri S, et al. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia 2012;55:636–43. https://doi.org/10.1007/s00125-011-2404-1
Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 2010; 375:481–9. https://doi.org/10.1016/S0140-6736(09)61969-3
Control G, Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009;52:2288–98. https://doi.org/10.1007/s00125-009-1470-0
Caturano A, Galiero R, Pafundi PC, Cesaro A, Vetrano E, Palmiero G, et al. Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence. Diabetes Res Clin Pract 2021;178:108959. https://doi.org/10.1016/j.diabres.2021.108959
Soehnlein O, Libby P. Targeting inflammation in atherosclerosis—from experimental insights to the clinic. Nat Rev Drug Discov 2021;20:589–610. https://doi.org/10.1038/ s41573-021-00198-1
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017;377:1119–31. https://doi.org/10.1056/NEJMoa1707914
Samuel M, Tardif JC, Bouabdallaoui N, Khairy P, Dubé M-P, Blondeau L, et al. Colchicine for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Can J Cardiol 2021;37:776–85. https://doi.org/10.1016/j.cjca.2020.10.006
Antonopoulos AS, Papanikolaou E, Vogiatzi G, Oikonomou E, Tousoulis D. Anti-inflammatory agents in peripheral arterial disease. Curr Opin Pharmacol 2018; 39:1–8. https://doi.org/10.1016/j.coph.2017.11.001
Mills JL, Sr, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, et al. The Society for Vascular Surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014;59:220–34.e1–2. https://doi.org/10.1016/j.jvs.2013.08.003
Fowkes FG, Aboyans V, Fowkes FJ, McDermott MM, Sampson UKA, Criqui MH, Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol 2017;14:156–70. https://doi.org/10.1038/nrcardio.2016.179
Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009;120:2053–61. https://doi.org/10.1161/circulationaha.109.865600
McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001;286:1599–606. https://doi.org/10.1001/jama.286.13.1599
Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007;45:1185–91. https://doi.org/10.1016/j.jvs.2007.02.004
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007;33:S1–75. https://doi.org/10.1016/j.ejvs.2006.09.024
Buso G, Aboyans V, Mazzolai L. Lower extremity artery disease in patients with type 2 diabetes. Eur J Prev Cardiol 2019;26:114–24. https://doi.org/10.1177/20474873198 80044
Porras CP, Bots ML, Teraa M, van Doorn S, Vernooij RWM. Differences in symptom presentation in women and men with confirmed lower limb peripheral artery disease: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2022;63:602–12. https://doi.org/10.1016/j.ejvs.2021.12.039
Fereydooni A, Gorecka J, Dardik A. Using the epidemiology of critical limb ischemia to estimate the number of patients amenable to endovascular therapy. Vasc Med 2020; 25:78–87. https://doi.org/10.1177/1358863X19878271
Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg 2019;58:S1–109.e33. https://doi.org/10.1016/j.ejvs.2019.05.006
Sigvant B, Lundin F, Wahlberg E. The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg 2016;51:395–403. https://doi.org/10.1016/j.ejvs.2015.10.022
Hageman SHJ, de Borst GJ, Dorresteijn JAN, Bots ML, Westerink J, Asselbergs FW, et al. Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease. Heart 2020;106:1686–92. https://doi.org/10.1136/heartjnl-2019-316088
Anand SS, Caron F, Eikelboom JW, Bosch J, Dyal L, Aboyans V, et al. Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial. J Am Coll Cardiol 2018;71:2306–15. https://doi.org/10.1016/j.jacc.2018.03.008
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 2017;377:1319–30. https://doi.org/10.1056/NEJMoa1709118
Agnelli G, Belch JJF, Baumgartner I, Giovas P, Hoffmann U. Morbidity and mortality associated with atherosclerotic peripheral artery disease: a systematic review. Atherosclerosis 2020;293:94–100. https://doi.org/10.1016/j.atherosclerosis.2019.09.012
Wijnand JGJ, van Koeverden ID, Teraa M, Spreen MI, Mali WPTM, van Overhagen H, et al. Validation of randomized controlled trial-derived models for the prediction of postintervention outcomes in chronic limb-threatening ischemia. J Vasc Surg 2020; 71:869–79. https://doi.org/10.1016/j.jvs.2019.06.195
Jaramillo EA, Smith EJT, Matthay ZA, Sanders KM, Hiramoto JS, Gasper WJ, et al. Racial and ethnic disparities in major adverse limb events persist for chronic limb threatening ischemia despite presenting limb threat severity after peripheral vascular intervention. J Vasc Surg 2023;77:848–57.e2. https://doi.org/10.1016/j.jvs.2022.10.043
Brizuela Sanz JA, Gonzalez Fajardo JA, Taylor JH, Río Solá L, Muñoz Moreno MF, Vaquero Puerta C, et al. Design of a new risk score in critical limb ischaemia: the ERICVA model. Eur J Vasc Endovasc Surg 2016;51:90–9. https://doi.org/10.1016/j.ejvs.2015.09.025
Kreutzburg T, Peters F, Kuchenbecker J, Marschall U, Lee R, Kriston L, et al. Editor’s choice—the GermanVasc score: a pragmatic risk score predicts five year amputation free survival in patients with peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg 2021;61:248–56. https://doi.org/10.1016/j.ejvs.2020.11.013
Niazi K, Khan TH, Easley KA. Diagnostic utility of the two methods of ankle brachial index in the detection of peripheral arterial disease of lower extremities. Catheter Cardiovasc Interv 2006;68:788–92. https://doi.org/10.1002/ccd.20906
Crawford F, Welch K, Andras A, Chappell FM. Ankle brachial index for the diagnosis of lower limb peripheral arterial disease. Cochrane Database Syst Rev 2016;9:CD010680. https://doi.org/10.1002/14651858.CD010680.pub2
Aday AW, Kinlay S, Gerhard-Herman MD. Comparison of different exercise ankle pressure indices in the diagnosis of peripheral artery disease. Vasc Med 2018;23: 541–8. https://doi.org/10.1177/1358863X18781723
Tehan PE, Barwick AL, Sebastian M, Chuter VH. Diagnostic accuracy of the postexercise ankle-brachial index for detecting peripheral artery disease in suspected claudicants with and without diabetes. Vasc Med 2018;23:116–25. https://doi.org/10.1177/ 1358863X17751259
Manu CA, Freedman B, Rashid H, Winkley K, Edmonds ME. Peripheral arterial disease located in the feet of patients with diabetes and foot ulceration demands a new approach to the assessment of ischemia. Int J Low Extrem Wounds 2022;21:397–404. https://doi.org/10.1177/1534734620947979
Salaun P, Desormais I, Lapébie FX, Rivière AB, Aboyans V, Lacroix P, et al. Comparison of ankle pressure, systolic toe pressure, and transcutaneous oxygen pressure to predict major amputation after 1 year in the copart cohort. Angiology 2019;70:229–36. https://doi.org/10.1177/0003319718793566
Fowkes FG, Murray GD, Butcher I, Folsom AR, Hirsch AT, Couper DJ, et al. Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. Eur J Prev Cardiol 2014;21:310–20. https://doi.org/10.1177/ 2047487313516564
Wang FM, Yang C, Ballew SH, Kalbaugh CA, Meyer ML, Tanaka H, et al. Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2021; 336:39–47. https://doi.org/10.1016/j.atherosclerosis.2021.09.028
Cull DL, Manos G, Hartley MC, Taylor SM, Langan EM, Eidt JF, et al. An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system. J Vasc Surg 2014;60:1535–42. https://doi.org/10.1016/j.jvs.2014.08.107
Liette MD, Crisologo PA, Masadeh S, Yang SH, Bergmann CB, Caldwell CC, et al. A prospective analysis of the SVS WIfI classification system to stratify immediate and 1-year patient outcomes. J Foot Ankle Surg 2023;62:661–5. https://doi.org/10.1053/j.jfas.2023.02.003
van Reijen NS, Ponchant K, Ubbink DT, Koelemay MJW. Editor’s choice—the prognostic value of the WIfI classification in patients with chronic limb threatening ischaemia: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2019;58:362–71. https://doi.org/10.1016/j.ejvs.2019.03.040
Eiberg JP, Gronvall Rasmussen JB, Hansen MA, Schroeder TV. Duplex ultrasound scanning of peripheral arterial disease of the lower limb. Eur J Vasc Endovasc Surg 2010;40: 507–12. https://doi.org/10.1016/j.ejvs.2010.06.002
Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 2009;301:415–24. https://doi.org/10.1001/jama.301.4.415
Itoga NK, Kim T, Sailer AM, Fleischmann D, Mell MW. Lower extremity computed tomography angiography can help predict technical success of endovascular revascularization in the superficial femoral and popliteal artery. J Vasc Surg 2017;66:835–43.e1. https://doi.org/10.1016/j.jvs.2017.02.031
Selvin E, Hirsch AT. Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999–2004. Atherosclerosis 2008; 201:425–33. https://doi.org/10.1016/j.atherosclerosis.2008.02.002
Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation 2011;124:17–23. https://doi.org/10.1161/circulationaha.110.003954
Krishnamurthy V, Munir K, Rectenwald JE, Mansour A, Hans S, Eliason JL, et al. Contemporary outcomes with percutaneous vascular interventions for peripheral critical limb ischemia in those with and without poly-vascular disease. Vasc Med 2014;19:491–9. https://doi.org/10.1177/1358863x14552013
Penin-Grandes S, Lopez-Ortiz S, Maroto-Izquierdo S, Menéndez H, Pinto-Fraga J, Martín-Hernández J, et al. Winners do what they fear: exercise and peripheral arterial disease–an umbrella review. Eur J Prev Cardiol 2024;31:380–388. https://doi.org/10.1093/eurjpc/zwad261
Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995;274:975–80.
Parmenter BJ, Raymond J, Dinnen P, Singh MA. A systematic review of randomized controlled trials: walking versus alternative exercise prescription as treatment for intermittent claudication. Atherosclerosis 2011;218:1–12. https://doi.org/10.1016/j.atherosclerosis.2011.04.024
Fakhry F, van de Luijtgaarden KM, Bax L, den Hoed PT, Hunink MGGM, Rouwet EV, et al. Supervised walking therapy in patients with intermittent claudication. J Vasc Surg 2012;56:1132–42. https://doi.org/10.1016/j.jvs.2012.04.046
Parmenter BJ, Dieberg G, Smart NA. Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sports Med 2015;45:231–44. https://doi.org/10.1007/s40279-014-0261-z
Lane R, Harwood A, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev 2017;12:CD000990. https://doi.org/10.1002/14651858.CD000990.pub4
Parmenter BJ, Mavros Y, Ritti Dias R, King S, Fiatarone Singh M. Resistance training as a treatment for older persons with peripheral artery disease: a systematic review and meta-analysis. Br J Sports Med 2020;54:452–61. https://doi.org/10.1136/bjsports-2018-100205
Perks J, Zaccardi F, Paterson C, Houghton JSM, Nickinson ATO, Pepper CJ, et al. Effect of high-pain versus low-pain structured exercise on walking ability in people with intermittent claudication: meta-analysis. Br J Surg 2022;109:686–94. https://doi.org/10.1093/bjs/znac134
Guidon M, McGee H. Exercise-based interventions and health-related quality of life in intermittent claudication: a 20-year (1989–2008) review. Eur J Cardiovasc Prev Rehabil 2010;17:140–54. https://doi.org/10.1097/HJR.0b013e3283377f08
Parmenter BJ, Dieberg G, Phipps G, Smart NA. Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med 2015;20:30–40. https://doi.org/10.1177/1358863x14559092
Gommans LN, Fokkenrood HJ, van Dalen HC, Scheltinga MRM, Teijink JAW, Peters RJG. Safety of supervised exercise therapy in patients with intermittent claudication. J Vasc Surg 2015;61:512–8.e2. https://doi.org/10.1016/j.jvs.2014.08.070
Harwood AE, Pymer S, Ibeggazene S, Ingle L, Caldow E, Birkett ST. Provision of exercise services in patients with peripheral artery disease in the United Kingdom. Vascular 2022;30:874–81. https://doi.org/10.1177/17085381211035259
Lanzi S, Belch J, Brodmann M, Madaric J, Bura-Riviere A, Visonà A, et al. Supervised exercise training in patients with lower extremity peripheral artery disease. Vasa 2022; 51:267–74. https://doi.org/10.1024/0301-1526/a001024
Gommans LN, Saarloos R, Scheltinga MR, Houterman S, de Bie RA, Fokkenrood HJP, et al. Editor’s choice—the effect of supervision on walking distance in patients with intermittent claudication: a meta-analysis. Eur J Vasc Endovasc Surg 2014;48:169–84. https://doi.org/10.1016/j.ejvs.2014.04.019
Vemulapalli S, Dolor RJ, Hasselblad V, Schmit K, Banks A, Heidenfelder B, et al. Supervised vs unsupervised exercise for intermittent claudication: a systematic review and meta-analysis. Am Heart J 2015;169:924–37.e3. https://doi.org/10.1016/j.ahj.2015.03.009
Hageman D, Fokkenrood HJ, Gommans LN, van den Houten MM, Teijink JA. Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication. Cochrane Database Syst Rev 2018;4:CD005263. https://doi.org/10.1002/14651858.CD005263.pub4
Pymer S, Ibeggazene S, Palmer J, Tew GA, Ingle L, Smith GE, et al. An updated systematic review and meta-analysis of home-based exercise programs for individuals with intermittent claudication. J Vasc Surg 2021;74:2076–85.e20. https://doi.org/10.1016/j.jvs.2021.03.063
Waddell A, Seed S, Broom DR, McGregor G, Birkett ST, Harwood AE. Safety of home-based exercise for people with intermittent claudication: a systematic review. Vasc Med 2022;27:186–92. https://doi.org/10.1177/1358863x211060388
Golledge J, Singh TP, Alahakoon C, Pinchbeck J, Yip L, Moxon JV, et al. Meta-analysis of clinical trials examining the benefit of structured home exercise in patients with peripheral artery disease. Br J Surg 2019;106:319–31. https://doi.org/10.1002/bjs.11101
Bulmer AC, Coombes JS. Optimising exercise training in peripheral arterial disease. Sports Med 2004;34:983–1003. https://doi.org/10.2165/00007256-200434140-00004
Ehrman JK, Gardner AW, Salisbury D, Lui K, Treat-Jacobson D. Supervised exercise therapy for symptomatic peripheral artery disease: a review of current experience and practice-based recommendations. J Cardiopulm Rehabil Prev 2023;43:15–21. https://doi.org/10.1097/hcr.0000000000000723
McDermott MM, Spring B, Tian L, Treat-Jacobson D, Ferrucci L, Lloyd-Jones D, et al. Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial. JAMA 2021; 325:1266–76. https://doi.org/10.1001/jama.2021.2536
Jansen SC, Abaraogu UO, Lauret GJ, Fakhry F, Fokkenrood HJP, Teijink JAW. Modes of exercise training for intermittent claudication. Cochrane Database Syst Rev 2020;8: CD009638. https://doi.org/10.1002/14651858.CD009638.pub3
Gardner AW, Parker DE, Montgomery PS, Blevins SM. Diabetic women are poor responders to exercise rehabilitation in the treatment of claudication. J Vasc Surg 2014; 59:1036–43. https://doi.org/10.1016/j.jvs.2013.10.058
Gommans LN, Scheltinga MR, van Sambeek MR, Maas AHEM, Bendermacher BLW, Teijink JAW. Gender differences following supervised exercise therapy in patients with intermittent claudication. J Vasc Surg 2015;62:681–8. https://doi.org/10.1016/j.jvs.2015.03.076
Dipnarine K, Barak S, Martinez CA, Carmeli E, Stopka CB. Pain-free treadmill exercise for patients with intermittent claudication: are there gender differences? Vascular 2016; 24:304–14. https://doi.org/10.1177/1708538115592800
Gardner AW, Parker DE, Montgomery PS. Sex-specific predictors of improved walking with step-monitored, home-based exercise in peripheral artery disease. Vasc Med 2015;20:424–31. https://doi.org/10.1177/1358863x15596237
Ney B, Lanzi S, Calanca L, Mazzolai L. Multimodal supervised exercise training is effective in improving long term walking performance in patients with symptomatic lower extremity peripheral artery disease. J Clin Med 2021;10:2057.https://doi.org/10.3390/ jcm10102057
Lanzi S, Pousaz A, Calanca L, Mazzolai L. Sex-based differences in supervised exercise therapy outcomes for symptomatic peripheral artery disease. Vasc Med 2023;28: 147–9. https://doi.org/10.1177/1358863x221149454
Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JAW, Hoffmann WH, et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA 2015;314:1936–44. https://doi.org/10.1001/jama.2015.14851
Pandey A, Banerjee S, Ngo C, Mody P, Marso SP, Brilakis ES, et al. Comparative efficacy of endovascular revascularization versus supervised exercise training in patients with intermittent claudication: meta-analysis of randomized controlled trials. JACC Cardiovasc Interv 2017;10:712–24. https://doi.org/10.1016/j.jcin.2017.01.027
Dorn A, Dorweiler B, Ahmad W, Mylonas S, Becker I, Majd P. Low and high ankle-brachial index are both associated with mortality in German nursing home residents–the five-year follow-up of the ‘allo-study’ Cohort. J Clin Med 2023;12:4411. https://doi.org/10.3390/jcm12134411
Fowkes FG, Price JF, Stewart MC, Butcher I, Leng GC, Pell AC, et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA 2010;303:841–8. https://doi.org/10.1001/jama.2010.221
Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008;337:a1840. https://doi.org/10.1136/bmj. a1840
Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J, et al. Effects of aspirin for primary prevention in persons with diabetes mellitus. N Engl J Med 2018; 379:1529–39. https://doi.org/10.1056/NEJMoa1804988
Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71–86. https://doi.org/10.1136/bmj.324.7329.71
De Carlo M, Di Minno G, Sayre T, Fazeli MS, Siliman G, Cimminiello C. Efficacy and safety of antiplatelet therapies in symptomatic peripheral artery disease: a systematic review and network meta-analysis. Curr Vasc Pharmacol 2021;19:542–55. https://doi.org/10.2174/1570161118666200820141131
Willems LH, Maas D, Kramers K, Reijnen MMPJ, Riksen NP, Ten Cate H, et al. Antithrombotic therapy for symptomatic peripheral arterial disease: a systematic review and network meta-analysis. Drugs 2022;82:1287–302. https://doi.org/10.1007/ s40265-022-01756-6
Katsanos K, Spiliopoulos S, Saha P, Diamantopoulos A, Karunanithy N, Krokidis M, et al. Comparative efficacy and safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: a systematic review and network meta-analysis. PLoS One 2015;10:e0135692. https://doi.org/10.1371/journal.pone.0135692
Basili S, Raparelli V, Vestri A, Di Tanna GL, Violi F. Comparison of efficacy of antiplatelet treatments for patients with claudication. A meta-analysis. Thromb Haemost 2010; 103:766–73. https://doi.org/10.1160/th09-09-0635
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329–39. https://doi.org/10.1016/s0140-6736(96)09457-3
Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA 2009;301:1909–19. https://doi.org/10.1001/jama.2009.623
Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med 2017;376: 32–40. https://doi.org/10.1056/NEJMoa1611688
Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706–17. https://doi.org/10.1056/NEJMoa060989
Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 2007;49:1982–8. https://doi.org/10.1016/j.jacc.2007.03.025
Kaplovitch E, Eikelboom JW, Dyal L, Aboyans V, Abola MT, Verhamme P, et al. Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial. JAMA Cardiol 2021;6:21–9. https://doi.org/10.1001/jamacardio.2020.4390
Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet 2018;391: 219–29. https://doi.org/10.1016/s0140-6736(17)32409-1
Strobl FF, Brechtel K, Schmehl J, Zeller T, Reiser MF, Claussen CD, et al. Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease. J Endovasc Ther 2013;20: 699–706. https://doi.org/10.1583/13-4275mr.1
Tsai SY, Li YS, Lee CH, Cha S-W, Wang Y-C, Su T-W, et al. Mono or dual antiplatelet therapy for treating patients with peripheral artery disease after lower extremity revascularization: a systematic review and meta-analysis. Pharmaceuticals (Basel) 2022; 15:596. https://doi.org/10.3390/ph15050596
Thott O, Granath F, Malmstedt J, Wahlgren CM. Editor’s choice—dual antiplatelet therapy improves outcome in diabetic patients undergoing endovascular femoropopliteal stenting for critical limb ischaemia. Eur J Vasc Endovasc Surg 2017;53:403–10. https://doi.org/10.1016/j.ejvs.2016.12.014
Cho S, Lee YJ, Ko YG, Kang TS, Lim S-H, Hong S-J, et al. Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease. JACC Cardiovasc Interv 2019;12:2359–70. https://doi.org/10.1016/j.jcin.2019.08. 006
Ipema J, Welling RHA, Bakker OJ, Bokkers RPH, de Vries J-PPM, Ünlü Ç. Short-term clinical outcomes of single versus dual antiplatelet therapy after infrainguinal endovascular treatment for peripheral arterial disease. J Clin Med 2020;9:3515. https://doi.org/10.3390/jcm9113515
Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med 2020; 382:1994–2004. https://doi.org/10.1056/NEJMoa2000052
Hiatt WR, Bonaca MP, Patel MR, Nehler MR, Debus ES, Anand SS, et al. Rivaroxaban and aspirin in peripheral artery disease lower extremity revascularization: impact of concomitant clopidogrel on efficacy and safety. Circulation 2020;142:2219–30. https://doi.org/10.1161/circulationaha.120.050465
Duff S, Mafilios MS, Bhounsule P, Hasegawa JT. The burden of critical limb ischemia: a review of recent literature. Vasc Health Risk Manag 2019;15:187–208. https://doi.org/10.2147/VHRM.S209241
Sarac TP, Huber TS, Back MR, Ozaki CK, Carlton LM, Flynn TC, et al. Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. J Vasc Surg 1998;28:446–57. https://doi.org/10.1016/s0741-5214(98)70130-2
Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (the Dutch bypass oral anticoagulants or aspirin study): a randomised trial. Lancet 2000;355:346–51. https://doi.org/10.1016/S0140-6736(99)07199-8
Belch JJ, Dormandy J, Biasi GM, Cairols M, Diehm C, Eikelboom B, et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 2010;52:825–33.e2. https://doi.org/10.1016/j.jvs.2010.04.027
Brumberg RS, Back MR, Armstrong PA, Cuthbertson D, Shames ML, Johnson BL, et al. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure. J Vasc Surg 2007;46:1160–6. https://doi.org/10.1016/j.jvs.2007.07. 046
Van Gelder IC, Kotecha D, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, et al. 2024 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2024. https://doi.org/10.1093/eurheartj/ehae176
Spiliopoulos S, Pastromas G, Katsanos K, Kitrou P, Karnabatidis D, Siablis D. Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: the PRECLOP study: clinical impact and optimal cutoff value of on-treatment high platelet reactivity. J Am Coll Cardiol 2013;61:2428–34. https://doi.org/10.1016/j.jacc.2013.03.036
Busch L, Stern M, Dannenberg L, Mourikis P, Gröne M, Özaslan G, et al. Impact of high on-treatment platelet reactivity after angioplasty in patients with peripheral arterial disease. Platelets 2021;32:391–7. https://doi.org/10.1080/09537104.2020.1742314
Cosmi B, Conti E, Coccheri S. Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication. Cochrane Database Syst Rev 2014;5:CD001999. https://doi.org/10.1002/14651858.CD001999.pub2
Bagger JP, Helligsoe P, Randsbaek F, Kimose HH, Jensen BS. Effect of verapamil in intermittent claudication. A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment. Circulation 1997;95:411–4. https://doi.org/10.1161/01.cir.95.2.411
Gargiulo G, Giugliano G, Brevetti L, Sannino A, Schiattarella GG, Serino F, et al. Use of statins in lower extremity artery disease: a review. BMC Surg 2012;12:S15. https://doi.org/10.1186/1471-2482-12-s1-s15
McDermott MM, Guralnik JM, Greenland P, Pearce WH, Criqui MH, Liu K, et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation 2003;107:757–61. https://doi.org/10.1161/01.cir.0000050380.64025.07
Robertson L, Andras A. Prostanoids for intermittent claudication. Cochrane Database Syst Rev 2013;4:CD000986. https://doi.org/10.1002/14651858.CD000986.pub3
Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, et al. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication. Br J Surg 2012;99:1630–8. https://doi.org/10.1002/bjs.8895
Bedenis R, Stewart M, Cleanthis M, Robless P, Mikhailidis DP, Stansby G. Cilostazol for intermittent claudication. Cochrane Database Syst Rev 2014;10:CD003748. https://doi.org/10.1002/14651858.CD003748.pub4
Hiatt WR, Money SR, Brass EP. Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (cilostazol: a study in long-term effects). J Vasc Surg 2008;47:330–6. https://doi.org/10.1016/j.jvs.2007.10.009
Iida O, Yokoi H, Soga Y, Inoue N, Suzuki K, Yokoi Y, et al. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the sufficient treatment of peripheral intervention by cilostazol study. Circulation 2013;127: 2307–15. https://doi.org/10.1161/circulationaha.112.000711
de Backer TL, Vander Stichele R, Lehert P, Van Bortel L. Naftidrofuryl for intermittent claudication. Cochrane Database Syst Rev 2012;12:Cd001368. https://doi.org/10.1002/14651858.CD001368.pub4
Boccalon H, Lehert P, Mosnier M. Effect of naftidrofuryl on physiological walking distance in patients with intermittent claudication. Ann Cardiol Angeiol 2001;50:175–82. https://doi.org/10.1016/s0003-3928(01)00016-6
Broderick C, Forster R, Abdel-Hadi M, Salhiyyah K. Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev 2020;10:Cd005262. https://doi.org/10.1002/14651858.CD005262.pub4
Nicolaï SP, Kruidenier LM, Bendermacher BL, Prins MH, Stokmans RA, Broos PPHL, et al. Ginkgo biloba for intermittent claudication. Cochrane Database Syst Rev 2013; 6:Cd006888. https://doi.org/10.1002/14651858.CD006888.pub3
Premaratne S, Newman J, Hobbs S, Garnham A, Wall M. Meta-analysis of direct surgical versus endovascular revascularization for aortoiliac occlusive disease. J Vasc Surg 2020;72:726–37. https://doi.org/10.1016/j.jvs.2019.12.035
Aboyans V, Björck M, Brodmann M, Collet J-P, Czerny M, De Carlo M, et al. Questions and answers on diagnosis and management of patients with peripheral arterial diseases: a companion document of the 2017 ESC Guidelines for the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO), The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018;39:e35–41. https://doi.org/10.1093/eurheartj/ehx499
McQuade K, Gable D, Pearl G, Theune B, Black S. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2010;52:584–91.e7. https://doi.org/10.1016/j.jvs.2010.03.071
Bosiers M, Deloose K, Callaert J, Moreels N, Keirse K, Verbist J, et al. Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions. J Vasc Surg 2011;54:1042–50. https://doi.org/10.1016/j.jvs.2011.03.272
Farhan S, Enzmann FK, Bjorkman P, Kamran H, Zhang Z, Sartori S, et al. Revascularization strategies for patients with femoropopliteal peripheral artery disease. J Am Coll Cardiol 2023;81:358–70. https://doi.org/10.1016/j.jacc.2022.10.036
Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2018;7:e011245. https://doi.org/10.1161/jaha.118.011245
Ouriel K, Adelman MA, Rosenfield K, Scheinert D, Brodmann M, Peña C, et al. Safety of paclitaxel-coated balloon angioplasty for femoropopliteal peripheral artery disease. JACC Cardiovasc Interv 2019;12:2515–24. https://doi.org/10.1016/j.jcin.2019.08.025
Freisinger E, Koeppe J, Gerss J, Goerlich D, Malyar NM, Marschall U, et al. Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis. Eur Heart J 2020;41:3732–9. https://doi.org/10.1093/eurheartj/ehz698
Lyden SP, Brodmann M, Parikh SA, Krishnan P, Schroeder H, Werner M, et al. Four-year patient-level pooled mortality analysis of the ILLUMENATE US pivotal and EU randomized controlled trials. J Vasc Surg 2022;75:600–7. https://doi.org/10.1016/j.jvs.2021.07.244
Secemsky EA, Song Y, Schermerhorn M, Yeh RW. Update from the longitudinal assessment of safety of femoropopliteal endovascular treatment with paclitaxel-coated devices among medicare beneficiaries: the SAFE-PAD study. Circ Cardiovasc Interv 2022;15:e012074. https://doi.org/10.1161/circinterventions.122.012074
Nordanstig J, James S, Andersson M, Andersson M, Danielsson P, Gillgren P, et al. Mortality with paclitaxel-coated devices in peripheral artery disease. N Engl J Med 2020;383:2538–46. https://doi.org/10.1056/NEJMoa2005206
Fashandi AZ, Mehaffey JH, Hawkins RB, Kron IL, Upchurch GR, Robinson WP. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication. J Vasc Surg 2018;68:1817–23. https://doi.org/10.1016/j.jvs.2018.06.193
Koelemay MJW, van Reijen NS, van Dieren S, Frans FA, Vermeulen EJG, Buscher HCJL, et al. Editor’s choice—randomised clinical trial of supervised exercise therapy vs. endovascular revascularisation for intermittent claudication caused by iliac artery obstruction: the SUPER study. Eur J Vasc Endovasc Surg 2022;63:421–9. https://doi.org/10.1016/j.ejvs.2021.09.042
Dormandy J, Mahir M, Ascady G, Balsano F, De Leeuw P, Blombery P, et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg (Torino) 1989;30: 50–7.
Jelnes R, Gaardsting O, Hougaard Jensen K, Baekgaard N, Tonnesen KH, Schroeder T. Fate in intermittent claudication: outcome and risk factors. BMJ 1986;293:1137–40. https://doi.org/10.1136/bmj.293.6555.1137
Leng GC, Lee AJ, Fowkes FG, Whiteman M, Dunbar J, Housley E, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996;25:1172–81. https://doi.org/10.1093/ije/25.6.1172
Bloor K. Natural history of arteriosclerosis of the lower extremities: Hunterian lecture delivered at the Royal College of Surgeons of England on 22nd April 1960. Ann R Coll Surg Engl 1961;28:36–52.
Goode SD, Cleveland TJ, Gaines PA, Collaborators S. Randomized clinical trial of stents versus angioplasty for the treatment of iliac artery occlusions (STAG trial). Br J Surg 2013;100:1148–53. https://doi.org/10.1002/bjs.9197
Hajibandeh S, Hajibandeh S, Antoniou SA, Torella F, Antoniou GA. Covered vs uncovered stents for aortoiliac and femoropopliteal arterial disease: a systematic review and meta-analysis. J Endovasc Ther 2016;23:442–52. https://doi.org/10.1177/ 1526602816643834
Krankenberg H, Zeller T, Ingwersen M, Schmalstieg J, Gissler HM, Nikol S, et al. Self-expanding versus balloon-expandable stents for iliac artery occlusive disease: the randomized ICE trial. JACC Cardiovasc Interv 2017;10:1694–704. https://doi.org/10.1016/j.jcin.2017.05.015
Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997;204:87–96. https://doi.org/10.1148/radiology.204.1.9205227
Committee TS, Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II). J Endovasc Ther 2015;22: 663–77. https://doi.org/10.1177/1526602815592206
Boc V, Kozak M, Erzen B, Božič Mijovski M, Boc A, Blinc A. Prognostic factors for restenosis of superficial femoral artery after endovascular treatment. J Clin Med 2023;12: 6343. https://doi.org/10.3390/jcm12196343
Alves-Cabratosa L, Comas-Cufi M, Ponjoan A, Garcia-Gil M, Martí-Lluch R, Blanch J, et al. Levels of ankle-brachial index and the risk of diabetes mellitus complications. BMJ Open Diabetes Res Care 2020;8:e000977. https://doi.org/10.1136/bmjdrc-2019-000977
Heiss C, Olinic DM, Belch JJF, Brodmann M, Mazzolai L, Stanek A, et al. Management of chronic peripheral artery disease patients with indication for endovascular revascularization. Vasa 2022;51:121–37. https://doi.org/10.1024/0301-1526/a000998
Hajibandeh S, Hajibandeh S, Shah S, Child E, Antoniou GA, Torella F. Prognostic significance of ankle brachial pressure index: a systematic review and meta-analysis. Vascular 2017;25:208–24. https://doi.org/10.1177/1708538116658392
Meza-Torres B, Cunningham SG, Heiss C, Joy M, Feher M, Leese GP, et al. Adherence to general diabetes and foot care processes, with prompt referral, are associated with amputation-free survival in people with type 2 diabetes and foot ulcers: a Scottish national registry analysis. J Diabetes Res 2022;2022:7414258. https://doi.org/10.1155/2022/7414258
Shishehbor MH, White CJ, Gray BH, Menard MT, Lookstein R, Rosenfield K, et al. Critical limb ischemia: an expert statement. J Am Coll Cardiol 2016;68:2002–15. https://doi.org/10.1016/j.jacc.2016.04.071
Misra S, Shishehbor MH, Takahashi EA, Aronow HD, Brewster LP, Bunte MC, et al. Perfusion assessment in critical limb ischemia: principles for understanding and the development of evidence and evaluation of devices: a scientific statement from the American Heart Association. Circulation 2019;140:e657–72. https://doi.org/10.1161/cir.0000000000000708
Sukul D, Grey SF, Henke PK, Gurm HS, Grossman PM. Heterogeneity of ankle-brachial indices in patients undergoing revascularization for critical limb ischemia. JACC Cardiovasc Interv 2017;10:2307–16. https://doi.org/10.1016/j.jcin.2017.08.026
Shishehbor MH, Hammad TA, Zeller T, Baumgartner I, Scheinert D, Rocha-Singh KJ. An analysis of IN.PACT DEEP randomized trial on the limitations of the societal guidelines–recommended hemodynamic parameters to diagnose critical limb ischemia. J Vasc Surg 2016;63:1311–7. https://doi.org/10.1016/j.jvs.2015.11.042
Randhawa MS, Reed GW, Grafmiller K, Gornik HL, Shishehbor MH. Prevalence of tibial artery and pedal arch patency by angiography in patients with critical limb ischemia and noncompressible ankle brachial index. Circ Cardiovasc Interv 2017;10:e004605. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004605
Mustapha JA, Saab FA, Martinsen BJ, Pena CS, Zeller T, Driver VR, et al. Digital subtraction angiography prior to an amputation for critical limb ischemia (CLI): an expert recommendation statement from the CLI global society to optimize limb salvage. J Endovasc Ther 2020;27:540–6. https://doi.org/10.1177/1526602820928590
Menke J, Larsen J. Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease. Ann Intern Med 2010;153:325–34. https://doi.org/10.7326/0003-4819-153-5-201009070-00007
Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Luders F, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J 2015;36:932–8. https://doi.org/10.1093/eurheartj/ehv006
Hess CN, Wang TY, Weleski Fu J, Gundrum J, Allen LaPointe NM, Rogers RK, et al. Long-term outcomes and associations with major adverse limb events after peripheral artery revascularization. J Am Coll Cardiol 2020;75:498–508. https://doi.org/10.1016/j.jacc.2019.11.050
Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FGR, Gillespie I, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 2010;51:52s–68s. https://doi.org/10.1016/j.jvs.2010.01.077
Meltzer AJ, Graham A, Connolly PH, Meltzer EC, Karwowski JK, Bush HL, et al. The comprehensive risk assessment for bypass (CRAB) facilitates efficient perioperative risk assessment for patients with critical limb ischemia. J Vasc Surg 2013;57:1186–95. https://doi.org/10.1016/j.jvs.2012.09.083
van Netten JJ, Fortington LV, Hinchliffe RJ, Hijmans JM. Early post-operative mortality after major lower limb amputation: a systematic review of population and regional based studies. Eur J Vasc Endovasc Surg 2016;51:248–57. https://doi.org/10.1016/j.ejvs.2015.10.001
Farber A, Menard MT, Conte MS, Kaufman JA, Powell RJ, Choudhry NK, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med 2022; 387:2305–16. https://doi.org/10.1056/NEJMoa2207899
Meza-Torres B, Carinci F, Heiss C, Joy M, de Lusignan S. Health service organisation impact on lower extremity amputations in people with type 2 diabetes with foot ulcers: systematic review and meta-analysis. Acta Diabetol 2021;58:735–47. https://doi.org/10.1007/s00592-020-01662-x
Peters EJ, Lipsky BA, Berendt AR, Embil JM, Lavery LA, Senneville E, et al. A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot. Diabetes Metab Res Rev 2012;28:142–62. https://doi.org/10.1002/dmrr. 2247
Peters EJG, Lipsky BA, Senneville É, Abbas ZG, Aragón-Sánchez J, Diggle M, et al. Interventions in the management of infection in the foot in diabetes: a systematic review. Diabetes Metab Res Rev 2020;36:e3282. https://doi.org/10.1002/dmrr.3282
Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev 2017;6:CD011038. https://doi.org/10.1002/14651858.CD011038.pub2
Luo Y, Li L, Zhao P, Yang C, Zhang J. Effectiveness of silver dressings in the treatment of diabetic foot ulcers: a systematic review and meta-analysis. J Wound Care 2022;31: 979–86. https://doi.org/10.12968/jowc.2022.31.11.979
Shu H, Xia Z, Qin X, Wang X, Lu W, Luo Q, et al. The clinical efficacy of collagen dressing on chronic wounds: a meta-analysis of 11 randomized controlled trials. Front Surg 2022;9:978407. https://doi.org/10.3389/fsurg.2022.978407
Zhang F, Chen Z, Su F, Zhang T. Comparison of topical honey and povidone iodine-based dressings for wound healing: a systematic review and meta-analysis. J Wound Care 2021;30:S28–s36. https://doi.org/10.12968/jowc.2021.30.Sup4.S28
Yin XL, Hu L, Li T, Zou Y, Li HL. A meta-analysis on the efficacy of vacuum sealing drainage combined with autologous platelet-rich plasma in the treatment of grade 2 and grade 3 diabetic foot ulcers. Int Wound J 2022;20:1033–41. https://doi.org/10.1111/iwj.13956
Lim K, Lim X, Hong Q, Yong E, Chandrasekar S, Tan GWL, et al. Use of home negative pressure wound therapy in peripheral artery disease and diabetic limb salvage. Int Wound J 2020;17:531–9. https://doi.org/10.1111/iwj.13307
Uddin A, Russell D, Game F, Santos D, Siddle HJ. The effectiveness of systemic antibiotics for osteomyelitis of the foot in adults with diabetes mellitus: a systematic review protocol. J Foot Ankle Res 2022;15:48. https://doi.org/10.1186/s13047-022-00554-3
O’Meara S, Nelson EA, Golder S, Dalton JE, Craig D, Iglesias C. Systematic review of methods to diagnose infection in foot ulcers in diabetes. Diabet Med 2006;23:341–7. https://doi.org/10.1111/j.1464-5491.2006.01830.x
Nelson A, Wright-Hughes A, Backhouse MR, Lipsky BA, Nixon J, Bhogal MS, et al. CODIFI (concordance in diabetic foot ulcer infection): a cross-sectional study of wound swab versus tissue sampling in infected diabetic foot ulcers in England. BMJ Open 2018;8:e019437. https://doi.org/10.1136/bmjopen-2017-019437
Gardner SE, Frantz RA. Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs 2008;10:44–53. https://doi.org/10.1177/ 1099800408319056
Selva Olid A, Solà I, Barajas-Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database Syst Rev 2015;9: CD009061. https://doi.org/10.1002/14651858.CD009061.pub2
Patton D, Avsar P, Sayeh A, Budri A, O’Connor T, Walsh S, et al. A meta-review of the impact of compression therapy on venous leg ulcer healing. Int Wound J 2023;20: 430–47. https://doi.org/10.1111/iwj.13891
Lazzarini PA, Armstrong DG, Crews RT, Gooday C, Jarl G, Kirketerp-Moller K, et al. Effectiveness of offloading interventions for people with diabetes-related foot ulcers: a systematic review and meta-analysis. Diabetes Metab Res Rev 2024;40:e3650. https://doi.org/10.1002/dmrr.3650
Elraiyah T, Prutsky G, Domecq JP, Tsapas A, Nabhan M, Frykberg RG, et al. A systematic review and meta-analysis of off-loading methods for diabetic foot ulcers. J Vasc Surg 2016;63:59S–68S.e2. https://doi.org/10.1016/j.jvs.2015.10.006
Lumsden AB, Davies MG, Peden EK. Medical and endovascular management of critical limb ischemia. J Endovasc Ther 2009;16:Ii31–62. https://doi.org/10.1583/08-2657.1
Manzi M, Palena L, Cester G. Endovascular techniques for limb salvage in diabetics with crural and pedal disease. J Cardiovasc Surg 2011;52:485–92.
Dominguez A, III, Bahadorani J, Reeves R, Mahmud E, Patel M. Endovascular therapy for critical limb ischemia. Expert Rev Cardiovasc Ther 2015;13:429–44. https://doi.org/10.1586/14779072.2015.1019472
Abu Dabrh AM, Steffen MW, Undavalli C, Asi N, Wang Z, Elamin MB, et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg 2015;62:1642–51.e3. https://doi.org/10.1016/j.jvs.2015.07.065
Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925–34. https://doi.org/10.1016/s0140-6736(05)67704-5
Bradbury AW, Moakes CA, Popplewell M, Meecham L, Bate GR, Kelly L, et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet 2023;401:1798–809. https://doi.org/10.1016/S0140-6736(23)00462-2
Popplewell MA, Davies H, Jarrett H, Bate G, Grant M, Patel S, et al. Bypass versus angio plasty in severe ischaemia of the leg—2 (BASIL-2) trial: study protocol for a randomised controlled trial. Trials 2016;17:11. https://doi.org/10.1186/s13063-015-1114-2
Patel K, Liu Y, Etaee F, Patel C, Monteleone P, Patel M, et al. Differences between patients with intermittent claudication and critical limb ischemia undergoing endovascular intervention: insights from the excellence in peripheral artery disease registry. Circ Cardiovasc Interv 2021;14:e010635. https://doi.org/10.1161/CIRCINTERVENTIONS. 121.010635
Almasri J, Adusumalli J, Asi N, Lakis S, Alsawas M, Prokop LJ, et al. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg 2019;58:S110–s119. https://doi.org/10.1016/j.ejvs.2019.04.013
Söder HK, Manninen HI, Jaakkola P, Matsi PJ, Räsänen HT, Kaukanen E, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol 2000;11:1021–31. https://doi.org/10.1016/s1051-0443(07)61332-3
Balmer H, Mahler F, Do DD, Triller J, Baumgartner I. Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome. J Endovasc Ther 2002;9:403–10. https://doi.org/10.1177/152660280200900403
Kudo T, Chandra FA, Kwun WH, Haas BT, Ahn SS. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg 2006;44:304–13. https://doi.org/10.1016/j.jvs.2006.03.040
Kim KG, Meshkin DH, Tirrell AR, Bekeny JC, Tefera EA, Fan KL, et al. A systematic review and meta-analysis of endovascular angiosomal revascularization in the setting of collateral vessels. J Vasc Surg 2021;74:1406–16.e3. https://doi.org/10.1016/j.jvs.2021.04.026
Shishehbor MH, Powell RJ, Montero-Baker MF, Dua A, Martínez-Trabal JL, Bunte MC, et al. Transcatheter arterialization of deep veins in chronic limb-threatening ischemia. N Engl J Med 2023;388:1171–80. https://doi.org/10.1056/NEJMoa2212754
Salem M, Hosny MS, Francia F, Sallam M, Saratzis A, Saha P, et al. Management of extensive aorto-iliac disease: a systematic review and meta-analysis of 9319 patients. Cardiovasc Intervent Radiol 2021;44:1518–35. https://doi.org/10.1007/s00270-021-02785-6
Bekken JA, Vroegindeweij D, Vos JA, de Vries J-PPM, Lardenoije JWHP, Petri B-J, et al. Editor’s choice—two year results of the randomised DISCOVER trial comparing covered versus bare metal stents in the common iliac artery. Eur J Vasc Endovasc Surg 2023; 65:359–68. https://doi.org/10.1016/j.ejvs.2022.11.008
Jongkind V, Akkersdijk GJ, Yeung KK, Wisselink W. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg 2010;52:1376–83. https://doi.org/10.1016/j.jvs.2010.04.080
Ye W, Liu CW, Ricco JB, Mani K, Zeng R, Jiang J. Early and late outcomes of percutaneous treatment of TransAtlantic inter-society consensus class C and D aorto-iliac lesions. J Vasc Surg 2011;53:1728–37. https://doi.org/10.1016/j.jvs.2011.02.005
Bosiers M, Deloose K, Callaert J, Maene L, Beelen R, Keirse K, et al. BRAVISSIMO: 12-month results from a large scale prospective trial. J Cardiovasc Surg 2013;54: 235–53.
Danczyk RC, Mitchell EL, Petersen BD, Edwards J, Liem TK, Landry GJ, et al. Outcomes of open operation for aortoiliac occlusive disease after failed endovascular therapy. Arch Surg 2012;147:841–5. https://doi.org/10.1001/archsurg.2012.1649
Fereydooni A, Zhou B, Xu Y, Deng Y, Dardik A, Ochoa Chaar CI. Rapid increase in hybrid surgery for the treatment of peripheral artery disease in the vascular quality initiative database. J Vasc Surg 2020;72:977–86.e1. https://doi.org/10.1016/j.jvs.2019.11. 041
Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A, et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol 2014;64:1568–76. https://doi.org/10.1016/j.jacc.2014.06.1198
Zeller T, Micari A, Scheinert D, Baumgartner I, Bosiers M, Vermassen FEG, et al. The IN.PACT DEEP clinical drug-coated balloon trial: 5-year outcomes. JACC Cardiovasc Interv 2020;13:431–43. https://doi.org/10.1016/j.jcin.2019.10.059
Brizzi V, Caradu C, Berard X, Sassoust G, Midy D, Ducasse E. Six-year multicenter experience of standard endovascular treatment of critical limb ischemia in the era of drug-eluting devices. J Cardiovasc Surg 2018;59:707–15. https://doi.org/10.23736/S0021-9509.16.09737-8
Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001;24: 1433–7. https://doi.org/10.2337/diacare.24.8.1433
Ozkan U, Oguzkurt L, Tercan F. Atherosclerotic risk factors and segmental distribution in symptomatic peripheral artery disease. J Vasc Interv Radiol 2009;20:437–41. https://doi.org/10.1016/j.jvir.2009.01.010
Todd KE, Jr, Ahanchi SS, Maurer CA, Kim JH, Chipman CR, Panneton JM. Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia. J Vasc Surg 2013;58:941–8. https://doi.org/10.1016/j.jvs.2013.04.024
Teichgraber U, Lehmann T, Thieme M, Wahl K-U, Stelzner C, Bormann A, et al. Drug-coated balloon angioplasty of infrapopliteal lesions in patients with critical limb ischaemia: 1-year results of the APOLLO trial. Cardiovasc Intervent Radiol 2019;42: 1380–90. https://doi.org/10.1007/s00270-019-02279-6
Yang X, Lu X, Ye K, Li X, Qin J, Jiang M. Systematic review and meta-analysis of balloon angioplasty versus primary stenting in the infrapopliteal disease. Vasc Endovascular Surg 2014;48:18–26. https://doi.org/10.1177/1538574413510626
Zhang J, Xu X, Kong J, Xu R, Fan X, Chen J, et al. Systematic review and meta-analysis of drug-eluting balloon and stent for infrapopliteal artery revascularization. Vasc Endovascular Surg 2017;51:72–83. https://doi.org/10.1177/1538574416689426
Matsuoka EK, Hasebe T, Ishii R, Miyazaki N, Soejima K, Iwasaki K. Comparative performance analysis of interventional devices for the treatment of ischemic disease in below-the-knee lesions: a systematic review and meta-analysis. Cardiovasc Interv Ther 2022;37:145–57. https://doi.org/10.1007/s12928-021-00758-7
Fong KY, Xin L, Ng J, Loh SEK, Ng JJ, Choong AMTL. A systematic review and meta-analysis of sirolimus-eluting stents for treatment of below-the-knee arterial disease. J Vasc Surg 2023;77:1264–73.e3. https://doi.org/10.1016/j.jvs.2022.09.022
Ubbink DT, Vermeulen H. Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev 2013;2:CD004001. https://doi.org/10.1002/14651858.CD004001.pub3
Asimakidou E, Matis GK. Spinal cord stimulation in the treatment of peripheral vascular disease: a systematic review—revival of a promising therapeutic option? Br J Neurosurg 2022;36:555–63. https://doi.org/10.1080/02688697.2021.1884189
Nicoloff AD, Taylor LM, Jr, Sexton GJ, Schuff RA, Edwards JM, Yeager RA, et al. Relationship between site of initial symptoms and subsequent progression of disease in a prospective study of atherosclerosis progression in patients receiving long-term treatment for symptomatic peripheral arterial disease. J Vasc Surg 2002;35:38–46; discussion 46–37.
Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180–9. https://doi.org/10.1001/jama.295.2.180
Wilson YG, Davies AH, Currie IC, Morgan M, McGrath C, Baird RN, et al. Vein graft stenosis: incidence and intervention. Eur J Vasc Endovasc Surg 1996;11:164–9. https://doi.org/10.1016/s1078-5884(96)80046-3
Armstrong PA, Bandyk DF, Wilson JS, Shames ML, Johnson BL, Back MR. Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy. J Vasc Surg 2004;40:724–31; discussion 730–721. https://doi.org/10.1016/j.jvs.2004.07.037
Pulli R, Dorigo W, Fargion A, Innocenti AA, Pratesi G, Marek J, et al. Early and long-term comparison of endovascular treatment of iliac artery occlusions and stenosis. J Vasc Surg 2011;53:92–8. https://doi.org/10.1016/j.jvs.2010.08.034
Lo RC, Darling J, Bensley RP, Giles KA, Dahlberg SE, Hamdan AD, et al. Outcomes following infrapopliteal angioplasty for critical limb ischemia. J Vasc Surg 2013;57: 1455–64; discussion 1463–1454. https://doi.org/10.1016/j.jvs.2012.10.109
Rodway AD, Hanna L, Harris J, Jarrett R, Allan C, Pazos Casal F, et al. Prognostic and predictive value of ultrasound-based estimated ankle brachial pressure index at early follow-up after endovascular revascularization of chronic limb-threatening ischaemia: a prospective, single-centre, service evaluation. EClinicalMedicine 2024;68:102410. https://doi.org/10.1016/j.eclinm.2023.102410
Poursina O, Elizondo-Adamchik H, Montero-Baker M, Pallister ZS, Mills JL, Chung J. Safety and efficacy of an endovascular-first approach to acute limb ischemia. J Vasc Surg 2021;73:1741–9. https://doi.org/10.1016/j.jvs.2020.10.002
Hawkins KE, Valentine RJ, Duke JM, Wang Q, Reed AB. Ankle-brachial index use in peripheral vascular interventions for claudication. J Vasc Surg 2022;76:196–201. https://doi.org/10.1016/j.jvs.2022.02.049
Armstrong EJ, Chen DC, Westin GG, Singh S, McCoach CE, Bang H, et al. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. J Am Heart Assoc 2014;3:e000697. https://doi.org/10.1161/jaha.113. 000697
Araujo ST, Moreno DH, Cacione DG. Percutaneous thrombectomy or ultrasound-accelerated thrombolysis for initial management of acute limb ischaemia. Cochrane Database Syst Rev 2022;1:CD013486. https://doi.org/10.1002/14651858.CD013486.pub2
Kokkinidis DG, Arfaras-Melainis A, Giannopoulos S, Katsaros I, Jawaid O, Jonnalagadda AK, et al. Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: a systematic review and meta-analysis. Vasc Med 2020;25:106–17. https://doi.org/10.1177/1358863x19894055
Londero LS, Nørgaard B, Houlind K. Patient delay is the main cause of treatment delay in acute limb ischemia: an investigation of pre- and in-hospital time delay. World J Emerg Surg 2014;9:56. https://doi.org/10.1186/1749-7922-9-56
Duval S, Keo HH, Oldenburg NC, Baumgartner I, Jaff MR, Peacock JM, et al. The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: the FRIENDS registry. Am Heart J 2014;168:577–87. https://doi.org/10.1016/j.ahj.2014.06. 013
Kulezic A, Macek M, Acosta S. Inadequacies of physical examination in patients with acute lower limb ischemia are associated with dreadful consequences. Ann Vasc Surg 2022;82:190–6. https://doi.org/10.1016/j.avsg.2021.10.067
Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 2002;10:620–30. https://doi.org/10.1016/s0967-2109(02)00070-4
Jivegård L, Bergqvist D, Holm J. When is urgent revascularization unnecessary for acute lower limb ischaemia? Eur J Vasc Endovasc Surg 1995;9:448–53. https://doi.org/10.1016/ s1078-5884(05)80014-0
Crawford JD, Perrone KH, Jung E, Mitchell EL, Landry GJ, Moneta GL, et al. Arterial duplex for diagnosis of peripheral arterial emboli. J Vasc Surg 2016;64:1351–6. https://doi.org/10.1016/j.jvs.2016.04.005
Hemingway J, Emanuels D, Aarabi S, Quiroga E, Tran N, Starnes B, et al. Safety of transfer, type of procedure, and factors predictive of limb salvage in a modern series of acute limb ischemia. J Vasc Surg 2019;69:1174–9. https://doi.org/10.1016/j.jvs.2018.08.174
Currie IS, Wakelin SJ, Lee AJ, Chalmers RT. Plasma creatine kinase indicates major amputation or limb preservation in acute lower limb ischemia. J Vasc Surg 2007;45:733–9. https://doi.org/10.1016/j.jvs.2006.12.050
Brow TD, Kakkar VV, Das SK. The significance of creatine kinase in cardiac patients with acute limb ischaemia. J Cardiovasc Surg 1999;40:637–44.
Adiseshiah M, Round JM, Jones DA. Reperfusion injury in skeletal muscle: a prospective study in patients with acute limb ischaemia and claudicants treated by revascularization. Br J Surg 2005;79:1026–9. https://doi.org/10.1002/bjs.1800791013
Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517–38. https://doi.org/10.1016/s0741-5214(97)70045-4
Ontario Health. Mechanical thrombectomy for acute and subacute blocked arteries and veins in the lower limbs: a health technology assessment. Ont Health Technol Assess Ser 2023;23:1–244.
Gong M, He X, Zhao B, Kong J, Gu J, Chen G, et al. Endovascular revascularization strategies using catheter-based thrombectomy versus conventional catheter-directed thrombolysis for acute limb ischemia. Thromb J 2021;19:96. https://doi.org/10.1186/ s12959-021-00349-9
Doelare SAN, Koedam TWA, Ebben HP, Tournoij E, Hoksbergen AWJ, Yeung KK, et al. Catheter directed thrombolysis for not immediately threatening acute limb ischaemia: systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2023;65: 537–45. https://doi.org/10.1016/j.ejvs.2022.12.030
Veenstra EB, van der Laan MJ, Zeebregts CJ, de Heide E-J, Kater M, Bokkers RPH. A systematic review and meta-analysis of endovascular and surgical revascularization techniques in acute limb ischemia. J Vasc Surg 2020;71:654–68.e3. https://doi.org/10.1016/j.jvs.2019.05.031
Kolte D, Kennedy KF, Shishehbor MH, Mamdani ST, Stangenberg L, Hyder ON, et al. Endovascular versus surgical revascularization for acute limb ischemia: a propensity-score matched analysis. Circ Cardiovasc Interv 2020;13:e008150. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008150
Grip O, Wanhainen A, Michaelsson K, Lindhagen L, Bjorck M. Open or endovascular revascularization in the treatment of acute lower limb ischaemia. Br J Surg 2018;105: 1598–606. https://doi.org/10.1002/bjs.10954
Darwood R, Berridge DC, Kessel DO, Robertson I, Forster R. Surgery versus thrombolysis for initial management of acute limb ischaemia. Cochrane Database Syst Rev 2018; 8:CD002784. https://doi.org/10.1002/14651858.CD002784.pub3
Schrijver AM, van Leersum M, Fioole B, Reijnen MMPJ, Hoksbergen AWJ, Vahl AC, et al. Dutch randomized trial comparing standard catheter-directed thrombolysis and ultrasound-accelerated thrombolysis for arterial thromboembolic infrainguinal disease (DUET). J Endovasc Ther 2015;22:87–95. https://doi.org/10.1177/ 1526602814566578
Juneja A, Garuthara M, Talathi S, Rao A, Landis G, Etkin Y. Predictors of poor outcomes after lower extremity revascularization for acute limb ischemia. Vascular 2024;32:632–9. https://doi.org/10.1177/17085381231154290
Ouriel K, Veith FJ. Acute lower limb ischemia: determinants of outcome. Surgery 1998; 124:336–41; discussion 341–332. https://doi.org/10.1016/S0039-6060(98)70139-4
Sobel M, Verhaeghe R. Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008;133:815s–43s. https://doi.org/10.1378/chest.08-0686
Hess CN, Debus ES, Nehler MR, Anand SS, Patel MR, Szarek M, et al. Reduction in acute limb ischemia with rivaroxaban versus placebo in peripheral artery disease after lower extremity revascularization: insights from VOYAGER PAD. Circulation 2021; 144:1831–41. https://doi.org/10.1161/circulationaha.121.055146
Jivegård L, Holm J, Bergqvist D, Björck CG, Björkman H, Brunius U, et al. Acute lower limb ischemia: failure of anticoagulant treatment to improve one-month results of arterial thromboembolectomy. A prospective randomized multi-center study. Surgery 1991;109:610–6.
Jivegård L, Holm J, Scherstén T. Arterial thromboembolectomy—should anticoagulants be administered? Acta Chir Scand 1986;152:493–7.
Campbell WB, Ridler BM, Szymanska TH. Two-year follow-up after acute thromboembolic limb ischaemia: the importance of anticoagulation. Eur J Vasc Endovasc Surg 2000;19:169–73. https://doi.org/10.1053/ejvs.1999.0999
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics–2018 update: a report from the American Heart Association. Circulation 2018;137:e67–492. https://doi.org/10.1161/cir. 0000000000000558
Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004–2006–2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012;34:290–6. https://doi.org/10.1159/000343145
Johri AM, Nambi V, Naqvi TZ, Feinstein SB, Kim ESH, Park MM, et al. Recommendations for the assessment of carotid arterial plaque by ultrasound for the characterization of atherosclerosis and evaluation of cardiovascular risk: from the American Society of Echocardiography. J Am Soc Echocardiogr 2020;33:917–33. https://doi.org/10.1016/j.echo.2020.04.021
Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ, Ferguson GG, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445–53. https://doi.org/10.1056/ nejm199108153250701
Gornik HL, Rundek T, Gardener H, Benenati JF, Dahiya N, Hamburg NM, et al. Optimization of duplex velocity criteria for diagnosis of internal carotid artery (ICA) stenosis: a report of the Intersocietal Accreditation Commission (IAC) Vascular Testing Division Carotid Diagnostic Criteria Committee. Vasc Med 2021;26:515–25. https://doi.org/10.1177/1358863X211011253
Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: grayscale and Doppler ultrasound diagnosis—Society of Radiologists in ultrasound consensus conference. Ultrasound Q 2003;19:190–8. https://doi.org/10.1097/00013644-200312000-00005
Rustempasic N, Gengo M. Assesment of carotid stenosis with CT angiography and col- or Doppler ultrasonography. Med Arch 2019;73:321–5. https://doi.org/10.5455/medarh.2019.73.321-325
Clezar CN, Flumignan CD, Cassola N, Nakano LCU, Trevisani VFM, Flumignan RLG. Pharmacological interventions for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2023;8:CD013573. https://doi.org/10.1002/14651858.CD013573.pub2
Côté R, Battista RN, Abrahamowicz M, Langlois Y, Bourque F, Mackey A. Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The asymptomatic cervical bruit study group. Ann Intern Med 1995;123:649–55. https://doi.org/10.7326/0003-4819-123-9-199511010-00002
Aboyans V, Bauersachs R, Mazzolai L, Brodmann M, Palomares JFR, Debus S, et al. Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy. Eur Heart J 2021;42:4013–24. https://doi.org/10.1093/eurheartj/ ehab390
Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 2018;379:215–25. https://doi.org/10.1056/NEJMoa1800410
Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013;369:11–9. https://doi.org/10.1056/NEJMoa1215340
Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007;6:961–9. https://doi.org/10.1016/ S1474-4422(07)70250-8
Murphy SJX, Naylor AR, Ricco JB, Sillesen H, Kakkos S, Halliday A, et al. Optimal antiplatelet therapy in moderate to severe asymptomatic and symptomatic carotid stenosis: a comprehensive review of the literature. Eur J Vasc Endovasc Surg 2019;57: 199–211. https://doi.org/10.1016/j.ejvs.2018.09.018
King A, Shipley M, Markus H, Investigators A. The effect of medical treatments on stroke risk in asymptomatic carotid stenosis. Stroke 2013;44:542–6. https://doi.org/10.1161/STROKEAHA.112.673608
Endarterectomy for asymptomatic carotid artery stenosis. Executive committee for the asymptomatic carotid atherosclerosis study. JAMA 1995;273:1421–8.
Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491–502. https://doi.org/10.1016/s0140-6736(04)16146-1
Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 2010;376:1074–84. https://doi.org/10.1016/s0140-6736(10)61197-x
Rothwell PM, Goldstein LB. Carotid endarterectomy for asymptomatic carotid stenosis: asymptomatic carotid surgery trial. Stroke 2004;35:2425–7. https://doi.org/10.1161/01.STR.0000141706.50170.a7
Hadar N, Raman G, Moorthy D, O’Donnell TF, Thaler DE, Feldmann E, et al. Asymptomatic carotid artery stenosis treated with medical therapy alone: temporal trends and implications for risk assessment and the design of future studies. Cerebrovasc Dis 2014;38:163–73. https://doi.org/10.1159/000365206
Reiff T, Eckstein HH, Mansmann U, Jansen O, Fraedrich G, Mudra H, et al. Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: one-year interim results of SPACE-2. Int J Stroke 2020;15:638–49. https:// doi.org/10.1177/1747493019833017
Naylor AR, Schroeder TV, Sillesen H. Clinical and imaging features associated with an increased risk of late stroke in patients with asymptomatic carotid disease. Eur J Vasc Endovasc Surg 2014;48:633–40. https://doi.org/10.1016/j.ejvs.2014.08.017
Paraskevas KI, Brown MM, Lal BK, Myrcha P, Lyden SP, Schneider PA, et al. Recent advances and controversial issues in the optimal management of asymptomatic carotid stenosis. J Vasc Surg 2024;79:695–703. https://doi.org/10.1016/j.jvs.2023.11.004
Naylor R, Rantner B, Ancetti S, de Borst GJ, De Carlo M, Halliday A, et al. Editor’s choice—European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease. Eur J Vasc Endovasc Surg 2023;65:7–111. https://doi.org/10.1016/j.ejvs.2022.04.011
Kashyap VS, Schneider PA, Foteh M, Motaganahalli R, Shah R, Eckstein H-H, et al. Early outcomes in the ROADSTER 2 study of transcarotid artery revascularization in patients with significant carotid artery disease. Stroke 2020;51:2620–9. https://doi.org/10.1161/strokeaha.120.030550
Nicolaides AN, Kakkos SK, Griffin M, Sabetai M, Dhanjil S, Tegos T, et al. Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur J Vasc Endovasc Surg 2005;30:275–84. https://doi.org/10.1016/j.ejvs.2005.04.031
Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004;62:569–73. https://doi.org/10.1212/01.wnl.0000110311.09970.83
Kakkos SK, Sabetai M, Tegos T, Stevens J, Thomas D, Griffin M, et al. Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. J Vasc Surg 2009;49: 902–9. https://doi.org/10.1016/j.jvs.2008.10.059
Kakkos SK, Nicolaides AN, Charalambous I, Thomas D, Giannopoulos A, Naylor AR, et al. Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. J Vasc Surg 2014;59:956–67.e1. https://doi.org/10.1016/j.jvs.2013.10. 073
Markus HS, King A, Shipley M, Topakian R, Cullinane M, Reihill S, et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol 2010;9:663–71. https://doi.org/10.1016/s1474-4422(10)70120-4
Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Stroke 1977;8:301–14. https://doi.org/10.1161/01.str.8.3.301
King A, Serena J, Bornstein NM, Markus HS. Does impaired cerebrovascular reactivity predict stroke risk in asymptomatic carotid stenosis? A prospective substudy of the asymptomatic carotid emboli study. Stroke 2011;42:1550–5. https://doi.org/10.1161/strokeaha.110.609057
Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, et al. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. Lancet Neurol 2017;16:301–10. https://doi.org/10.1016/s1474-4422(17)30038-8
Kakkos SK, Griffin MB, Nicolaides AN, Kyriacou E, Sabetai MM, Tegos T, et al. The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke. J Vasc Surg 2013;57:609–18.e1; discussion 617–608. https://doi.org/10.1016/j.jvs.2012.09.045
Gupta A, Kesavabhotla K, Baradaran H, Kamel H, Pandya A, Giambrone AE, et al. Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis. Stroke 2015;46:91–7. https://doi.org/10.1161/strokeaha.114. 006091
Palacio S, Hart RG, Pearce LA, Anderson DC, Sharma M, Birnbaum LA, et al. Effect of addition of clopidogrel to aspirin on stroke incidence: meta-analysis of randomized trials. Int J Stroke 2015;10:686–91. https://doi.org/10.1111/ijs.12050
Gupta A, Baradaran H, Schweitzer AD, Kamel H, Pandya A, Delgado D, et al. Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke 2013;44: 3071–7. https://doi.org/10.1161/strokeaha.113.002551
Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010;9:489–97. https://doi.org/10.1016/s1474-4422(10)70060-0
Karlöf E, Buckler A, Liljeqvist ML, Lengquist M, Kronqvist M, Toonsi MA, et al. Carotid plaque phenotyping by correlating plaque morphology from computed tomography angiography with transcriptional profiling. Eur J Vasc Endovasc Surg 2021;62:716–26. https://doi.org/10.1016/j.ejvs.2021.07.011
Silver FL, Mackey A, Clark WM, Brooks W, Timaran CH, Chiu D, et al. Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke 2011;42:675–80. https://doi.org/10.1161/strokeaha.110.610212
Baker WH, Howard VJ, Howard G, Toole JF. Effect of contralateral occlusion on long-term efficacy of endarterectomy in the asymptomatic carotid atherosclerosis study (ACAS). ACAS Investigators. Stroke 2000;31:2330–4. https://doi.org/10.1161/01.str. 31.10.2330
Kamtchum-Tatuene J, Noubiap JJ, Wilman AH, Saqqur M, Shuaib A, Jickling GC. Prevalence of high-risk plaques and risk of stroke in patients with asymptomatic carotid stenosis: a meta-analysis. JAMA Neurol 2020;77:1524–35. https://doi.org/10.1001/jamaneurol.2020.2658
Saratzis A, Naylor R. 30 day outcomes after carotid interventions: an updated meta-analysis of randomised controlled trials in asymptomatic patients. Eur J Vasc Endovasc Surg 2022;63:157–8. https://doi.org/10.1016/j.ejvs.2021.10.029
Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, et al. Ticagrelor added to aspirin in acute nonsevere ischemic stroke or transient ischemic attack of atherosclerotic origin. Stroke 2020;51:3504–13. https://doi.org/10.1161/strokeaha.120.032239
Halliday A, Bulbulia R, Bonati LH, Chester J, Cradduck-Bamford A, Peto R, et al. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet 2021;398:1065–73. https://doi.org/10.1016/s0140-6736(21)01910-3
Rosenfield K, Matsumura JS, Chaturvedi S, Riles T, Ansel GM, Metzger DC, et al. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med 2016;374:1011–20. https://doi.org/10.1056/NEJMoa1515706
Brott TG, Howard G, Roubin GS, Meschia JF, Mackey A, Brooks W, et al. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med 2016;374:1021–31. https://doi.org/10.1056/NEJMoa1505215
Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–501. https://doi.org/10.1056/NEJMoa040127
Karpenko A, Bugurov S, Ignatenko P, Starodubtsev V, Popova I, Malinowski K, et al. Randomized controlled trial of conventional versus micronet-covered stent in carotid artery revascularization. JACC Cardiovasc Interv 2021;14:2377–87. https://doi.org/10.1016/j.jcin.2021.08.005
Karpenko A, Bugurov S, Ignatenko P, Starodubtsev V, Popova I, Malinowski K, et al. Randomized controlled trial of conventional versus micronet-covered stent in carotid artery revascularization: 12-month outcomes. JACC Cardiovasc Interv 2023;16:878–80. https://doi.org/10.1016/j.jcin.2023.01.369
Columbo JA, Martinez-Camblor P, Stone DH, Goodney PP, O’Malley AJ. Procedural safety comparison between transcarotid artery revascularization, carotid endarterectomy, and carotid stenting: perioperative and 1-year rates of stroke or death. J Am Heart Assoc 2022;11:e024964. https://doi.org/10.1161/jaha.121.024964
de Borst GJ. Transcarotid artery revascularization. Br J Surg 2023;110:127–8. https://doi.org/10.1093/bjs/znac421
Hawkins BM, Kennedy KF, Aronow HD, Nguyen LL, White CJ, Rosenfield K, et al. Hospital variation in carotid stenting outcomes. JACC Cardiovasc Interv 2015;8: 858–63. https://doi.org/10.1016/j.jcin.2015.01.026
Paraskevas KI, Kalmykov EL, Naylor AR. Stroke/death rates following carotid artery stenting and carotid endarterectomy in contemporary administrative dataset registries: a systematic review. Eur J Vasc Endovasc Surg 2016;51:3–12. https://doi.org/10.1016/j.ejvs.2015.07.032
Brott TG, Hobson RW, II, Howard G, Roubin GS, Clark WM, Brooks W, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010; 363:11–23. https://doi.org/10.1056/NEJMoa0912321
Sacco RL, Diener HC, Yusuf S, Cotton D, Ôunpuu S, Lawton WA, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008;359:1238–51. https://doi.org/10.1056/NEJMoa0805002
Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial. Lancet Neurol 2007;6:115–24. https://doi.org/10.1016/s1474-4422(06)70685-8
Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation 2005;111:2233–40. https://doi.org/10.1161/01.Cir.0000163561.90680.1c
Johnston SC, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, et al. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med 2020;383:207–17. https://doi.org/10.1056/NEJMoa1916870
Wang Y, Pan Y, Li H, Amarenco P, Denison H, Evans SR, et al. Efficacy and safety of ticagrelor and aspirin in patients with moderate ischemic stroke: an exploratory analysis of the THALES randomized clinical trial. JAMA Neurol 2021;78:1091–8. https://doi.org/10.1001/jamaneurol.2021.2440
Messas E, Goudot G, Halliday A, Sitruk J, Mirault T, Khider L, et al. Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review. Eur Heart J Suppl 2020;22:M35–42. https://doi.org/10.1093/eurheartj/ suaa162
Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361:107–16. https://doi.org/10.1016/ s0140-6736(03)12228-3
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351: 1379–87. https://doi.org/10.1016/S0140-6736(97)09292-1
Mayberg MR, Wilson SE, Yatsu F, Weiss DG, Messina L, Hershey LA, et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans affairs cooperative studies program 309 trialist group. JAMA 1991;266: 3289–94.
Naylor AR, Sillesen H, Schroeder TV. Clinical and imaging features associated with an increased risk of early and late stroke in patients with symptomatic carotid disease. Eur J Vasc Endovasc Surg 2015;49:513–23. https://doi.org/10.1016/j.ejvs.2015.01.011
Tsantilas P, Kuehnl A, König T, Breitkreuz T, Kallmayer M, Knappich C, et al. Short time interval between neurologic event and carotid surgery is not associated with an increased procedural risk. Stroke 2016;47:2783–90. https://doi.org/10.1161/strokeaha.116.014058
Loftus IM, Paraskevas KI, Johal A, Waton S, Heikkila K, Naylor AR, et al. Editor’s choice —delays to surgery and procedural risks following carotid endarterectomy in the UK national vascular registry. Eur J Vasc Endovasc Surg 2016;52:438–43. https://doi.org/10.1016/j.ejvs.2016.05.031
Strömberg S, Gelin J, Osterberg T, Bergström GML, Karlström L, Österberg K, et al. Very urgent carotid endarterectomy confers increased procedural risk. Stroke 2012; 43:1331–5. https://doi.org/10.1161/strokeaha.111.639344
Bush CK, Kurimella D, Cross LJ, Conner KR, Martin-Schild D, He J, et al. Endovascular treatment with stent-retriever devices for acute ischemic stroke: a meta-analysis of randomized controlled trials. PLoS One 2016;11:e0147287. https://doi.org/10.1371/journal.pone.0147287
Savardekar AR, Narayan V, Patra DP, Spetzler RF, Sun H. Timing of carotid endarterectomy for symptomatic carotid stenosis: a snapshot of current trends and systematic review of literature on changing paradigm towards early surgery. Neurosurgery 2019; 85:E214–25. https://doi.org/10.1093/neuros/nyy557
Hill MD, Brooks W, Mackey A, Clark WM, Meschia JF, Morrish WF, et al. Stroke after carotid stenting and endarterectomy in the carotid revascularization endarterectomy versus stenting trial (CREST). Circulation 2012;126:3054–61. https://doi.org/10.1161/circulationaha.112.120030
Blackshear JL, Cutlip DE, Roubin GS, Hill MD, Leimgruber PP, Begg RJ, et al. Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation 2011;123:2571–8. https://doi.org/10.1161/circulationaha.110.008250
Howard G, Roubin GS, Jansen O, Hendrikse J, Halliday A, Fraedrich G, et al. Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials. Lancet 2016;387:1305–11. https://doi.org/10.1016/s0140-6736(15)01309-4
Alamowitch S, Eliasziw M, Algra A, Meldrum H, Barnett HJ. Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet 2001;357:1154–60. https://doi.org/10.1016/s0140-6736(00)04332-4
Bonati LH, Lyrer P, Ederle J, Featherstone R, Brown MM. Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev 2012;9:CD000515. https://doi.org/10.1002/14651858.CD000515.pub4
Economopoulos KP, Sergentanis TN, Tsivgoulis G, Mariolis AD, Stefanadis C. Carotid artery stenting versus carotid endarterectomy: a comprehensive meta-analysis of short-term and long-term outcomes. Stroke 2011;42:687–92. https://doi.org/10.1161/strokeaha.110.606079
Bonati LH, Dobson J, Featherstone RL, Ederle J, van der Worp HB, de Borst GJ, et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet 2015;385:529–38. https://doi.org/10.1016/s0140-6736(14)61184-3
Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915–24. https://doi.org/10.1016/s0140-6736(04)15785-1
Rantner B, Kollerits B, Roubin GS, Ringleb PA, Jansen O, Howard G, et al. Early endarterectomy carries a lower procedural risk than early stenting in patients with symptomatic stenosis of the internal carotid artery: results from 4 randomized controlled trials. Stroke 2017;48:1580–7. https://doi.org/10.1161/strokeaha.116.016233
Schermerhorn ML, Fokkema M, Goodney P, Dillavou ED, Jim J, Kenwood CT, et al. The impact of centers for medicare and medicaid services high-risk criteria on outcome after carotid endarterectomy and carotid artery stenting in the SVS vascular registry. J Vasc Surg 2013;57:1318–24. https://doi.org/10.1016/j.jvs.2012.10.107
Schermerhorn ML, Liang P, Eldrup-Jorgensen J, Cronenwett JL, Nolan BW, Kashyap VS, et al. Association of transcarotid artery revascularization vs transfemoral carotid artery stenting with stroke or death among patients with carotid artery stenosis. JAMA 2019;322:2313–22. https://doi.org/10.1001/jama.2019.18441
Pineau S, Fajardo A, Saqib NU, Tanaka A, Motaganahalli RL, Keyhani A, et al. Transcarotid revascularization timing and early postoperative outcomes in symptomatic patients. Vasc Endovascular Surg 2023;57:344–9. https://doi.org/10.1177/ 15385744221146678
Kieffer E, Praquin B, Chiche L, Koskas F, Bahnini A. Distal vertebral artery reconstruction: long-term outcome. J Vasc Surg 2002;36:549–54. https://doi.org/10.1067/mva.2002.126092
Berguer R, Flynn LM, Kline RA, Caplan L. Surgical reconstruction of the extracranial vertebral artery: management and outcome. J Vasc Surg 2000;31:9–18. https://doi.org/10.1016/s0741-5214(00)70063-2
Markus HS, Harshfield EL, Compter A, Kuker W, Kappelle LJ, Clifton A, et al. Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis. Lancet Neurol 2019;18:666–73. https://doi.org/10.1016/s1474-4422(19) 30149-8
Hanel RA, Brasiliense LB, Spetzler RF. Microsurgical revascularization of proximal vertebral artery: a single-center, single-operator analysis. Neurosurgery 2009;64:1043–51; discussion 1051. https://doi.org/10.1227/01.Neu.0000347099.17437.64
Asiddao CB, Donegan JH, Whitesell RC, Kalbfleisch JH. Factors associated with perioperative complications during carotid endarterectomy. Anesth Analg 1982;61:631–7.
Obeid T, Arhuidese I, Gaidry A, Qazi U, Abularrage C, Goodney P, et al. Beta-blocker use is associated with lower stroke and death after carotid artery stenting. J Vasc Surg 2016;63:363–9. https://doi.org/10.1016/j.jvs.2015.08.108
Abou-Chebl A, Reginelli J, Bajzer CT, Yadav JS. Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting. Catheter Cardiovasc Interv 2007;69:690–6. https://doi.org/10.1002/ccd. 20693
Lindblad B, Persson NH, Takolander R, Bergqvist D. Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial. Stroke 1993;24:1125–8. https://doi.org/10.1161/01.str.24.8.1125
Kretschmer G, Pratschner T, Prager M, Wenzi E, Polterauer P, Schemper M, et al. Antiplatelet treatment prolongs survival after carotid bifurcation endarterectomy. Analysis of the clinical series followed by a controlled trial. Ann Surg 1990;211: 317–22. https://doi.org/10.1097/00000658-199003000-00002
Dalainas I, Nano G, Bianchi P, Stegher S, Malacrida G, Tealdi DG. Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting. Cardiovasc Intervent Radiol 2006;29:519–21. https://doi.org/10.1007/s00270-005-5288-y
AbuRahma AF, Avgerinos ED, Chang RW, Darling RC, Duncan AA, Forbes TL, et al. The Society for Vascular Surgery implementation document for management of extracranial cerebrovascular disease. J Vasc Surg 2022;75:26s–98s. https://doi.org/10.1016/j.jvs.2021.04.074
Naylor AR, Ricco JB, de Borst GJ, Debus S, de Haro J, Halliday A, et al. Editor’s choice—management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2018;55:3–81. https://doi.org/10.1016/j.ejvs.2017.06.021
Ghamraoui AK, Chang H, Maldonado TS, Ricotta JJ, II. Clopidogrel versus ticagrelor for antiplatelet therapy in transcarotid artery revascularization in the Society for Vascular Surgery vascular quality initiative. J Vasc Surg 2022;75:1652–60. https://doi.org/10.1016/j.jvs.2021.11.060
Marcaccio CL, Patel PB, Liang P, Rastogi V, Stangenberg L, Jim J, et al. Efficacy and safety of perioperative dual antiplatelet therapy with ticagrelor versus clopidogrel in carotid artery stenting. J Vasc Surg 2022;75:1293–303.e8. https://doi.org/10.1016/j.jvs.2021.09. 045
Ghamraoui AK, Ricotta JJ, II. Outcomes and strategy of tailored antiplatelet therapy with ticagrelor in patients undergoing transcarotid artery revascularization. J Vasc Surg 2021;73:132–41. https://doi.org/10.1016/j.jvs.2020.04.518
Zierler RE, Jordan WD, Lal BK, Mussa F, Leers S, Fulton J, et al. The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures. J Vasc Surg 2018;68:256–84. https://doi.org/10.1016/j.jvs.2018.04.018
Cheun TJ, Jayakumar L, Sheehan MK, Sideman MJK, Pounds LL, Davies MG. Outcomes of upper extremity interventions for chronic critical ischemia. J Vasc Surg 2019;69: 120–8.e2. https://doi.org/10.1016/j.jvs.2018.04.056
Awad El-Karim G, Kennedy SA, Ferraresi R, Addas JAK, Oreopoulos GD, Jaberi A, et al. Percutaneous transluminal angioplasty for below-the-elbow critical hand ischemia: a systematic review. J Endovasc Ther 2022;29:468–77. https://doi.org/10.1177/ 15266028211050309
Raimbeau A, Pistorius MA, Goueffic Y, Connault J, Plissonneau-Duquene P, Maurel B, et al. Digital ischaemia aetiologies and mid-term follow-up: a cohort study of 323 patients. Medicine 2021;100:e25659. https://doi.org/10.1097/md.0000000000025659
Clark CE, Taylor RS, Shore AC, Ukoumunne OC, Campbell JL. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet 2012;379:905–14. https://doi.org/10.1016/s0140-6736(11)61710-8
Aboyans V, Kamineni A, Allison MA, McDermott MM, Crouse JR, Ni H, et al. The epidemiology of subclavian stenosis and its association with markers of subclinical atherosclerosis: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 2010;211: 266–70. https://doi.org/10.1016/j.atherosclerosis.2010.01.013
Labropoulos N, Nandivada P, Bekelis K. Prevalence and impact of the subclavian steal syndrome. Ann Surg 2010;252:166–70. https://doi.org/10.1097/SLA. 0b013e3181e3375a
Zhang J, Wang L, Chen Y, Wang S, Xing Y, Cui L. Color Doppler ultrasonography for the evaluation of subclavian artery stenosis. Front Neurol 2022;13:804039. https://doi.org/10.3389/fneur.2022.804039
Harper C, Cardullo PA, Weyman AK, Patterson RB. Transcranial Doppler ultrasonography of the basilar artery in patients with retrograde vertebral artery flow. J Vasc Surg 2008;48:859–64. https://doi.org/10.1016/j.jvs.2008.05.057
Chidambaram PK, Swaminathan RK, Ganesan P, Mayavan M. Segmental comparison of peripheral arteries by Doppler ultrasound and CT angiography. J Clin Diagn Res 2016; 10:TC12–16. https://doi.org/10.7860/JCDR/2016/17191.7242
Tsao TF, Cheng KL, Shen CY, Wu M-C, Huang H-H, Su C-H, et al. Diagnostic performance of combined contrast-enhanced magnetic resonance angiography and phase-contrast magnetic resonance imaging in suspected subclavian steal syndrome. Can Assoc Radiol J 2016;67:190–201. https://doi.org/10.1016/j.carj.2015.08.007
Klitfod L, Jensen LP. Treatment of chronic upper limb ischaemia is safe and results are good. Dan Med J 2014;61:A4859.
Duran M, Grotemeyer D, Danch MA, Grabitz K, Schelzig H, Sagban TA. Subclavian carotid transposition: immediate and long-term outcomes of 126 surgical reconstructions. Ann Vasc Surg 2015;29:397–403. https://doi.org/10.1016/j.avsg.2014.09.030
Daniel VT, Madenci AL, Nguyen LL, Eslami MH, Kalish JA, Farber A, et al. Contemporary comparison of supra-aortic trunk surgical reconstructions for occlusive disease. J Vasc Surg 2014;59:1577–82, 1582.e1–2. https://doi.org/10.1016/j.jvs.2013.12.017
Burihan E, Soma F, Iared W. Angioplasty versus stenting for subclavian artery stenosis. Cochrane Database Syst Rev 2011;10:CD008461. https://doi.org/10.1002/14651858.CD008461.pub2
Hüttl K, Nemes B, Simonffy A, Entz L, Bérczi V. Angioplasty of the innominate artery in 89 patients: experience over 19 years. Cardiovasc Intervent Radiol 2002;25:109–14. https://doi.org/10.1007/s00270-001-0074-y
Modarai B, Ali T, Dourado R, Reidy JF, Taylor PR, Burnand KG. Comparison of extra-anatomic bypass grafting with angioplasty for atherosclerotic disease of the supra-aortic trunks. Br J Surg 2004;91:1453–7. https://doi.org/10.1002/bjs.4751
Song L, Zhang J, Li J, Gu Y, Yu H, Chen B, et al. Endovascular stenting vs. extrathoracic surgical bypass for symptomatic subclavian steal syndrome. J Endovasc Ther 2012;19: 44–51. https://doi.org/10.1583/11-3692.1
Owens LV, Tinsley EA, Jr, Criado E, Burnham SJ, Keagy BA. Extrathoracic reconstruction of arterial occlusive disease involving the supraaortic trunks. J Vasc Surg 1995;22: 217–21; discussion 221–2. https://doi.org/10.1016/s0741-5214(95)70133-8
Huijben M, Meershoek AJA, de Borst GJ, Toorop RJ. Long-term outcome of axillo-axillary bypass in patients with subclavian or innominate artery stenosis. Ann Vasc Surg 2021;73:321–8. https://doi.org/10.1016/j.avsg.2020.10.029
Lee AD, Agarwal S, Sadhu D. A 7-year experience with thoracoscopic sympathectomy for critical upper limb ischemia. World J Surg 2006;30:1644–7. https://doi.org/10.1007/ s00268-005-0559-y
Schillinger M, Haumer M, Schillinger S, Mlekusch W, Ahmadi R, Minar E. Outcome of conservative versus interventional treatment of subclavian artery stenosis. J Endovasc Ther 2002;9:139–46. https://doi.org/10.1177/152660280200900201
Ahmed AT, Mohammed K, Chehab M, Brinjikji W, Hassan Murad M, Cloft H, et al. Comparing percutaneous transluminal angioplasty and stent placement for treatment of subclavian arterial occlusive disease: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 2016;39:652–67. https://doi.org/10.1007/s00270-015-1250-9
Che W, Dong H, Jiang X, Peng M, Zou Y, Song L, et al. Subclavian artery stenting for coronary-subclavian steal syndrome. Catheter Cardiovasc Interv 2017;89:601–8. https://doi.org/10.1002/ccd.26902
Hamdan R, Guilleminot P, Leclercq T, Monin A. Coronary-subclavian steal syndrome causing myocardial infarction after arteriovenous fistula creation: a case report. ESC Heart Fail 2023;10:2084–9. https://doi.org/10.1002/ehf2.14341
Che WQ, Dong H, Jiang XJ, Peng M, Zou Y, Qian H, et al. Stenting for left subclavian artery stenosis in patients scheduled for left internal mammary artery-coronary artery bypass grafting. Catheter Cardiovasc Interv 2016;87:579–88. https://doi.org/10.1002/ccd.26477
Muller AM, Bertram J, Bradaric C, Koppara T, Cassese S, Xhepa E, et al. Frequency of subclavian artery stenosis in patients with mammarian artery coronary bypass and suspected coronary artery disease progression. Clin Res Cardiol 2023;112:1204–11. https://doi.org/10.1007/s00392-022-02113-z
Angle JF, Matsumoto AH, McGraw JK, Spinosa DJ, Hagspiel KD, Leung DA, et al. Percutaneous angioplasty and stenting of left subclavian artery stenosis in patients with left internal mammary-coronary bypass grafts: clinical experience and long-term follow-up. Vasc Endovascular Surg 2003;37:89–97. https://doi.org/10.1177/ 153857440303700202
Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001;344:431–42. https://doi.org/10.1056/nejm200102083440607
Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002;36: 443–51. https://doi.org/10.1067/mva.2002.127351
Aboyans V, Desormais I, Magne J, Morange G, Mohty D, Lacroix P. Renal artery stenosis in patients with peripheral artery disease: prevalence, risk factors and long-term prognosis. Eur J Vasc Endovasc Surg 2017;53:380–5. https://doi.org/10.1016/j.ejvs.2016.10.029
Safian RD. Renal artery stenosis. Prog Cardiovasc Dis 2021;65:60–70. https://doi.org/10.1016/j.pcad.2021.03.003
Messerli FH, Bangalore S, Makani H, Rimoldi SF, Allemann Y, White CJ, et al. Flash pulmonary oedema and bilateral renal artery stenosis: the pickering syndrome. Eur Heart J 2011;32:2231–5. https://doi.org/10.1093/eurheartj/ehr056
Zeller T, Bonvini RF, Sixt S. Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization. Catheter Cardiovasc Interv 2008;71:995–9. https://doi.org/10.1002/ccd.21525
Prince M, Tafur JD, White CJ. When and how should we revascularize patients with atherosclerotic renal artery stenosis? JACC Cardiovasc Interv 2019;12:505–17. https://doi.org/10.1016/j.jcin.2018.10.023
AbuRahma AF, Yacoub M. Renal imaging: duplex ultrasound, computed tomography angiography, magnetic resonance angiography, and angiography. Semin Vasc Surg 2013;26:134–43. https://doi.org/10.1053/j.semvascsurg.2014.06.001
Staub D, Canevascini R, Huegli RW, Aschwanden M, Thalhammer C, Imfeld S, et al. Best duplex-sonographic criteria for the assessment of renal artery stenosis—correlation with intra-arterial pressure gradient. Ultraschall Med 2007;28:45–51. https://doi.org/10.1055/s-2007-962881
Williams GJ, Macaskill P, Chan SF, Karplus TE, Yung W, Hodson EM, et al. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol 2007;188:798–811. https://doi.org/10.2214/ajr.06.0355
Parikh SA, Shishehbor MH, Gray BH, White CJ, Jaff MR. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv 2014;84: 1163–71. https://doi.org/10.1002/ccd.25559
Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998;98:2866–72. https://doi.org/10.1161/01.cir.98.25.2866
Amighi J, Schlager O, Haumer M, Dick P, Mlekusch W, Loewe C, et al. Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease. Eur J Clin Invest 2009;39:784–92. https://doi.org/10.1111/j.1365-2362.2009.02180.x
Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 2001;37: 1184–90. https://doi.org/10.1053/ajkd.2001.24521
Ritchie J, Green D, Alderson HV, Chrysochou C, Vassallo D, Sinha S, et al. Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease. J Am Soc Hypertens 2016;10:149–58.e3. https://doi.org/10.1016/j.jash.2015.12.002
Raman G, Adam GP, Halladay CW, Langberg VN, Azodo IA, Balk EM. Comparative effectiveness of management strategies for renal artery stenosis: an updated systematic review. Ann Intern Med 2016;165:635–49. https://doi.org/10.7326/M16-1053
Bhalla V, Textor SC, Beckman JA, Casanegra AI, Cooper CJ, Kim ESH, et al. Revascularization for renovascular disease: a scientific statement from the American Heart Association. Hypertension 2022;79:e128–43. https://doi.org/10.1161/hyp. 0000000000000217
Piaggio D, Bracale U, Pecchia L, Di Taranto MD, Sodo M, Bracale UM. Endovascular treatment versus medical therapy for hypertensive patients with renal artery stenosis: an updated systematic review. Ann Vasc Surg 2019;61:445–54. https://doi.org/10.1016/j.avsg.2019.04.050
Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361:1953–62. https://doi.org/10.1056/NEJMoa0905368
Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 2009;150:840–8, w150–1. https://doi.org/10.7326/0003-4819-150-12-200906160-00119
Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998;12: 329–35. https://doi.org/10.1038/sj.jhh.1000599
van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FHM, Deinum J, Postma CT, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000;342:1007–14. https://doi.org/10.1056/nejm200004063421403
Plouin PF, Chatellier G, Darné B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998;31:823–9. https://doi.org/10.1161/01.hyp.31.3.823
Abela R, Ivanova S, Lidder S, Morris R, Hamilton G. An analysis comparing open surgical and endovascular treatment of atherosclerotic renal artery stenosis. Eur J Vasc Endovasc Surg 2009;38:666–75. https://doi.org/10.1016/j.ejvs.2009.08.002
Balzer KM, Pfeiffer T, Rossbach S, Voiculescu A, Mödder U, Godehardt E, et al. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD). J Vasc Surg 2009;49:667–75; discussion 674–665. https://doi.org/10.1016/j.jvs.2008.10.006
Mohler ER, III, Gornik HL, Gerhard-Herman M, Misra S, Olin JW, Zierler RE. ACCF/ ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS/SVU [corrected] 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part I: arterial ultrasound and physiological testing: a report of the American College of Cardiology Foundation appropriate use criteria task force, American College of Radiology, American Institute of Ultrasound in Medicine, American Society of Echocardiography, American Society of Nephrology, Intersocietal Commission for the Accreditation of Vascular Laboratories, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Interventional Radiology, Society for Vascular Medicine, Society for Vascular Surgery, [corrected] and Society for Vascular Ultrasound. [corrected]. J Am Coll Cardiol 2012;60:242–76. https://doi.org/10.1016/j.jacc.2012.02.009
Davies MG, Saad WA, Bismuth JX, Peden EK, Naoum JJ, Lumsden AB. Outcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting. J Vasc Surg 2009;49:946–52. https://doi.org/10.1016/j.jvs.2008.11.039
Hicks CW, Clark TWI, Cooper CJ, de Bhailís ÁM, De Carlo M, Green D, et al. Atherosclerotic renovascular disease: A KDIGO (kidney disease: improving global outcomes) controversies conference. Am J Kidney Dis 2022;79:289–301. https://doi.org/10.1053/j.ajkd.2021.06.025
Johansen KL, Garimella PS, Hicks CW, Kalra PA, Kelly DM, Martens S, et al. Central and peripheral arterial diseases in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 2021;100:35–48. https://doi.org/10.1016/j.kint.2021.04.029
Pappaccogli M, Robberechts T, Lengele JP, Van der Niepen P, Sarafidis P, Rabbia F, et al. Endovascular versus medical management of atherosclerotic renovascular disease: update and emerging concepts. Hypertension 2023;80:1150–61. https://doi.org/10.1161/HYPERTENSIONAHA.122.17965
Tian Y, Yuan B, Zhang N, Huang Z. Outcomes following the endovascular treatment of renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Ann Vasc Surg 2022;78:362–72. https://doi.org/10.1016/j.avsg.2021.06. 042
Persu A, Giavarini A, Touzé E, Januszewicz A, Sapoval M, Azizi M, et al. European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens 2014; 32:1367–78. https://doi.org/10.1097/hjh.0000000000000213
Zeller T, Krankenberg H, Erglis A, Blessing E, Fuss T, Scheinert D, et al. A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR)—one-year results of a pre-maturely terminated study. Trials 2017;18:380. https://doi.org/10.1186/s13063-017-2126-x
Tamme K, Reintam Blaser A, Laisaar KT, Mändul M, Kals J, Forbes A, et al. Incidence and outcomes of acute mesenteric ischaemia: a systematic review and meta-analysis. BMJ Open 2022;12:e062846. https://doi.org/10.1136/bmjopen-2022-062846
Acosta S. Epidemiology of mesenteric vascular disease: clinical implications. Semin Vasc Surg 2010;23:4–8. https://doi.org/10.1053/j.semvascsurg.2009.12.001
Acosta S, Ogren M, Sternby NH, Bergqvist D, Björck M. Incidence of acute thromboembolic occlusion of the superior mesenteric artery—a population-based study. Eur J Vasc Endovasc Surg 2004;27:145–50. https://doi.org/10.1016/j.ejvs.2003.11.003
Carver TW, Vora RS, Taneja A. Mesenteric ischemia. Crit Care Clin 2016;32:155–71. https://doi.org/10.1016/j.ccc.2015.11.001
Klass AA. Embolectomy in acute mesenteric occlusion. Ann Surg 1951;134:913–7. https://doi.org/10.1097/00000658-195111000-00016
Acosta S, Björck M. Acute thrombo-embolic occlusion of the superior mesenteric artery: a prospective study in a well defined population. Eur J Vasc Endovasc Surg 2003;26: 179–83. https://doi.org/10.1053/ejvs.2002.1893
Kärkkäinen JM, Acosta S. Acute mesenteric ischemia (part I)—incidence, etiologies, and how to improve early diagnosis. Best Pract Res Clin Gastroenterol 2017;31: 15–25. https://doi.org/10.1016/j.bpg.2016.10.018
Kärkkäinen JM. Acute mesenteric ischemia: a challenge for the acute care surgeon. Scand J Surg 2021;110:150–8. https://doi.org/10.1177/14574969211007590
Powell A, Armstrong P. Plasma biomarkers for early diagnosis of acute intestinal ischemia. Semin Vasc Surg 2014;27:170–5. https://doi.org/10.1053/j.semvascsurg.2015.01. 008
Block T, Nilsson TK, Björck M, Acosta S. Diagnostic accuracy of plasma biomarkers for intestinal ischaemia. Scand J Clin Lab Invest 2008;68:242–8. https://doi.org/10.1080/ 00365510701646264
Kougias P, Lau D, El Sayed HF, Zhou W, Huynh TT, Lin PH. Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia. J Vasc Surg 2007;46:467–74. https://doi.org/10.1016/j.jvs.2007.04.045
Lehtimäki TT, Kärkkäinen JM, Saari P, Manninen H, Paajanen H, Vanninen R. Detecting acute mesenteric ischemia in CT of the acute abdomen is dependent on clinical suspicion: review of 95 consecutive patients. Eur J Radiol 2015;84:2444–53. https://doi.org/10.1016/j.ejrad.2015.09.006
Kirkpatrick ID, Kroeker MA, Greenberg HM. Biphasic CT with mesenteric CT angiography in the evaluation of acute mesenteric ischemia: initial experience. Radiology 2003; 229:91–8. https://doi.org/10.1148/radiol.2291020991
Oliva IB, Davarpanah AH, Rybicki FJ, Desjardins B, Flamm SD, Francois CJ, et al. ACR appropriateness Criteria ® imaging of mesenteric ischemia. Abdom Imaging 2013;38: 714–9. https://doi.org/10.1007/s00261-012-9975-2
Salsano G, Salsano A, Sportelli E, Petrocelli F, Dahmane M, Spinella G, et al. What is the best revascularization strategy for acute occlusive arterial mesenteric ischemia: systematic review and meta-analysis. Cardiovasc Intervent Radiol 2018;41:27–36. https://doi.org/10.1007/s00270-017-1749-3
El Farargy M, Abdel Hadi A, Abou Eisha M, Bashaeb K, Antoniou GA. Systematic review and meta-analysis of endovascular treatment for acute mesenteric ischaemia. Vascular 2017;25:430–8. https://doi.org/10.1177/1708538116689353
Kärkkäinen JM, Acosta S. Acute mesenteric ischemia (part II)—vascular and endovascular surgical approaches. Best Pract Res Clin Gastroenterol 2017;31:27–38. https://doi.org/10.1016/j.bpg.2016.11.003
Wyers MC, Powell RJ, Nolan BW, Cronenwett JL. Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia. J Vasc Surg 2007;45: 269–75. https://doi.org/10.1016/j.jvs.2006.10.047
Tilsed JV, Casamassima A, Kurihara H, Mariani D, Martinez I, Pereira J, et al. ESTES guidelines: acute mesenteric ischaemia. Eur J Trauma Emerg Surg 2016;42:253–70. https://doi.org/10.1007/s00068-016-0634-0
Tallarita T, Oderich GS, Gloviczki P, Duncan AA, Kalra M, Cha S, et al. Patient survival after open and endovascular mesenteric revascularization for chronic mesenteric ischemia. J Vasc Surg 2013;57:747–55; discussion 754–745. https://doi.org/10.1016/j.jvs.2012.09.047
Alahdab F, Arwani R, Pasha AK, Razouki ZA, Prokop LJ, Huber TS, et al. A systematic review and meta-analysis of endovascular versus open surgical revascularization for chronic mesenteric ischemia. J Vasc Surg 2018;67:1598–605. https://doi.org/10.1016/j.jvs.2017.12.046
Mensink PB, Moons LM, Kuipers EJ. Chronic gastrointestinal ischaemia: shifting paradigms. Gut 2011;60:722–37. https://doi.org/10.1136/gut.2009.199695
Roobottom CA, Dubbins PA. Significant disease of the celiac and superior mesenteric arteries in asymptomatic patients: predictive value of Doppler sonography. AJR Am J Roentgenol 1993;161:985–8. https://doi.org/10.2214/ajr.161.5.8273642
Høyer C, Christensen MH, Sandermann J, Leusink R, Abrahamsen J. Chronic mesenteric ischaemia: the importance of the individual mesenteric artery. Clin Physiol Funct Imaging 2022;42:15–22. https://doi.org/10.1111/cpf.12730
Mensink PB, van Petersen AS, Geelkerken RH, Otte JA, Huisman AB, Kolkman JJ, et al. Clinical significance of splanchnic artery stenosis. Br J Surg 2006;93:1377–82. https://doi.org/10.1002/bjs.5481
van Noord D, Mensink PB, de Knegt RJ, Ouwendijk M, Francke J, van Vuuren AJ, et al. Serum markers and intestinal mucosal injury in chronic gastrointestinal ischemia. Dig Dis Sci 2011;56:506–12. https://doi.org/10.1007/s10620-010-1303-5
Mensink PB, Hol L, Borghuis-Koertshuis N, Geelkerken RH, Huisman AB, Doelman CJA, et al. Transient postprandial ischemia is associated with increased intestinal fatty acid binding protein in patients with chronic gastrointestinal ischemia. Eur J Gastroenterol Hepatol 2009;21:278–82. https://doi.org/10.1097/MEG. 0b013e32832183a7
van Noord D, Kolkman JJ. Functional testing in the diagnosis of chronic mesenteric ischemia. Best Pract Res Clin Gastroenterol 2017;31:59–68. https://doi.org/10.1016/j.bpg.2016.12.002
van Petersen AS, Meerwaldt R, Kolkman JJ, Huisman AB, van der Palen J, van Bockel JH, et al. The influence of respiration on criteria for transabdominal duplex examination of the splanchnic arteries in patients with suspected chronic splanchnic ischemia. J Vasc Surg 2013;57:1603–11, 1611.e1–10. https://doi.org/10.1016/j.jvs.2012.11.120
Zwolak RM, Fillinger MF, Walsh DB, LaBombard FA, Musson A, Darling CE, et al. Mesenteric and celiac duplex scanning: a validation study. J Vasc Surg 1998;27: 1078–88; discussion 1088. https://doi.org/10.1016/s0741-5214(98)60010-0
Schaefer PJ, Pfarr J, Trentmann J, Wulff A, Langer C, Siggelkow M, et al. Comparison of noninvasive imaging modalities for stenosis grading in mesenteric arteries. Rofo 2013; 185:628–34. https://doi.org/10.1055/s-0033-1335212
Cademartiri F, Palumbo A, Maffei E, Martini C, Malagò R, Belgrano M, et al. Noninvasive evaluation of the celiac trunk and superior mesenteric artery with multislice CT in patients with chronic mesenteric ischaemia. Radiol Med 2008;113:1135–42. https://doi.org/10.1007/s11547-008-0330-1
Pecoraro F, Rancic Z, Lachat M, Mayer D, Amann-Vesti B, Pfammatter T, et al. Chronic mesenteric ischemia: critical review and guidelines for management. Ann Vasc Surg 2013;27:113–22. https://doi.org/10.1016/j.avsg.2012.05.012
Gupta PK, Horan SM, Turaga KK, Miller WJ, Pipinos II. Chronic mesenteric ischemia: endovascular versus open revascularization. J Endovasc Ther 2010;17:540–9. https://doi.org/10.1583/09-2935.1
Huber TS, Björck M, Chandra A, Clouse WD, Dalsing MC, Oderich GS, et al. Chronic mesenteric ischemia: clinical practice guidelines from the society for vascular surgery. J Vasc Surg 2021;73:87s–115s. https://doi.org/10.1016/j.jvs.2020.10.029
Fernández-Friera L, Fuster V, López-Melgar B, Oliva B, Sánchez-González J, Macías A, et al. Vascular inflammation in subclinical atherosclerosis detected by hybrid PET/MRI. J Am Coll Cardiol 2019;73:1371–82. https://doi.org/10.1016/j.jacc.2018.12.075
Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O’Fallon WM, Pascoe RD, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke prevention: assessment of risk in a community. Mayo Clin Proc 1999;74:862–9. https://doi.org/10.4065/74.9.862
Russo C, Jin Z, Rundek T, Homma S, Sacco RL, Di Tullio MR. Atherosclerotic disease of the proximal aorta and the risk of vascular events in a population-based cohort: the Aortic Plaques and Risk of Ischemic Stroke (APRIS) study. Stroke 2009;40:2313–8. https://doi.org/10.1161/strokeaha.109.548313
Oyama N, Gona P, Salton CJ, Chuang ML, Jhaveri RR, Blease SJ, et al. Differential impact of age, sex, and hypertension on aortic atherosclerosis: the Framingham heart study. Arterioscler Thromb Vasc Biol 2008;28:155–9. https://doi.org/10.1161/atvbaha.107. 153544
Montgomery DH, Ververis JJ, McGorisk G, Frohwein S, Martin RP, Taylor WR. Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J Am Coll Cardiol 1996;27:95–101. https://doi.org/10.1016/0735-1097(95)00431-9
Amarenco P, Cohen A, Hommel M, Moulin T, Leys D, Bousser M-G. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996;334:1216–21. https://doi.org/10.1056/nejm199605093341902
Fujimoto S, Yasaka M, Otsubo R, Oe H, Nagatsuka K, Minematsu K. Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke. Stroke 2004;35:1426–9. https://doi.org/10.1161/01.STR.0000127788.32550.d4
Koren MJ, Bryant B, Hilton TC. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1995;332:1237–8. author reply 1237-1238. https://doi.org/10.1056/NEJM199505043321815
Meissner I, Khandheria BK, Sheps SG, Schwartz GL, Wiebers DO, Whisnant JP, et al. Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study. J Am Coll Cardiol 2004;44:1018–24. https://doi.org/10.1016/j.jacc.2004.05.075
Mitusch R, Doherty C, Wucherpfennig H, Memmesheimer C, Tepe C, Stierle U, et al. Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke 1997;28:36–9. https://doi.org/10.1161/01.str.28.1.36
Tunick PA, Rosenzweig BP, Katz ES, Freedberg RS, Perez JL, Kronzon I. High risk for vascular events in patients with protruding aortic atheromas: a prospective study. J Am Coll Cardiol 1994;23:1085–90. https://doi.org/10.1016/0735-1097(94)90595-9
Di Tullio MR, Russo C, Jin Z, Sacco RL, Mohr JP, Homma S. Aortic arch plaques and risk of recurrent stroke and death. Circulation 2009;119:2376–82. https://doi.org/10.1161/circulationaha.108.811935
Tunick PA, Nayar AC, Goodkin GM, Mirchandani S, Francescone S, Rosenzweig BP, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol 2002;90:1320–5. https://doi.org/10.1016/s0002-9149(02)02870-9
Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331–7. https://doi.org/10.1016/s0140-6736(04)16721-4
Bowdish ME, Weaver FA, Liebman HA, Rowe VL, Hood DB. Anticoagulation is an effective treatment for aortic mural thrombi. J Vasc Surg 2002;36:713–9.
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/ American Stroke Association. Stroke 2021;52:e364–467. https://doi.org/10.1161/str.0000000000000375
Amarenco P, Davis S, Jones EF, Cohen AA, Heiss W-D, Kaste M, et al. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke 2014;45: 1248–57. https://doi.org/10.1161/strokeaha.113.004251
Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012; 367:817–25. https://doi.org/10.1056/NEJMoa1204133
Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y, et al. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med 2020;382:9. https://doi.org/10.1056/NEJMoa1910355
Devereux RB, de Simone G, Arnett DK, Best LG, Boerwinkle E, Howard BV, et al. Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age. Am J Cardiol 2012;110: 1189–94. https://doi.org/10.1016/j.amjcard.2012.05.063
van Kimmenade RR, Kempers M, de Boer MJ, Loeys BL, Timmermans J. A clinical appraisal of different Z-score equations for aortic root assessment in the diagnostic evaluation of Marfan syndrome. Genet Med 2013;15:528–32. https://doi.org/10. 1038/gim.2012.172
Davies RR, Gallo A, Coady MA, Tellides G, Botta DM, Burke B, et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg 2006;81:169–77. https://doi.org/10.1016/j.athoracsur.2005.06.026
Hannawa KK, Eliason JL, Upchurch GR, Jr. Gender differences in abdominal aortic aneurysms. Vascular 2009;17:30–9. https://doi.org/10.2310/6670.2008.00092
Boczar KE, Cheung K, Boodhwani M, Beauchesne L, Dennie C, Nagpal S, et al. Sex differences in thoracic aortic aneurysm growth. Hypertension 2019;73:190–6. https://doi.org/10.1161/hypertensionaha.118.11851
Hultgren R, Larsson E, Wahlgren CM, Swedenborg J. Female and elderly abdominal aortic aneurysm patients more commonly have concurrent thoracic aortic aneurysm. Ann Vasc Surg 2012;26:918–23. https://doi.org/10.1016/j.avsg.2012.01.023
Chaer RA, Vasoncelos R, Marone LK, Al-Khoury G, Rhee RY, Cho JS, et al. Synchronous and metachronous thoracic aneurysms in patients with abdominal aortic aneurysms. J Vasc Surg 2012;56:1261–5. https://doi.org/10.1016/j.jvs.2012.04.056
Olsen PS, Schroeder T, Agerskov K, Agerskov K, Røder O, Sørensen S, et al. Surgery for abdominal aortic aneurysms. A survey of 656 patients. J Cardiovasc Surg 1991;32: 636–42.
Tuveson V, Löfdahl HE, Hultgren R. Patients with abdominal aortic aneurysm have a high prevalence of popliteal artery aneurysms. Vasc Med 2016;21:369–75. https://doi.org/10.1177/1358863x16648404
Brunkwall J, Hauksson H, Bengtsson H, Bergqvist D, Takolander R, Bergentz S-E. Solitary aneurysms of the iliac arterial system: an estimate of their frequency of occurrence. J Vasc Surg 1989;10:381–4. https://doi.org/10.1067/mva.1989.13733
Bickerstaff LK, Pairolero PC, Hollier LH, Melton LJ, Van Peenen HJ, Cherry KJ, et al. Thoracic aortic aneurysms: a population-based study. Surgery 1982;92:1103–8.
Coady MA, Rizzo JA, Goldstein LJ, Elefteriades JA. Natural history, pathogenesis, and etiology of thoracic aortic aneurysms and dissections. Cardiol Clin 1999;17:615–35; vii. https://doi.org/10.1016/s0733-8651(05)70105-3
Diwan A, Sarkar R, Stanley JC, Zelenock GB, Wakefield TW. Incidence of femoral and popliteal artery aneurysms in patients with abdominal aortic aneurysms. J Vasc Surg 2000;31:863–9. https://doi.org/10.1067/mva.2000.105955
Brown LC, Thompson SG, Greenhalgh RM, Powell JT. Incidence of cardiovascular events and death after open or endovascular repair of abdominal aortic aneurysm in the randomized EVAR trial 1. Br J Surg 2011;98:935–42. https://doi.org/10.1002/bjs. 7485
Hammo S, Grannas D, Wahlgren CM. High risk of early and late cardiovascular events after endovascular aortic aneurysm repair. Ann Vasc Surg 2022;86:320–7. https://doi.org/10.1016/j.avsg.2022.04.028
Kuzmik GA, Sang AX, Elefteriades JA. Natural history of thoracic aortic aneurysms. J Vasc Surg 2012;56:565–71. https://doi.org/10.1016/j.jvs.2012.04.053
Olsson C, Thelin S, Ståhle E, Ekbom A, Granath F. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation 2006;114:2611–8. https://doi.org/10.1161/circulationaha.106.630400
Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, et al. 2010 ACCF/ AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121:e266–369. https://doi.org/10.1161/CIR.0b013e3181d4739e
Goldfinger JZ, Halperin JL, Marin ML, Stewart AS, Eagle KA, Fuster V. Thoracic aortic aneurysm and dissection. J Am Coll Cardiol 2014;64:1725–39. https://doi.org/10.1016/j.jacc.2014.08.025
Caruana M, Baars MJ, Bashiardes E, Benke K, Björck E, Codreanu A, et al. HTAD patient pathway: strategy for diagnostic work-up of patients and families with (suspected) heritable thoracic aortic diseases (HTAD). A statement from the HTAD working group of VASCERN. Eur J Med Genet 2023;66:104673. https://doi.org/10.1016/j.ejmg.2022.104673
Patel HJ, Deeb GM. Ascending and arch aorta: pathology, natural history, and treatment. Circulation 2008;118:188–95. https://doi.org/10.1161/circulationaha.107. 690933
Boodhwani M, de Kerchove L, Glineur D, Poncelet A, Rubay J, Astarci P, et al. Repair-oriented classification of aortic insufficiency: impact on surgical techniques and clinical outcomes. J Thorac Cardiovasc Surg 2009;137:286–94. https://doi.org/10.1016/j.jtcvs.2008.08.054
Ganapathi AM, Ranney DN, Peterson MD, Lindsay ME, Patel HJ, Pyeritz RE, et al. Location of aortic enlargement and risk of type A dissection at smaller diameters. J Am Coll Cardiol 2022;79:1890–7. https://doi.org/10.1016/j.jacc.2022.02.053
Kalogerakos PD, Zafar MA, Li Y, Mukherjee SK, Ziganshin BA, Rizzo JA, et al. Root dilatation is more malignant than ascending aortic dilation. J Am Heart Assoc 2021;10: e020645. https://doi.org/10.1161/jaha.120.020645
Della Corte A, Bancone C, Buonocore M, Dialetto G, Covino FE, Manduca S, et al. Pattern of ascending aortic dimensions predicts the growth rate of the aorta in patients with bicuspid aortic valve. JACC Cardiovasc Imaging 2013;6:1301–10. https://doi.org/10.1016/j.jcmg.2013.07.009
Kim JB, Spotnitz M, Lindsay ME, MacGillivray TE, Isselbacher EM, Sundt TM. Risk of aortic dissection in the moderately dilated ascending aorta. J Am Coll Cardiol 2016;68: 1209–19. https://doi.org/10.1016/j.jacc.2016.06.025
Saeyeldin A, Zafar MA, Velasquez CA, Ip K, Gryaznov A, Brownstein AJ, et al. Natural history of aortic root aneurysms in Marfan syndrome. Ann Cardiothorac Surg 2017;6: 625–32. https://doi.org/10.21037/acs.2017.11.10
Cheung K, Boodhwani M, Chan KL, Beauchesne L, Dick A, Coutinho T. Thoracic aortic aneurysm growth: role of sex and aneurysm etiology. J Am Heart Assoc 2017;6: e003792. https://doi.org/10.1161/jaha.116.003792
Nataf P, Lansac E. Dilation of the thoracic aorta: medical and surgical management. Heart 2006;92:1345–52. https://doi.org/10.1136/hrt.2005.074781
Yiu RS, Cheng SW. Natural history and risk factors for rupture of thoracic aortic arch aneurysms. J Vasc Surg 2016;63:1189–94. https://doi.org/10.1016/j.jvs.2015.12.043
Coady MA, Rizzo JA, Hammond GL, Mandapati D, Darr U, Kopf GS, et al. What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Thorac Cardiovasc Surg 1997;113:476–91; discussion 489–491. https://doi.org/10.1016/ s0022-5223(97)70360-x
Safi HJ, Winnerkvist A, Miller CC, III, Iliopoulos DC, Reardon MJ, Espada R, et al. Effect of extended cross-clamp time during thoracoabdominal aortic aneurysm repair. Ann Thorac Surg 1998;66:1204–8. https://doi.org/10.1016/s0003-4975(98)00781-4
Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation 2005;111: 816–28. https://doi.org/10.1161/01.Cir.0000154569.08857.7a
Zafar MA, Chen JF, Wu J, Li Y, Papanikolaou D, Abdelbaky M, et al. Natural history of descending thoracic and thoracoabdominal aortic aneurysms. J Thorac Cardiovasc Surg 2021;161:498–511.e1. https://doi.org/10.1016/j.jtcvs.2019.10.125
Oladokun D, Patterson BO, Sobocinski J, Karthikesalingam A, Loftus I, Thompson MM, et al. Systematic review of the growth rates and influencing factors in thoracic aortic aneurysms. Eur J Vasc Endovasc Surg 2016;51:674–81. https://doi.org/10.1016/j.ejvs.2016.01.017
Davies RR, Goldstein LJ, Coady MA, Tittle SL, Rizzo JA, Kopf GS, et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg 2002;73:17–28; discussion 27–18. https://doi.org/10.1016/s0003-4975(01) 03236-2
Verloes A, Sakalihasan N, Koulischer L, Limet R. Aneurysms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees. J Vasc Surg 1995; 21:646–55. https://doi.org/10.1016/s0741-5214(95)70196-6
Thompson SG, Brown LC, Sweeting MJ, Bown MJ, Kim LG, Glover MJ, et al. Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness. Health Technol Assess 2013;17:1–118. https://doi.org/10.3310/hta17410
Sakalihasan N, Defraigne JO, Kerstenne MA, Cheramy-Bien J-P, Smelser DT, Tromp G, et al. Family members of patients with abdominal aortic aneurysms are at increased risk for aneurysms: analysis of 618 probands and their families from the Liege AAA family study. Ann Vasc Surg 2014;28:787–97. https://doi.org/10.1016/j.avsg.2013.11.005
Brown LC, Powell JT. Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK small aneurysm trial participants. Ann Surg 1999;230:289–96; discussion 296–287. https://doi.org/10.1097/00000658-199909000-00002
Mani K, Wanhainen A. Accurate and reproducible diameter measurement is essential in surveillance and treatment of thoracic aortic aneurysms. Eur J Vasc Endovasc Surg 2014;47:27. https://doi.org/10.1016/j.ejvs.2013.10.004
Isselbacher EM, Preventza O, Hamilton Black J, III, Augoustides JG, Beck AW, Bolen MA, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology joint committee on clinical practice guidelines. Circulation 2022;146:e334-482. https://doi.org/10.1161/cir.0000000000001106
Booher AM, Eagle KA. Diagnosis and management issues in thoracic aortic aneurysm. Am Heart J 2011;162:38–46.e1. https://doi.org/10.1016/j.ahj.2011.04.010
Wang TKM, Desai MY. Thoracic aortic aneurysm: optimal surveillance and treatment. Cleve Clin J Med 2020;87:557–68. https://doi.org/10.3949/ccjm.87a.19140-1
Roberts DA. Magnetic resonance imaging of thoracic aortic aneurysm and dissection. Semin Roentgenol 2001;36:295–308. https://doi.org/10.1053/sroe.2001.26938
Rajiah P. CT and MRI in the evaluation of thoracic aortic diseases. Int J Vasc Med 2013; 2013:797189. https://doi.org/10.1155/2013/797189
Lin FY, Devereux RB, Roman MJ, Meng J, Jow VM, Jacobs A, et al. Assessment of the thoracic aorta by multidetector computed tomography: age- and sex-specific reference values in adults without evident cardiovascular disease. J Cardiovasc Comput Tomogr 2008;2:298–308. https://doi.org/10.1016/j.jcct.2008.08.002
McPhee JT, Hill JS, Eslami MH. The impact of gender on presentation, therapy, and mortality of abdominal aortic aneurysm in the United States, 2001–2004. J Vasc Surg 2007;45:891–9. https://doi.org/10.1016/j.jvs.2007.01.043
Forsdahl SH, Singh K, Solberg S, Jacobsen BK. Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø study, 1994–2001. Circulation 2009;119: 2202–8. https://doi.org/10.1161/circulationaha.108.817619
Jahangir E, Lipworth L, Edwards TL, Kabagambe EK, Mumma MT, Mensah GA, et al. Smoking, sex, risk factors and abdominal aortic aneurysms: a prospective study of 18 782 persons aged above 65 years in the southern community cohort study. J Epidemiol Community Health 2015;69:481–8. https://doi.org/10.1136/jech-2014-204920
Strachan DP. Predictors of death from aortic aneurysm among middle-aged men: the Whitehall study. Br J Surg 2005;78:401–4. https://doi.org/10.1002/bjs.1800780407
Wanhainen A, Bergqvist D, Boman K, Nilsson TK, Rutegård J, Björck M. Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. J Vasc Surg 2005;41:390–6. https://doi.org/10.1016/j.jvs.2005.01.002
Kent KC, Zwolak RM, Egorova NN, Riles TS, Manganaro A, Moskowitz AJ, et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg 2010;52:539–48. https://doi.org/10.1016/j.jvs.2010.05.090
Raffort J, Lareyre F, Clément M, Hassen-Khodja R, Chinetti G, Mallat Z. Diabetes and aortic aneurysm: current state of the art. Cardiovasc Res 2018;114:1702–13. https://doi.org/10.1093/cvr/cvy174
Avdic T, Franzén S, Zarrouk M, Acosta S, Nilsson P, Gottsäter A, et al. Reduced long-term risk of aortic aneurysm and aortic dissection among individuals with type 2 diabetes mellitus: a nationwide observational study. J Am Heart Assoc 2018;7:e007618. https://doi.org/10.1161/jaha.117.007618
Nordness MJ, Baxter BT, Matsumura J, Terrin M, Zhang K, Ye F, et al. The effect of diabetes on abdominal aortic aneurysm growth over 2 years. J Vasc Surg 2022;75: 1211–22.e1. https://doi.org/10.1016/j.jvs.2021.10.019
Yusuf K, Murat B, Unal A, Ulku K, Taylan K, Ozerdem O, et al. Inflammatory abdominal aortic aneurysm: predictors of long-term outcome in a case-control study. Surgery 2007;141:83–9. https://doi.org/10.1016/j.surg.2006.04.007
Oliver-Williams C, Sweeting MJ, Turton G, Parkin D, Cooper D, Rodd C, et al. Lessons learned about prevalence and growth rates of abdominal aortic aneurysms from a 25-year ultrasound population screening programme. Br J Surg 2018;105:68–74. https://doi.org/10.1002/bjs.10715
Golledge J, Tsao PS, Dalman RL, Norman PE. Circulating markers of abdominal aortic aneurysm presence and progression. Circulation 2008;118:2382–92. https://doi.org/10.1161/circulationaha.108.802074
Vermeulen JJM, Meijer M, de Vries FBG, Reijnen MMPJ, Holewijn S, Thijssen DHJ, et al. A systematic review summarizing local vascular characteristics of aneurysm wall to predict for progression and rupture risk of abdominal aortic aneurysms. J Vasc Surg 2023;77:288–98.e2. https://doi.org/10.1016/j.jvs.2022.07.008
Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 2004; 110:16–21. https://doi.org/10.1161/01.Cir.0000133279.07468.9f
Malayala SV, Raza A, Vanaparthy R. Gender-based differences in abdominal aortic aneurysm rupture: a retrospective study. J Clin Med Res 2020;12:794–802. https://doi.org/10.14740/jocmr4376
Skibba AA, Evans JR, Hopkins SP, Yoon HR, Katras T, Kalbfleisch JH, et al. Reconsidering gender relative to risk of rupture in the contemporary management of abdominal aortic aneurysms. J Vasc Surg 2015;62:1429–36. https://doi.org/10.1016/j.jvs.2015.07.079
Catalano O, Siani A. Ruptured abdominal aortic aneurysm: categorization of sonographic findings and report of 3 new signs. J Ultrasound Med 2005;24:1077–83. https://doi.org/10.7863/jum.2005.24.8.1077
Schermerhorn ML, Bensley RP, Giles KA, Hurks R, O’Malley AJ, Cotterill P, et al. Changes in abdominal aortic aneurysm rupture and short-term mortality, 1995-2008: a retrospective observational study. Ann Surg 2012;256:651–8. https://doi.org/10.1097/SLA.0b013e31826b4f91
Rakita D, Newatia A, Hines JJ, Siegel DN, Friedman B. Spectrum of CT findings in rupture and impending rupture of abdominal aortic aneurysms. Radiographics 2007;27: 497–507. https://doi.org/10.1148/rg.272065026
Schwartz SA, Taljanovic MS, Smyth S, O’Brien MJ, Rogers LF. CT findings of rupture, impending rupture, and contained rupture of abdominal aortic aneurysms. AJR Am J Roentgenol 2007;188:W57–62. https://doi.org/10.2214/ajr.05.1554
Tomee SM, Bulder RMA, Meijer CA, van Berkum I, Hinnen J-W, Schoones JW, et al. Excess mortality for abdominal aortic aneurysms and the potential of strict implementation of cardiovascular risk management: a multifaceted study integrating meta-analysis, national registry, and PHAST and TEDY trial data. Eur J Vasc Endovasc Surg 2023;65:348–57. https://doi.org/10.1016/j.ejvs.2022.11.019
Freiberg MS, Arnold AM, Newman AB, Edwards MS, Kraemer KL, Kuller LH. Abdominal aortic aneurysms, increasing infrarenal aortic diameter, and risk of total mortality and incident cardiovascular disease events: 10-year follow-up data from the cardiovascular health study. Circulation 2008;117:1010–7. https://doi.org/10.1161/circulationaha.107.720219
Bown MJ, Sweeting MJ, Brown LC, Powell JT, Thompson SG. Surveillance intervals for small abdominal aortic aneurysms: a meta-analysis. JAMA 2013;309:806–13. https://doi.org/10.1001/jama.2013.950
Dugas A, Therasse E, Kauffmann C, Tang A, Elkouri S, Nozza A, et al. Reproducibility of abdominal aortic aneurysm diameter measurement and growth evaluation on axial and multiplanar computed tomography reformations. Cardiovasc Intervent Radiol 2012;35: 779–87. https://doi.org/10.1007/s00270-011-0259-y
Kontopodis N, Metaxa E, Gionis M, Papaharilaou Y, Ioannou CV. Discrepancies in determination of abdominal aortic aneurysms maximum diameter and growth rate, using axial and orhtogonal computed tomography measurements. Eur J Radiol 2013;82: 1398–403. https://doi.org/10.1016/j.ejrad.2013.04.031
Foo FJ, Hammond CJ, Goldstone AR, Abuhamdiah M, Rashid ST, West RM, et al. Agreement between computed tomography and ultrasound on abdominal aortic aneurysms and implications on clinical decisions. Eur J Vasc Endovasc Surg 2011;42: 608–14. https://doi.org/10.1016/j.ejvs.2011.07.003
Zhu C, Tian B, Leach JR, Liu Q, Lu J, Chen L, et al. Non-contrast 3D black blood MRI for abdominal aortic aneurysm surveillance: comparison with CT angiography. Eur Radiol 2017;27:1787–94. https://doi.org/10.1007/s00330-016-4559-0
Sakalihasan N, Michel JB, Katsargyris A, Kuivaniemi H, Defraigne J-O, Nchimi A, et al. Abdominal aortic aneurysms. Nat Rev Dis Primers 2018;4:34. https://doi.org/10.1038/ s41572-018-0030-7
Wemmelund H, Jørgensen TM, Høgh A, Behr-Rasmussen C, Johnsen SP, Lindholt JS, et al. Low-dose aspirin and rupture of abdominal aortic aneurysm. J Vasc Surg 2017;65: 616–5.e4. https://doi.org/10.1016/j.jvs.2016.04.061
Wanhainen A, Mani K, Kullberg J, Svensjö S, Bersztel A, Karlsson L, et al. The effect of ticagrelor on growth of small abdominal aortic aneurysms–a randomized controlled trial. Cardiovasc Res 2020;116:450–6. https://doi.org/10.1093/cvr/cvz133
Golledge J, Thanigaimani S, Powell JT, Tsao PS. Pathogenesis and management of abdominal aortic aneurysm. Eur Heart J 2023;44:2682–97. https://doi.org/10.1093/eurheartj/ehad386
Sweeting MJ, Thompson SG, Brown LC, Powell JT, Collaborators R. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg 2012;99:655–65. https://doi.org/10.1002/bjs.8707
Golledge J, Moxon J, Pinchbeck J, Anderson G, Rowbotham S, Jenkins J, et al. Association between metformin prescription and growth rates of abdominal aortic aneurysms. Br J Surg 2017;104:1486–93. https://doi.org/10.1002/bjs.10587
Thanigaimani S, Singh TP, Unosson J, Phie J, Moxon J, Wanhainen A, et al. Editor’s choice—association between metformin prescription and abdominal aortic aneurysm growth and clinical events: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2021;62:747–56. https://doi.org/10.1016/j.ejvs.2021.06.013
Wong KHF, Zlatanovic P, Bosanquet DC, Saratzis A, Kakkos SK, Aboyans V, et al. Antithrombotic therapy for aortic aneurysms: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2022;64:544–56. https://doi.org/10.1016/j.ejvs.2022.07.008
Newton ER, Akerman AW, Strassle PD, Kibbe MR. Association of fluoroquinolone use with short-term risk of development of aortic aneurysm. JAMA Surg 2021;156:264–72. https://doi.org/10.1001/jamasurg.2020.6165
Wee I, Chin B, Syn N, Lee KS, Ng JJ, Choong AMTL. The association between fluoroquinolones and aortic dissection and aortic aneurysms: a systematic review and meta-analysis. Sci Rep 2021;11:11073. https://doi.org/10.1038/s41598-021-90692-8
Pasternak B, Inghammar M, Svanström H. Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study. BMJ 2018;360:k678. https://doi.org/10.1136/bmj.k678
Garg M, Venugopalan V, Vouri SM, Diaby V, Iovine NM, Park H, et al. Oral fluoroquinolones and risk of aortic aneurysm or dissection: a nationwide population-based propensity score-matched cohort study. Pharmacotherapy 2023;43:883–93. https://doi.org/10.1002/phar.2841
Fatima K, Uzair SU, Salman A, Jawed A, Husain MA, Shah MG, et al. Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: an updated systematic review and meta-analysis including 53,651,283 patients. Minerva Cardiol Angiol 2023;71:485–93. https://doi.org/10.23736/S2724-5683.22.06124-5
LeMaire SA, Zhang L, Luo W, Ren P, Azares AR, Wang Y, et al. Effect of ciprofloxacin on susceptibility to aortic dissection and rupture in mice. JAMA Surg 2018;153: e181804. https://doi.org/10.1001/jamasurg.2018.1804
Brown JP, Wing K, Leyrat C, Evans SJ, Mansfield KE, Wong AYS, et al. Association between fluoroquinolone use and hospitalization with aortic aneurysm or aortic dissection. JAMA Cardiol 2023;8:865. https://doi.org/10.1001/jamacardio.2023.2418
Gopalakrishnan C, Bykov K, Fischer MA, Connolly JG, Gagne JJ, Fralick M. Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection. JAMA Intern Med 2020;180:1596–605. https://doi.org/10.1001/jamainternmed.2020.4199
Lee CC, Lee MT, Chen YS, Lee S-H, Chen Y-S, Chen S-C, et al. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone. JAMA Intern Med 2015; 175:1839–47. https://doi.org/10.1001/jamainternmed.2015.5389
Huh K, Kang M, Jung J. Lack of association between fluoroquinolone and aortic aneurysm or dissection. Eur Heart J 2023;44:4476–84. https://doi.org/10.1093/eurheartj/ ehad627
Klotz S, Stock S, Sievers HH, Diwoky M, Petersen M, Stierle U, et al. Survival and re-operation pattern after 20 years of experience with aortic valve-sparing root replacement in patients with tricuspid and bicuspid valves. J Thorac Cardiovasc Surg 2018;155: 1403–11.e1. https://doi.org/10.1016/j.jtcvs.2017.12.039
Lee H, Cho YH, Sung K, Kim WS, Park K-H, Jeong DS, et al. Clinical outcomes of root reimplantation and Bentall procedure: propensity score matching analysis. Ann Thorac Surg 2018;106:539–47. https://doi.org/10.1016/j.athoracsur.2018.02.057
Mastrobuoni S, de Kerchove L, Navarra E, Watremez C, Vancraeynest D, Rubay J, et al. Long-term experience with valve-sparing reimplantation technique for the treatment of aortic aneurysm and aortic regurgitation. J Thorac Cardiovasc Surg 2019;158:14–23. https://doi.org/10.1016/j.jtcvs.2018.10.155
Leontyev S, Schamberger L, Davierwala PM, Von Aspern K, Etz C, Lehmann S, et al. Early and late results after David vs Bentall procedure: a propensity matched analysis. Ann Thorac Surg 2020;110:120–6. https://doi.org/10.1016/j.athoracsur.2019.10.020
Elbatarny M, Tam DY, Edelman JJ, Rocha RV, Chu MWA, Peterson MD, et al. Valve-sparing root replacement versus composite valve grafting in aortic root dilation: a meta-analysis. Ann Thorac Surg 2020;110:296–306. https://doi.org/10.1016/j.athoracsur.2019.11.054
Leyh RG, Fischer S, Kallenbach K, Kofidis T, Pethig K, Harringer W, et al. High failure rate after valve-sparing aortic root replacement using the “remodeling technique” in acute type A aortic dissection. Circulation 2002;106:I229–33.
Schäfers H, Fries R, Langer F, Nikoloudakis N, Graeter T, Grundmann U. Valve-preserving replacement of the ascending aorta: remodeling versus reimplantation. J Thorac Cardiovasc Surg 1998;116:990–6. https://doi.org/10.1016/s0022-5223(98)70051-0
Rahnavardi M, Yan TD, Bannon PG, Wilson MK. Aortic valve-sparing operations in aortic root aneurysms: remodeling or reimplantation? Interact Cardiovasc Thorac Surg 2011;13:189–97. https://doi.org/10.1510/icvts.2011.267401
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/ EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022;43: 561–632. https://doi.org/10.1093/eurheartj/ehab395
Mok CK, Boey J, Wang R, Chan TK, Cheung KL, Lee PK, et al. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. Circulation 1985;72: 1059–63. https://doi.org/10.1161/01.cir.72.5.1059
Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635–41. https://doi.org/10.1161/01.cir.89.2.635
Brennan JM, Edwards FH, Zhao Y, O’Brien S, Booth ME, Dokholyan RS, et al. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. J Am Coll Cardiol 2012; 60:971–7. https://doi.org/10.1016/j.jacc.2012.05.029
Rafiq S, Steinbrüchel DA, Lilleør NB, Møller CH, Lund JT, Thiis JJ, et al. Antithrombotic therapy after bioprosthetic aortic valve implantation: warfarin versus aspirin, a randomized controlled trial. Thromb Res 2017;150:104–10. https://doi.org/10.1016/j.thromres.2016.11.021
Czerny M, Rylski B, Della Corte A, Krüger T. Decision-making to perform elective surgery for patients with proximal thoracic aortic pathology: a European perspective. J Thorac Cardiovasc Surg 2022;163:2025–30. https://doi.org/10.1016/j.jtcvs.2021.01.141
Vorp DA, Schiro BJ, Ehrlich MP, Juvonen TS, Ergin MA, Griffith BP. Effect of aneurysm on the tensile strength and biomechanical behavior of the ascending thoracic aorta. Ann Thorac Surg 2003;75:1210–4. https://doi.org/10.1016/s0003-4975(02)04711-2
Della Corte A, Lo Presti F, Saade W, Rubino AS, Palmieri L, Patanè F, et al. Acute type A aortic dissection in bicuspid versus tricuspid aortic valve patients: focus on geometrical features of the aorta. Eur J Cardiothorac Surg 2023;63:ezac576. https://doi.org/10.1093/ejcts/ezac576
Mullan CW, Mori M, Bin Mahmood SU, Yousef S, Mangi AA, Elefteriades JA, et al. Incidence and characteristics of hospitalization for proximal aortic surgery for acute syndromes and for aneurysms in the USA from 2005 to 2014. Eur J Cardiothorac Surg 2020;58:583–9. https://doi.org/10.1093/ejcts/ezaa067
Williams JB, Peterson ED, Zhao Y, O’Brien SM, Andersen ND, Miller DC, et al. Contemporary results for proximal aortic replacement in North America. J Am Coll Cardiol 2012;60:1156–62. https://doi.org/10.1016/j.jacc.2012.06.023
Wallen T, Habertheuer A, Bavaria JE, Hughes GC, Badhwar V, Jacobs JP, et al. Elective aortic root replacement in North America: analysis of STS adult cardiac surgery database. Ann Thorac Surg 2019;107:1307–12. https://doi.org/10.1016/j.athoracsur.2018.12.039
Mori M, Shioda K, Wang X, Mangi AA, Yun JJ, Darr U, et al. Perioperative risk profiles and volume-outcome relationships in proximal thoracic aortic surgery. Ann Thorac Surg 2018;106:1095–104. https://doi.org/10.1016/j.athoracsur.2018.05.081
Wojnarski CM, Svensson LG, Roselli EE, Idrees JJ, Lowry AM, Ehrlinger J, et al. Aortic dissection in patients with bicuspid aortic valve-associated aneurysms. Ann Thorac Surg 2015;100:1666–73; discussion 1673–74. https://doi.org/10.1016/j.athoracsur.2015.04. 126
Wu J, Zafar MA, Liu Y, Chen JF, Li Y, Ziganshin BA, et al. Fate of the unoperated ascending thoracic aortic aneurysm: three-decade experience from the Aortic Institute at Yale University. Eur Heart J 2023;44:4579–88. https://doi.org/10.1093/eurheartj/ehad148
Ziganshin BA, Zafar MA, Elefteriades JA. Descending threshold for ascending aortic aneurysmectomy: is it time for a “left-shift” in guidelines? J Thorac Cardiovasc Surg 2019; 157:37–42. https://doi.org/10.1016/j.jtcvs.2018.07.114
Rylski B, Branchetti E, Bavaria JE, Vallabhajosyula P, Szeto WY, Milewski RK, et al. Modeling of predissection aortic size in acute type A dissection: more than 90% fail to meet the guidelines for elective ascending replacement. J Thorac Cardiovasc Surg 2014;148:944–8.e1. https://doi.org/10.1016/j.jtcvs.2014.05.050
Mansour AM, Peterss S, Zafar MA, Rizzo JA, Fang H, Charilaou P, et al. Prevention of aortic dissection suggests a diameter shift to a lower aortic size threshold for intervention. Cardiology 2018;139:139–46. https://doi.org/10.1159/000481930
Masri A, Kalahasti V, Alkharabsheh S, Svensson LG, Sabik JF, Roselli EE, et al. Characteristics and long-term outcomes of contemporary patients with bicuspid aortic valves. J Thorac Cardiovasc Surg 2016;151:1650–9.e1. https://doi.org/10.1016/j.jtcvs.2015.12.019
Winkler A, Puiu P, Krombholz-Reindl P, Vötsch A, Steindl J, Neuner M, et al. Impact of concomitant replacement of the ascending aorta in patients undergoing aortic valve replacement on operative morbidity and mortality. Eur J Cardiothorac Surg 2022;61: 587–93. https://doi.org/10.1093/ejcts/ezab420
Peterss S, Charilaou P, Dumfarth J, Li Y, Bhandari R, Tranquilli M, et al. Aortic valve disease with ascending aortic aneurysm: impact of concomitant root-sparing (supra-coronary) aortic replacement in nonsyndromic patients. J Thorac Cardiovasc Surg 2016;152:791–8.e1. https://doi.org/10.1016/j.jtcvs.2016.05.020
Lim JY, Jung SH, Kim JB, Kim DK, Chung CH, Song H, et al. Concomitant replacement of the dilated ascending aorta during aortic valve replacement; does it increase the perioperative morbidity and mortality risks? J Card Surg 2013;28:285–90. https://doi.org/10.1111/jocs.12111
Idrees JJ, Roselli EE, Lowry AM, Reside JM, Javadikasgari H, Johnson DJ, et al. Outcomes after elective proximal aortic replacement: a matched comparison of isolated versus multicomponent operations. Ann Thorac Surg 2016;101:2185–92. https://doi.org/10.1016/j.athoracsur.2015.12.026
Idrees JJ, Roselli EE, Blackstone EH, Lowry AM, Soltesz EG, Johnston DR, et al. Risk of adding prophylactic aorta replacement to a cardiac operation. J Thorac Cardiovasc Surg 2020;159:1669–78.e10. https://doi.org/10.1016/j.jtcvs.2019.05.001
Grabenwöger M, Alfonso F, Bachet J, Bonser R, Czerny M, Eggebrecht H, et al. Thoracic Endovascular Aortic Repair (TEVAR) for the treatment of aortic diseases: a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2012;33:1558–63. https://doi.org/10.1093/eurheartj/ehs074
Eggebrecht H, Thompson M, Rousseau H, Czerny M, Lönn L, Mehta RH, et al. Retrograde ascending aortic dissection during or after thoracic aortic stent graft placement: insight from the European registry on endovascular aortic repair complications. Circulation 2009;120:S276–281. https://doi.org/10.1161/circulationaha.108.835926
Zerwes S, Leissner G, Gosslau Y, Jakob R, Bruijnen H-K, Oertl F, et al. Clinical outcomes in hybrid repair procedures for pathologies involving the aortic arch. Vascular 2015;23:9–16. https://doi.org/10.1177/1708538114525608
Czerny M, Weigang E, Sodeck G, Schmidli J, Antona C, Gelpi G, et al. Targeting landing zone 0 by total arch rerouting and TEVAR: midterm results of a transcontinental registry. Ann Thorac Surg 2012;94:84–9. https://doi.org/10.1016/j.athoracsur.2012.03.024
Chiesa R, Melissano G, Tshomba Y, Civilini E, Marone EM, Bertoglio L, et al. Ten years of endovascular aortic arch repair. J Endovasc Ther 2010;17:1–11. https://doi.org/10.1583/09-2884.1
Shrestha M, Bachet J, Bavaria J, Carrel TP, De Paulis R, Di Bartolomeo R, et al. Current status and recommendations for use of the frozen elephant trunk technique: a position paper by the vascular domain of EACTS. Eur J Cardiothorac Surg 2015;47:759–69. https://doi.org/10.1093/ejcts/ezv085
Czerny M, Schmidli J, Adler S, van den Berg JC, Bertoglio L, Carrel T, et al. Current options and recommendations for the treatment of thoracic aortic pathologies involving the aortic arch: an expert consensus document of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society for Vascular Surgery (ESVS). Eur J Cardiothorac Surg 2019;55:133–62. https://doi.org/10.1093/ejcts/ezy313
Abjigitova D, Veen KM, van Tussenbroek G, Mokhles MM, Bekkers JA, Takkenberg JJM, et al. Cerebral protection in aortic arch surgery: systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 2022;35:ivac270. https://doi.org/10.1093/icvts/ivac128
1000. Malaisrie SC, Duncan BF, Mehta CK, Badiwala MV, Rinewalt D, Kruse J, et al. The addition of hemiarch replacement to aortic root surgery does not affect safety. J Thorac Cardiovasc Surg 2015;150:118–24.e2. https://doi.org/10.1016/j.jtcvs.2015.03.020
1001. Borger MA, Fedak PWM, Stephens EH, Gleason TG, Girdauskas E, Ikonomidis JS, et al. The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: full online-only version. J Thorac Cardiovasc Surg 2018;156:e41–74. https://doi.org/10.1016/j.jtcvs.2018.02.115
1002. Kim JB, Kim K, Lindsay ME, MacGillivray T, Isselbacher EM, Cambria RP, et al. Risk of rupture or dissection in descending thoracic aortic aneurysm. Circulation 2015;132: 1620–9. https://doi.org/10.1161/circulationaha.114.015177
1003. Chen JF, Zafar MA, Wu J, Li Y, Rizzo JA, Papanikolaou D, et al. Increased virulence of descending thoracic and thoracoabdominal aortic aneurysms in women. Ann Thorac Surg 2021;112:45–52. https://doi.org/10.1016/j.athoracsur.2020.08.026
1004. Lobato AC, Puech-Leão P. Predictive factors for rupture of thoracoabdominal aortic aneurysm. J Vasc Surg 1998;27:446–53. https://doi.org/10.1016/s0741-5214(98) 70319-2
1005. Harris DG, Olson SL, Panthofer AM, Matsumura JS, DiMusto PD. A frailty-based risk score predicts morbidity and mortality after elective endovascular repair of descending thoracic aortic aneurysms. Ann Vasc Surg 2020;67:90–9. https://doi.org/10.1016/j.avsg.2019.10.090
1006. Goodney PP, Travis L, Lucas FL, Fillinger MF, Goodman DC, Cronenwett JL, et al. Survival after open versus endovascular thoracic aortic aneurysm repair in an observational study of the Medicare population. Circulation 2011;124:2661–9. https://doi.org/10.1161/circulationaha.111.033944
1007. Grausgruber W, Scharfen E. Problems of the fight against zoonoses in Austria. Wien Tierarztl Monatsschr 1968;55:625–36.
1008. Chiu P, Goldstone AB, Schaffer JM, Lingala B, Miller DC, Mitchell RS, et al. Endovascular versus open repair of intact descending thoracic aortic aneurysms. J Am Coll Cardiol 2019;73:643–51. https://doi.org/10.1016/j.jacc.2018.10.086
1009. Fairman RM, Criado F, Farber M, Kwolek C, Mehta M, White R, et al. Pivotal results of the medtronic vascular talent thoracic stent graft system: the VALOR trial. J Vasc Surg 2008;48:546–54.e2. https://doi.org/10.1016/j.jvs.2008.03.061
1010. Matsumura JS, Cambria RP, Dake MD, Moore RD, Svensson LG, Snyder S. International controlled clinical trial of thoracic endovascular aneurysm repair with the Zenith TX2 endovascular graft: 1-year results. J Vasc Surg 2008;47:247–57; discussion 257. https://doi.org/10.1016/j.jvs.2007.10.032
1011. Coselli JS, Bozinovski J, LeMaire SA. Open surgical repair of 2286 thoracoabdominal aortic aneurysms. Ann Thorac Surg 2007;83:S862–4; discussion S890–862. https://doi.org/10.1016/j.athoracsur.2006.10.088
1012. Coselli JS, Green SY, Price MD, Hash JA, Ouyang Y, Volguina IV, et al. Results of open surgical repair in patients with Marfan syndrome and distal aortic dissection. Ann Thorac Surg 2016;101:2193–201. https://doi.org/10.1016/j.athoracsur.2015.11.008
1013. Tong MZ, Eagleton MJ, Roselli EE, Blackstone EH, Xiang F, Ibrahim M, et al. Outcomes of open versus endovascular repair of descending thoracic and thoracoabdominal aortic aneurysms. Ann Thorac Surg 2022;113:1144–52. https://doi.org/10.1016/j.athoracsur.2021.04.100
1014. Goldstein LJ, Davies RR, Rizzo JA, Davila JJ, Cooperberg MR, Shaw RK, et al. Stroke in surgery of the thoracic aorta: incidence, impact, etiology, and prevention. J Thorac Cardiovasc Surg 2001;122:935–45. https://doi.org/10.1067/mtc.2001.117276
1015. Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 1993;17:357–68; discussion 368–70.
1016. Schermerhorn ML, Giles KA, Hamdan AD, Dalhberg SE, Hagberg R, Pomposelli F. Population-based outcomes of open descending thoracic aortic aneurysm repair. J Vasc Surg 2008;48:821–7. https://doi.org/10.1016/j.jvs.2008.05.022
1017. Yamauchi T, Takano H, Nishimura M, Matsumiya G, Sawa Y. Paraplegia and paraparesis after descending thoracic aortic aneurysm repair: a risk factor analysis. Ann Thorac Cardiovasc Surg 2006;12:179–83.
1018. Patel VI, Mukhopadhyay S, Ergul E, Aranson N, Conrad MF, LaMuraglia GM, et al. Impact of hospital volume and type on outcomes of open and endovascular repair of descending thoracic aneurysms in the United States Medicare population. J Vasc Surg 2013;58:346–54. https://doi.org/10.1016/j.jvs.2013.01.035
1019. Cheng D, Martin J, Shennib H, Dunning J, Muneretto C, Schueler S, et al. Endovascular aortic repair versus open surgical repair for descending thoracic aortic disease a systematic review and meta-analysis of comparative studies. J Am Coll Cardiol 2010;55: 986–1001. https://doi.org/10.1016/j.jacc.2009.11.047
1020. Harky A, Kai Chan JS, Ming Wong CH, Bashir M. Open versus endovascular repair of descending thoracic aortic aneurysm disease: a systematic review and meta-analysis. Ann Vasc Surg 2019;54:304–15.e5. https://doi.org/10.1016/j.avsg.2018.05.043
1021. Ranney DN, Cox ML, Yerokun BA, Benrashid E, McCann RL, Hughes GC. Long-term results of endovascular repair for descending thoracic aortic aneurysms. J Vasc Surg 2018;67:363–8. https://doi.org/10.1016/j.jvs.2017.06.094
1022. Biancari F, Mariscalco G, Mariani S, Saari P, Satta J, Juvonen T. Endovascular treatment of degenerative aneurysms involving only the descending thoracic aorta: systematic review and meta-analysis. J Endovasc Ther 2016;23:387–92. https://doi.org/10.1177/ 1526602815626560
1023. Mousa AY, Morcos R, Broce M, Bates MC, AbuRahma AF. New preoperative spinal cord ischemia risk stratification model for patients undergoing thoracic endovascular aortic repair. Vasc Endovascular Surg 2020;54:487–96. https://doi.org/10.1177/ 1538574420929135
1024. Walsh SR, Tang TY, Sadat U, Naik J, Gaunt ME, Boyle JR, et al. Endovascular stenting versus open surgery for thoracic aortic disease: systematic review and meta-analysis of perioperative results. J Vasc Surg 2008;47:1094–8.e3. https://doi.org/10.1016/j.jvs.2007.09.062
1025. Kotelis D, Geisbüsch P, Hinz U, Hyhlik-Dürr A, von Tengg-Kobligk H, Allenberg JR, et al. Short and midterm results after left subclavian artery coverage during endovascular repair of the thoracic aorta. J Vasc Surg 2009;50:1285–92. https://doi. org/10.1016/j.jvs.2009.07.106
1026. Cooper DG, Walsh SR, Sadat U, Noorani A, Hayes PD, Boyle JR, et al. Neurological complications after left subclavian artery coverage during thoracic endovascular aortic repair: a systematic review and meta-analysis. J Vasc Surg 2009;49:1594–601. https://doi.org/10.1016/j.jvs.2008.12.075
1027. Buth J, Harris PL, Hobo R, van Eps R, Cuypers P, Duijm L, et al. Neurologic complications associated with endovascular repair of thoracic aortic pathology: incidence and risk factors. a study from the European Collaborators on Stent/Graft Techniques for Aortic Aneurysm Repair (EUROSTAR) registry. J Vasc Surg 2007;46:1103–10; discussion 1110–1. https://doi.org/10.1016/j.jvs.2007.08.020
1028. Teixeira PG, Woo K, Beck AW, Scali ST, Weaver FA. Association of left subclavian artery coverage without revascularization and spinal cord ischemia in patients undergoing thoracic endovascular aortic repair: a Vascular Quality Initiative® analysis. Vascular 2017;25:587–97. https://doi.org/10.1177/1708538116681910
1029. Chen X, Wang J, Premaratne S, Zhao J, Zhang WW. Meta-analysis of the outcomes of revascularization after intentional coverage of the left subclavian artery for thoracic endovascular aortic repair. J Vasc Surg 2019;70:1330–40. https://doi.org/10.1016/j.jvs.2019.03.022
1030. Banno H, Ikeda S, Kawai Y, Meshii K, Takahashi N, Sugimoto M, et al. Early and midterm outcomes of celiac artery coverage during thoracic endovascular aortic repair. J Vasc Surg 2020;72:1552–7. https://doi.org/10.1016/j.jvs.2020.02.025
1031. Argyriou C, Spiliopoulos S, Katsanos K, Papatheodorou N, Lazarides MK, Georgiadis GS. Safety and efficacy of intentional celiac artery coverage in endovascular management of thoracoabdominal aortic diseases: a systematic review and meta-analysis. J Endovasc Ther 2022;29:646–58. https://doi.org/10.1177/15266028211059451
1032. Hanna L, Lam K, Agbeko AE, Amoako JK, Ashrafian H, Sounderajah V, et al. Coverage of the coeliac artery during thoracic endovascular aortic repair: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2022;63:828–37. https://doi.org/10.1016/j.ejvs.2022.02.026
1033. Cambria RA, Gloviczki P, Stanson AW, Cherry KJ, Bower TC, Hallett JW, et al. Outcome and expansion rate of 57 thoracoabdominal aortic aneurysms managed nonoperatively. Am J Surg 1995;170:213–7. https://doi.org/10.1016/s0002-9610(99) 80289-x
1034. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 2002;74:S1877–80; discussion S1892–8. https://doi.org/10.1016/s0003-4975(02)04147-4
1035. Girardi LN, Ohmes LB, Lau C, Di Franco A, Gambardella I, Elsayed M, et al. Open repair of descending thoracic and thoracoabdominal aortic aneurysms in patients with preoperative renal failure. Eur J Cardiothorac Surg 2017;51:971–7. https://doi.org/10.1093/ejcts/ezx007
1036. LeMaire SA, Miller CC, III, Conklin LD, Schmittling ZC, Köksoy C, Coselli JS, et al. A new predictive model for adverse outcomes after elective thoracoabdominal aortic aneurysm repair. Ann Thorac Surg 2001;71:1233–8. https://doi.org/10.1016/s0003-4975(00)02678-3
1037. Suzuki S, Davis CA, III, Miller CC, III, Huynh TT, Estrera AL, Porat EE, et al. Cardiac function predicts mortality following thoracoabdominal and descending thoracic aortic aneurysm repair. Eur J Cardiothorac Surg 2003;24:119–24; discussion 124. https://doi.org/10.1016/s1010-7940(03)00170-2
1038. Mohebali J, Carvalho S, Lancaster RT, Ergul EA, Conrad MF, Clouse WD, et al. Use of extracorporeal bypass is associated with improved outcomes in open thoracic and thoracoabdominal aortic aneurysm repair. J Vasc Surg 2018;68:941–7. https://doi.org/10.1016/j.jvs.2017.12.072
1039. Coselli JS, LeMaire SA, Preventza O, de la Cruz KI, Cooley DA, Price MD, et al. Outcomes of 3309 thoracoabdominal aortic aneurysm repairs. J Thorac Cardiovasc Surg 2016;151:1323–38. https://doi.org/10.1016/j.jtcvs.2015.12.050
1040. Drinkwater SL, Goebells A, Haydar A, Bourke P, Brown L, Hamady M, et al.. The incidence of spinal cord ischaemia following thoracic and thoracoabdominal aortic endovascular intervention. Eur J Vasc Endovasc Surg 2010;40:729–35. https://doi.org/10.1016/j.ejvs.2010.08.013
1041. Bicknell CD, Riga CV, Wolfe JH. Prevention of paraplegia during thoracoabdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2009;37:654–60. https://doi.org/10.1016/j.ejvs.2009.02.008
1042. Von Aspern K, Luehr M, Mohr FW, Etz CD. Spinal cord protection in open- and endovascular thoracoabdominal aortic aneurysm repair: critical review of current concepts and future perspectives. J Cardiovasc Surg (Torino) 2015;56:745–9.
1043. Hsu CC, Kwan GN, van Driel ML, Rophael JA. Distal aortic perfusion during thoracoabdominal aneurysm repair for prevention of paraplegia. Cochrane Database Syst Rev 2012;3:CD008197. https://doi.org/10.1002/14651858.CD008197.pub2
1044. Bischoff MS, Di Luozzo G, Griepp EB, Griepp RB. Spinal cord preservation in thoracoabdominal aneurysm repair. Perspect Vasc Surg Endovasc Ther 2011;23:214–22. https://doi.org/10.1177/1531003511400622
1045. Cowan JA, Jr, Dimick JB, Henke PK, Huber TS, Stanley JC, Upchurch GR. Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: hospital and surgeon volume-related outcomes. J Vasc Surg 2003;37:1169–74. https://doi.org/10.1016/s0741-5214(03)00085-5
1046. Rigberg DA, McGory ML, Zingmond DS, Maggard MA, Agustin M, Lawrence PF, et al. Thirty-day mortality statistics underestimate the risk of repair of thoracoabdominal aortic aneurysms: a statewide experience. J Vasc Surg 2006;43:217–22; discussion 223. https://doi.org/10.1016/j.jvs.2005.10.070
1047. Pomy BJ, Rosenfeld ES, Lala S, Lee KB, Sparks AD, Amdur RL, et al. Fenestrated endovascular aneurysm repair affords fewer renal complications than open surgical repair for juxtarenal abdominal aortic aneurysms in patients with chronic renal insufficiency. Ann Vasc Surg 2021;75:349–57. https://doi.org/10.1016/j.avsg.2021.03. 026
1048. Varkevisser RRB, O’Donnell TFX, Swerdlow NJ, Liang P, Li C, Ultee KHJ, et al. Fenestrated endovascular aneurysm repair is associated with lower perioperative morbidity and mortality compared with open repair for complex abdominal aortic aneurysms. J Vasc Surg 2019;69:1670–8. https://doi.org/10.1016/j.jvs.2018.08.192
1049. Gallitto E, Faggioli G, Melissano G, Fargion A, Isernia G, Lenti M, et al. Preoperative and postoperative predictors of clinical outcome of fenestrated and branched endovascular repair for complex abdominal and thoracoabdominal aortic aneurysms in an Italian multicenter registry. J Vasc Surg 2021;74:1795–806.e6. https://doi.org/10.1016/j.jvs.2021.04.072
1050. Silverberg D, Bar-Dayan A, Hater H, Khaitovich B, Halak M. Short-term outcomes of inner branches for endovascular repair of complex abdominal and thoracoabdominal aortic aneurysms. Vascular 2021;29:644–51. https://doi.org/10.1177/ 1708538120977279
1051. Hu Z, Li Y, Peng R, Liu J, Jia X, Liu X, et al. Multibranched stent-grafts for the treatment of thoracoabdominal aortic aneurysms: a systematic review and meta-analysis. J Endovasc Ther 2016;23:626–33. https://doi.org/10.1177/1526602816647723
1052. Simonte G, Isernia G, Gatta E, Neri E, Parlani G, Candeloro L, et al. Inner branched complex aortic repair outcomes from a national multicenter registry using the E-xtra design platform. J Vasc Surg 2023;77:338–46. https://doi.org/10.1016/j.jvs.2022.08. 034
1053. Gallitto E, Faggioli G, Pini R, Logiacco A, Mascoli C, Fenelli C, et al. Proximal aortic coverage and clinical results of the endovascular repair of juxta-/para-renal and type IV thoracoabdominal aneurysm with custom-made fenestrated endografts. Ann Vasc Surg 2021;73:397–406. https://doi.org/10.1016/j.avsg.2020.12.008
1054. Sultan S, Concannon J, Veerasingam D, Tawfick W, McHugh P, Jordan F, et al. Endovascular versus conventional open surgical repair for thoracoabdominal aortic aneurysms. Cochrane Database Syst Rev 2022;4:CD012926. https://doi.org/10.1002/14651858.CD012926.pub2
1055. Kölbel T, Spanos K, Jama K, Behrendt CA, Panuccio G, Eleshra A, et al. Early outcomes of the t-Branch off-the-shelf multi-branched stent graft in 542 patients for elective and urgent aortic pathologies: a retrospective observational study. J Vasc Surg 2021;74:1817–24. https://doi.org/10.1016/j.jvs.2021.05.041
1056. Oderich GS, Ribeiro M, Hofer J, Wigham J, Cha S, Chini J, et al. Prospective, nonrandomized study to evaluate endovascular repair of pararenal and thoracoabdominal aortic aneurysms using fenestrated-branched endografts based on supraceliac sealing zones. J Vasc Surg 2017;65:1249–59.e10. https://doi.org/10.1016/j.jvs.2016.09.038
1057. Oderich GS, Tenorio ER, Mendes BC, Lima GBB, Marcondes GB, Saqib N, et al. Midterm outcomes of a prospective, nonrandomized study to evaluate endovascular repair of complex aortic aneurysms using fenestrated-branched endografts. Ann Surg 2021;274:491–9. https://doi.org/10.1097/sla.0000000000004982
1058. Konstantinou N, Antonopoulos CN, Jerkku T, Banafsche R, Kölbel T, Fiorucci B, et al. Systematic review and meta-analysis of published studies on endovascular repair of thoracoabdominal aortic aneurysms with the t-Branch off-the-shelf multibranched endograft. J Vasc Surg 2020;72:716–25.e1. https://doi.org/10.1016/j.jvs.2020.01.049
1059. Ellahi A, Shaikh FN, Kashif H, Khan H, Ali E, Nasim B, et al. Effectiveness of endovascular repair versus open surgery for the treatment of thoracoabdominal aneurysm: a systematic review and meta analysis. Ann Med Surg 2022;81:104477. https://doi.org/10.1016/j.amsu.2022.104477
1060. Hongku K, Sonesson B, Bjorses K, Holst J, Resch T, Dias NV, et al. Mid-term Outcomes of Endovascular Repair of Ruptured Thoraco-abdominal Aortic Aneurysms with Off the Shelf Branched Stent Grafts. Eur J Vasc Endovasc Surg 2018;55:377–84. https://doi.org/10.1016/j.ejvs.2017.11.021
1061. Youssef M, Deglise S, Szopinski P, Jost-Philipp S, Jomha A, Vahl CF, et al. A multicenter experience with a new fenestrated-branched device for endovascular repair of thoracoabdominal aortic aneurysms. J Endovasc Ther 2018;25:209–19. https://doi.org/10.1177/1526602817752147
1062. Ouzounian M, Tadros RO, Svensson LG, Lyden SP, Oderich GS, Coselli JS Thoracoabdominal aortic disease and repair: JACC focus seminar, part 3. J Am Coll Cardiol 2022;80:845–56. https://doi.org/10.1016/j.jacc.2021.05.056
1063. Hofmann Bowman MA, Eagle KA, Milewicz DM. Update on clinical trials of losartan with and without β-blockers to block aneurysm growth in patients with Marfan syndrome: a review. JAMA Cardiol 2019;4:702–7. https://doi.org/10.1001/jamacardio.2019.1176
1064. Mortality results for randomised controlled trial of early elective surgery or ultra-sonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet 1998;352:1649–55.
1065. Powell JT, Brady AR, Brown LC, Fowkes FG, Greenhalgh RM, Ruckley CV, et al. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002;346:1445–52. https://doi.org/10.1056/NEJMoa013527
1066. Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002;346:1437–44. https://doi.org/10.1056/NEJMoa012573
1067. Shirasu T, Takagi H, Yasuhara J, Kuno T, Kent KC, Clouse WD. Smaller size is more suitable for pharmacotherapy among undersized abdominal aortic aneurysm: a systematic review and meta-analysis. Vasc Med 2022;27:261–8. https://doi.org/10.1177/1358863x211061603
1068. Ouriel K, Clair DG, Kent KC, Zarins CK. Endovascular repair compared with surveillance for patients with small abdominal aortic aneurysms. J Vasc Surg 2010;51:1081–7. https://doi.org/10.1016/j.jvs.2009.10.113
1069. Golledge J, Parr A, Boult M, Maddern G, Fitridge R. The outcome of endovascular repair of small abdominal aortic aneurysms. Ann Surg 2007;245:326–33. https://doi.org/10.1097/01.sla.0000253965.95368.52
1070. Filardo G, Powell JT, Martinez MA, Ballard DJ. Surgery for small asymptomatic abdominal aortic aneurysms. Cochrane Database Syst Rev 2015;2:CD001835. https://doi.org/10.1002/14651858.CD001835.pub4
1071. Cao P, De Rango P, Verzini F, Parlani G, Romano L, Cieri E. Comparison of surveillance versus aortic endografting for small aneurysm repair (CAESAR): results from a randomised trial. Eur J Vasc Endovasc Surg 2011;41:13–25. https://doi.org/10.1016/j.ejvs.2010.08.026
1072. Lo RC, Lu B, Fokkema MT, Conrad M, Patel VI, Fillinger M, et al. Relative importance of aneurysm diameter and body size for predicting abdominal aortic aneurysm rupture in men and women. J Vasc Surg 2014;59:1209–16. https://doi.org/10.1016/j.jvs.2013.10.104
1073. Bath MF, Gokani VJ, Sidloff DA, Jones LR, Choke E, Sayers RD, et al. Systematic review of cardiovascular disease and cardiovascular death in patients with a small abdominal aortic aneurysm. Br J Surg 2015;102:866–72. https://doi.org/10.1002/bjs.9837
1074. Kristensen SD, Knuuti J. New ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J 2014;35:2344–5. https://doi.org/10.1093/eurheartj/ehu285
1075. Devereaux PJ, Chan MT, Alonso-Coello P, Walsh M, Berwanger O, Villar JC, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2012;307:2295–304. https://doi.org/10.1001/jama.2012.5502
1076. EVAR trial participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 2005;365:2179–86. https://doi.org/10.1016/s0140-6736(05)66627-5
1077. Lederle FA, Freischlag JA, Kyriakides TC, Padberg FT, Jr, Matsumura JS, Kohler TR, et al. Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA 2009;302:1535–42. https://doi.org/10.1001/jama.2009.1426
1078. Becquemin JP, Pillet JC, Lescalie F, Sapoval M, Goueffic Y, Lermusiaux P, et al. A randomized controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms in low- to moderate-risk patients. J Vasc Surg 2011;53: 1167–73.e1. https://doi.org/10.1016/j.jvs.2010.10.124
1079. Antoniou GA, Antoniou SA, Torella F. Editor’s choice—endovascular vs. open repair for abdominal aortic aneurysm: systematic review and meta-analysis of updated perioperative and long term data of randomised controlled trials. Eur J Vasc Endovasc Surg 2020;59:385–97. https://doi.org/10.1016/j.ejvs.2019.11.030
1080. Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J 2022;43:3826–924. https://doi.org/10.1093/eurheartj/ehac270
1081. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351:2795–804. https://doi.org/10.1056/NEJMoa041905
1082. Saida T, Mori K, Sato F, Shindo M, Takahashi H, Takahashi N, et al. Prospective intraindividual comparison of unenhanced magnetic resonance imaging vs contrast-enhanced computed tomography for the planning of endovascular abdominal aortic aneurysm repair. J Vasc Surg 2012;55:679–87. https://doi.org/10.1016/j.jvs.2011.09.091
1083. Parker MV, O’Donnell SD, Chang AS, Johnson CA, Gillespie DL, Goff JM, et al. What imaging studies are necessary for abdominal aortic endograft sizing? A prospective blinded study using conventional computed tomography, aortography, and three-dimensional computed tomography. J Vasc Surg 2005;41:199–205. https://doi.org/10.1016/j.jvs.2004.12.010
1084. Schanzer A, Greenberg RK, Hevelone N, Robinson WP, Eslami MH, Goldberg RJ, et al. Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair. Circulation 2011;123:2848–55. https://doi.org/10.1161/circulationaha.110. 014902
1085. Protto S, Hahl T, Koskinen KJA, Järvenpää V, Uurto I, Väärämäki S, et al. Endovascular repair of abdominal aortic aneurysms is a valid alternative to open repair also in patients treated outside of instructions for use criteria. Cardiovasc Intervent Radiol 2022;45:1765–73. https://doi.org/10.1007/s00270-022-03297-7
1086. Charbonneau P, Hongku K, Herman CR, Habib M, Girsowicz E, Doonan RJ, et al. Long-term survival after endovascular and open repair in patients with anatomy outside instructions for use criteria for endovascular aneurysm repair. J Vasc Surg 2019; 70:1823–30. https://doi.org/10.1016/j.jvs.2019.01.081
1087. O’Donnell TFX, McElroy IE, Boitano LT, Mohebali J, Lamuraglia GM, Kwolek CJ, et al. Comparison of treatment options for aortic necks outside standard endovascular aneurysm repair instructions for use. J Vasc Surg 2021;74:1548–57. https://doi.org/10.1016/j.jvs.2021.04.052
1088. Antoniou GA, Juszczak MT, Nasr H, Narlawar R, Antoniou SA, Matsagkas M, et al. Prognosis review and time-to-event data meta-analysis of endovascular aneurysm repair outside versus within instructions for use of aortic endograft devices. J Vasc Surg 2020;71:1415–31.e15. https://doi.org/10.1016/j.jvs.2019.08.247
1089. Chaikof EL, Blankensteijn JD, Harris PL, White GH, Zarins CK, Bernhard VM, et al. Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg 2002;35: 1048–60. https://doi.org/10.1067/mva.2002.123763
1090. Falster MO, Garland SK, Jorm LR, Beiles CB, Freeman AJ, Sedrakyan A, et al. Editor’s choice—comparison of outcomes for major contemporary endograft devices used for endovascular repair of intact abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2023;65:272–80. https://doi.org/10.1016/j.ejvs.2022.11.005
1091. van Laarhoven C, Jorritsma NKN, Balderston J, Brinjikji W, Björck M, van Herwaarden JA, et al. Systematic review of the co-prevalence of arterial aneurysms within the vasculature. Eur J Vasc Endovasc Surg 2021;61:473–83. https://doi.org/10.1016/j.ejvs.2020.10.002
1092. Hohneck A, Keese M, Ruemenapf G, Amendt K, Muertz H, Janda K, et al. Prevalence of abdominal aortic aneurysm and associated lower extremity artery aneurysm in men hospitalized for suspected or known cardiopulmonary disease. BMC Cardiovasc Disord 2019;19:284. https://doi.org/10.1186/s12872-019-1265-2
1093. D’Oria M, Scali S, Mao J, Szeberin Z, Thomson I, Beiles B, et al. Association between hospital volume and failure to rescue after open or endovascular repair of intact abdominal aortic aneurysms in the vascunet and international consortium of vascular registries. Ann Surg 2021;274:e452–9. https://doi.org/10.1097/sla. 0000000000005044
1094. Scali ST, Columbo JA, Suckow BD, D’Oria M, Neal D, Goodney PP, et al. Center volume is associated with diminished failure to rescue and improved outcomes following elective open abdominal aortic aneurysm repair. J Vasc Surg 2022;76:400–8.e2. https://doi.org/10.1016/j.jvs.2021.12.076
1095. Eid MA, Barnes JA, Mehta K, Wanken Z, Columbo J, Kang R, et al. Factors associated with preference of choice of aortic aneurysm repair in the PReference for Open Versus Endovascular repair of AAA (PROVE-AAA) study. J Vasc Surg 2022;76: 1556–64. https://doi.org/10.1016/j.jvs.2022.06.018
1096. Wanhainen A, Verzini F, Van Herzeele I, Allaire E, Bown M, Cohnert T, et al. Editor’s choice—European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg 2019;57:8–93. https://doi.org/10.1016/j.ejvs.2018.09.020
1097. Reise JA, Sheldon H, Earnshaw J, Naylor AR, Dick F, Powell JT, et al. Patient preference for surgical method of abdominal aortic aneurysm repair: postal survey. Eur J Vasc Endovasc Surg 2010;39:55–61. https://doi.org/10.1016/j.ejvs.2009.08.008
1098. EVAR trial participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet 2005;365:2187–92. https://doi.org/10.1016/s0140-6736(05)66628-7
1099. Greenhalgh RM, Brown LC, Powell JT, Thompson SG, Epstein D. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med 2010; 362:1872–80. https://doi.org/10.1056/NEJMoa0911056
1100. Patel R, Sweeting MJ, Powell JT, Greenhalgh RM. Endovascular versus open repair of abdominal aortic aneurysm in 15-years’ follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial. Lancet 2016;388:2366–74. https://doi.org/10.1016/s0140-6736(16)31135-7
1101. Lederle FA, Kyriakides TC, Stroupe KT, Freischlag JA, Padberg FT, Matsumura JS, et al. Open versus endovascular repair of abdominal aortic aneurysm. N Engl J Med 2019; 380:2126–35. https://doi.org/10.1056/NEJMoa1715955
1102. Lederle FA, Freischlag JA, Kyriakides TC, Matsumura JS, Padberg FT, Kohler TR, et al. Long-term comparison of endovascular and open repair of abdominal aortic aneurysm. N Engl J Med 2012;367:1988–97. https://doi.org/10.1056/NEJMoa1207481
1103. Schermerhorn ML, Buck DB, O’Malley AJ, Curran T, McCallum JC, Darling J, et al. Long-term outcomes of abdominal aortic aneurysm in the Medicare population. N Engl J Med 2015;373:328–38. https://doi.org/10.1056/NEJMoa1405778
1104. Nana P, Dakis K, Brodis A, Spanos K, Kouvelos G, Eckstein H-H, et al. A systematic review and meta-analysis on early mortality after abdominal aortic aneurysm repair in females in urgent and elective settings. J Vasc Surg 2022;75:1082–8.e6. https://doi.org/10.1016/j.jvs.2021.10.040
1105. Böckler D, Power AH, Bouwman LH, van Sterkenburg S, Bosiers M, Peeters P, et al. Improvements in patient outcomes with next generation endovascular aortic repair devices in the ENGAGE global registry and the EVAR-1 clinical trial. J Cardiovasc Surg 2020;61:604–9. https://doi.org/10.23736/s0021-9509.19.11021-x
1106. Teijink JAW, Power AH, Böckler D, Peeters P, van Sterkenburg S, Bouwman LH, et al. Editor’s choice—five year outcomes of the endurant stent graft for endovascular abdominal aortic aneurysm repair in the ENGAGE registry. Eur J Vasc Endovasc Surg 2019;58:175–81. https://doi.org/10.1016/j.ejvs.2019.01.008
1107. Oliveira-Pinto J, Oliveira NFG, Bastos-Gonçalves FM, Hoeks S, Rijn MJV, Raa ST, et al. Long-term results after standard endovascular aneurysm repair with the endurant and excluder stent grafts. J Vasc Surg 2020;71:64–74. https://doi.org/10.1016/j.jvs.2019.03.039
1108. Deery SE, Shean KE, Pothof AB, O'Donnell TFX, Dalebout BA, Darling JD, et al. Three-Year Results of the Endurant Stent Graft System Post Approval Study. Ann Vasc Surg 2018;50:202–8. https://doi.org/10.1016/j.avsg.2017.12.017
1109. Prinssen M, Verhoeven EL, Buth J, Cuypers PWM, van Sambeek MRHM, Balm R, et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 2004;351:1607–18. https://doi.org/10.1056/ NEJMoa042002
1110. Dakour-Aridi H, Paracha NZ, Locham S, Nejim B, Malas MB. Assessment of failure to rescue after abdominal aortic aneurysm repair using the National Surgical Quality Improvement Program procedure-targeted data set. J Vasc Surg 2018;68: 1335–44.e1. https://doi.org/10.1016/j.jvs.2018.01.059
1111. Scali ST, Giles KA, Kubilis P, Beck AW, Crippen CJ, Hughes SJ, et al. Impact of hospital volume on patient safety indicators and failure to rescue following open aortic aneurysm repair. J Vasc Surg 2020;71:1135–46.e4. https://doi.org/10.1016/j.jvs.2019.06.194
1112. Ma B, Wang YN, Chen KY, Zhang Y, Pan H, Yang K. Transperitoneal versus retro-peritoneal approach for elective open abdominal aortic aneurysm repair. Cochrane Database Syst Rev 2016;2:CD010373. https://doi.org/10.1002/14651858.CD010373.pub2
1113. Camazine M, Bath J, Singh P, Kruse RL, Vogel TR. Characteristics associated with failure to rescue after open abdominal aortic aneurysm repair. J Surg Res 2023;283: 683–9. https://doi.org/10.1016/j.jss.2022.11.018
1114. Blair R, Harkin D, Johnston D, Lim A, McFetridge L, Mitchell H. Open surgery for abdominal aortic aneurysm: 980 consecutive patient outcomes from a high-volume centre in the United Kingdom. Vasc Endovascular Surg 2023;57:463–70. https://doi.org/10.1177/15385744221149585
1115. Hoornweg LL, Storm-Versloot MN, Ubbink DT, Koelemay MJW, Legemate DA, Balm R, et al. Meta analysis on mortality of ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2008;35:558–70. https://doi.org/10.1016/j.ejvs.2007.11.019
1116. Kontopodis N, Galanakis N, Antoniou SA, Tsetis D, Ioannou CV, Veith FJ, et al. Meta-analysis and meta-regression analysis of outcomes of endovascular and open repair for ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2020;59: 399–410. https://doi.org/10.1016/j.ejvs.2019.12.023
1117. Wang LJ, Locham S, Al-Nouri O, Eagleton MJ, Clouse WD, Malas MB. Endovascular repair of ruptured abdominal aortic aneurysm is superior to open repair: propensity-matched analysis in the vascular quality initiative. J Vasc Surg 2020;72:498–507. https://doi.org/10.1016/j.jvs.2019.11.063
1118. Tan TW, Eslami M, Rybin D, Doros G, Zhang WW, Farber A. Outcomes of endovascular and open surgical repair of ruptured abdominal aortic aneurysms in elderly patients. J Vasc Surg 2017;66:64–70. https://doi.org/10.1016/j.jvs.2016.10.119
1119. Dewulf M, Muysoms F, Vierendeels T, Huyghe M, Miserez M, Ruppert M, et al. Prevention of incisional hernias by prophylactic mesh-augmented reinforcement of midline laparotomies for abdominal aortic aneurysm treatment: five-year follow-up of a randomized controlled trial. Ann Surg 2022;276:e217–22. https://doi.org/10.1097/sla.0000000000005545
1120. Honig S, Diener H, Kölbel T, Reinpold W, Zapf A, Bibiza-Freiwald E, et al. Abdominal incision defect following AAA-surgery (AIDA): 2-year results of prophylactic onlaymesh augmentation in a multicentre, double-blind, randomised controlled trial. Updates Surg 2022;74:1105–16. https://doi.org/10.1007/s13304-021-01125-0
1121. Indrakusuma R, Jalalzadeh H, van der Meij JE, Balm R, Koelemay MJW. Prophylactic mesh reinforcement versus sutured closure to prevent incisional hernias after open abdominal aortic aneurysm repair via midline laparotomy: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2018;56:120–8. https://doi.org/10.1016/j.ejvs.2018.03.021
1122. van Keulen JW, de Vries JP, Dekker H, Gonçalves FB, Moll FL, Verhagen HJ, et al. One-year multicenter results of 100 abdominal aortic aneurysm patients treated with the endurant stent graft. J Vasc Surg 2011;54:609–15. https://doi.org/10.1016/j.jvs.2011.02.053
1123. Piazza M, Squizzato F, Suominen V, Grego F, Trimarchi S, Antonello M, et al. Early and long-term outcomes of endovascular aortic repair in young and low surgical risk patients in the global registry for endovascular aortic treatment. J Endovasc Ther 2022; 29:248–57. https://doi.org/10.1177/15266028211045703
1124. Paravastu SC, Jayarajasingam R, Cottam R, Palfreyman SJ, Michaels JA, Thomas SM. Endovascular repair of abdominal aortic aneurysm. Cochrane Database Syst Rev 2014;1:CD004178. https://doi.org/10.1002/14651858.CD004178.pub2
1125. Dosluoglu HH, Lall P, Blochle R, Harris LM, Dryjski ML. Ambulatory percutaneous endovascular abdominal aortic aneurysm repair. J Vasc Surg 2014;59:58–64. https://doi.org/10.1016/j.jvs.2013.06.076
1126. Geragotellis A, Cox K, Yip HCA, Jubouri M, Williams IM, Bailey DM, et al. Renal outcomes of suprarenal vs. infrarenal endograft fixation in endovascular abdominal aortic aneurysm repair: a narrative review. Cardiovasc Diagn Ther 2022;12:531–44. https://doi.org/10.21037/cdt-22-196
1127. Verhoeven EL, Katsargyris A, Bachoo P, Larzon T, Fisher R, Ettles D, et al. Real-world performance of the new C3 gore excluder stent-graft: 1-year results from the European C3 module of the global registry for endovascular aortic treatment (GREAT). Eur J Vasc Endovasc Surg 2014;48:131–7. https://doi.org/10.1016/j.ejvs.2014.04.009
1128. Torsello G, Scheinert D, Brunkwall JS, Chiesa R, Coppi G, Pratesi C. Safety and effectiveness of the INCRAFT AAA stent graft for endovascular repair of abdominal aortic aneurysms. J Vasc Surg 2015;61:1–8. https://doi.org/10.1016/j.jvs.2014.06.007
1129. Kontopodis N, Galanakis N, Tzartzalou I, Tavlas E, Georgakarakos E, Dimopoulos I, et al. An update on the improvement of patient eligibility with the use of new generation endografts for the treatment of abdominal aortic aneurysms. Expert Rev Med Devices 2020;17:1231–8. https://doi.org/10.1080/17434440.2020.1841629
1130. Kontopodis N, Papadopoulos G, Galanakis N, Tsetis D, Ioannou CV. Improvement of patient eligibility with the use of new generation endografts for the treatment of abdominal aortic aneurysms. A comparison study among currently used endografts and literature review. Expert Rev Med Devices 2017;14:245–50. https://doi.org/10.1080/17434440.2017.1281738
1131. Zlatanovic P, Mascia D, Ancetti S, Yeung KK, Graumans MJ, Jongkind V, et al. Short term and long term clinical outcomes of endovascular versus open repair for juxtarenal and pararenal abdominal aortic aneurysms using propensity score matching: results from juxta- and pararenal aortic aneurysm multicentre European study (JAMES). Eur J Vasc Endovasc Surg 2023;65:828–36. https://doi.org/10.1016/j.ejvs.2023.02.070
1132. Hajibandeh S, Hajibandeh S, Antoniou SA, Child E, Torella F, Antoniou GA. Percutaneous access for endovascular aortic aneurysm repair: a systematic review and meta-analysis. Vascular 2016;24:638–48. https://doi.org/10.1177/ 1708538116639201
1133. Antoniou GA, Antoniou SA. Editor’s choice—percutaneous access does not confer superior clinical outcomes over cutdown access for endovascular aneurysm repair: meta-analysis and trial sequential analysis of randomised controlled trials. Eur J Vasc Endovasc Surg 2021;61:383–94. https://doi.org/10.1016/j.ejvs.2020.11.008
1134. Cao Z, Wu W, Zhao K, Yang Yu, Jiang C, Zhu R. Safety and efficacy of totally percutaneous access compared with open femoral exposure for endovascular aneurysm repair: a meta-analysis. J Endovasc Ther 2017;24:246–53. https://doi.org/10.1177/ 1526602816689679
1135. Wang Q, Wu J, Ma Y, Zhu Y, Song X, Xie S, et al. Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair. Cochrane Database Syst Rev 2023;1:CD010185. https://doi.org/10.1002/14651858.CD010185.pub4
1136. Antoniou GA, Georgiadis GS, Antoniou SA, Neequaye S, Brennan JA, Torella F, et al. Late rupture of abdominal aortic aneurysm after previous endovascular repair: a systematic review and meta-analysis. J Endovasc Ther 2015;22:734–44. https://doi.org/10.1177/1526602815601405
1137. Fransen GA, Vallabhaneni SR, Sr, van Marrewijk CJ, Laheij RJF, Harris PL, Buth J. Rupture of infra-renal aortic aneurysm after endovascular repair: a series from EUROSTAR registry. Eur J Vasc Endovasc Surg 2003;26:487–93. https://doi.org/10.1016/s1078-5884(03)00350-2
1138. Marcaccio CL, Patel PB, de Guerre L, Wade JE, Rastogi V, Anjorin A, et al. Disparities in 5-year outcomes and imaging surveillance following elective endovascular repair of abdominal aortic aneurysm by sex, race, and ethnicity. J Vasc Surg 2022;76: 1205–15.e4. https://doi.org/10.1016/j.jvs.2022.03.886
1139. Schlösser FJ, Gusberg RJ, Dardik A, Lin PH, Verhagen HJM, Moll FL, et al. Aneurysm rupture after EVAR: can the ultimate failure be predicted? Eur J Vasc Endovasc Surg 2009;37:15–22. https://doi.org/10.1016/j.ejvs.2008.10.011
1140. Stather PW, Sidloff D, Dattani N, Choke E, Bown MJ, Sayers RD. Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm. Br J Surg 2013;100:863–72. https://doi.org/10.1002/bjs. 9101
1141. Swart M, McCarthy R. Shared decision making for elective abdominal aortic aneurysm surgery. Clin Med (Lond) 2019;19:473–7. https://doi.org/10.7861/clinmed.2019-0352
1142. Stubenrouch FE, Peters LJ, de Mik SML, Klemm PL, Peppelenbosch AG, Schreurs SCWM, et al. Improving shared decision making in vascular surgery: a stepped wedge cluster randomised trial. Eur J Vasc Endovasc Surg 2022;64:73–81. https://doi.org/10.1016/j.ejvs.2022.04.016
1143. Machin M, Van Herzeele I, Ubbink D, Powell JT. Shared decision making in and management of intact abdominal aortic aneurysm: a scoping review of the literature. Eur J Vasc Endovasc Surg 2023;65:839–49. https://doi.org/10.1016/j.ejvs.2023.01.036
1144. Karthaus EG, Tong TML, Vahl A, Hamming JF. Saccular abdominal aortic aneurysms: patient characteristics, clinical presentation, treatment, and outcomes in the Netherlands. Ann Surg 2019;270:852–8. https://doi.org/10.1097/sla. 0000000000003529
1145. O’Donnell TF, McElroy IE, Mohebali J, Boitano LT, Lamuraglia GM, Kwolek CJ, et al. Late type 1A endoleaks: associated factors, prognosis and management strategies. Ann Vasc Surg 2022;80:273–82. https://doi.org/10.1016/j.avsg.2021.08.057
1146. De Rango P, Verzini F, Parlani G, Cieri E, Simonte G, Farchioni L, et al. Safety of chronic anticoagulation therapy after endovascular abdominal aneurysm repair (EVAR). Eur J Vasc Endovasc Surg 2014;47:296–303. https://doi.org/10.1016/j.ejvs.2013.12.009
1147. Rokosh RS, Wu WW, Dalman RL, Chaikof EL. Society for Vascular Surgery implementation of clinical practice guidelines for patients with an abdominal aortic aneurysm. Endoleak management. J Vasc Surg 2021;74:1792–4. https://doi.org/10.1016/j.jvs.2021.04.042
1148. Jordan WD, Jr, Mehta M, Varnagy D, Moore WM, Arko FR, Joye J, et al. Results of the ANCHOR prospective, multicenter registry of EndoAnchors for type Ia endoleaks and endograft migration in patients with challenging anatomy. J Vasc Surg 2014;60: 885–92.e2. https://doi.org/10.1016/j.jvs.2014.04.063
1149. Sidloff DA, Stather PW, Choke E, Bown MJ, Sayers RD. Type II endoleak after endovascular aneurysm repair. Br J Surg 2013;100:1262–70. https://doi.org/10.1002/bjs. 9181
1150. Daye D, Walker TG. Complications of endovascular aneurysm repair of the thoracic and abdominal aorta: evaluation and management. Cardiovasc Diagn Ther 2018;8: S138–56. https://doi.org/10.21037/cdt.2017.09.17
1151. Latson LA, Jr, DeAnda A, Jr, Ko JP. Imaging of the postsurgical thoracic aorta: a state-of-the-art review. J Thorac Imaging 2017;32:1–25. https://doi.org/10.1097/rti. 0000000000000246
1152. Prescott-Focht JA, Martinez-Jimenez S, Hurwitz LM, Hoang JK, Christensen JD, Ghoshhajra BB, et al. Ascending thoracic aorta: postoperative imaging evaluation. Radiographics 2013;33:73–85. https://doi.org/10.1148/rg.331125090
1153. Riambau V, Böckler D, Brunkwall J, Cao P, Chiesa R, Coppi G, et al. Editor’s choice—management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2017;53:4–52. https://doi.org/10.1016/j.ejvs.2016.06.005
1154. Quevedo HC, Santiago-Trinidad R, Castellanos J, Atianzar K, Anwar A, Abi Rafeh N. Systematic review of interventions to repair ascending aortic pseudoaneurysms. Ochsner J 2014;14:576–85.
1155. Mesana TG, Caus T, Gaubert J, Collart F, Ayari R, Bartoli J-M, et al. Late complications after prosthetic replacement of the ascending aorta: what did we learn from routine magnetic resonance imaging follow-up? Eur J Cardiothorac Surg 2000;18:313–20. https://doi.org/10.1016/s1010-7940(00)00512-1
1156. Bianco V, Kilic A, Gleason TG, Arnaoutakis GJ, Sultan I. Management of thoracic aortic graft infections. J Card Surg 2018;33:658–65. https://doi.org/10.1111/jocs.13792
1157. Liisberg M, Baudier F, Akgül C, Lindholt JS. Long-term thoracic endovascular repair follow-up from 1999 to 2019: a single-center experience. Ann Vasc Surg 2022;86: 399–407. https://doi.org/10.1016/j.avsg.2022.04.013
1158. Nakhaei P, Bashir M, Jubouri M, Banar S, Ilkhani S, Borzeshi EZ, et al. Aortic remodeling, distal stent-graft induced new entry and endoleak following frozen elephant trunk: a systematic review and meta-analysis. J Card Surg 2022;37:3848–62. https://doi.org/10.1111/jocs.16918
1159. Iribarne A, Keenan J, Benrashid E, Wang H, Meza JM, Ganapathi A, et al. Imaging surveillance after proximal aortic operations: is it necessary? Ann Thorac Surg 2017;103: 734–41. https://doi.org/10.1016/j.athoracsur.2016.06.085
1160. Hensley SE, Upchurch GR, Jr. Repair of abdominal aortic aneurysms: JACC focus seminar, part 1. J Am Coll Cardiol 2022;80:821–31. https://doi.org/10.1016/j.jacc.2022.04.066
1161. Bastos Gonçalves F, Baderkhan H, Verhagen HJ, Wanhainen A, Björck M, Stolker RJ, et al. Early sac shrinkage predicts a low risk of late complications after endovascular aortic aneurysm repair. Br J Surg 2014;101:802–10. https://doi.org/10.1002/bjs.9516
1162. Troutman DA, Chaudry M, Dougherty MJ, Calligaro KD. Endovascular aortic aneurysm repair surveillance may not be necessary for the first 3 years after an initially normal duplex postoperative study. J Vasc Surg 2014;60:558–62. https://doi.org/10.1016/j.jvs.2014.03.278
1163. Jean-Baptiste E, Feugier P, Cruzel C, Sarlon-Bartoli G, Reix T, Steinmetz E, et al. Computed tomography-aortography versus color-duplex ultrasound for surveillance of endovascular abdominal aortic aneurysm repair: a prospective multicenter diagnostic-accuracy study (the ESSEA trial). Circ Cardiovasc Imaging 2020;13: e009886. https://doi.org/10.1161/circimaging.119.009886
1164. Johnsen L, Hisdal J, Jonung T, Braaten A, Pedersen G. Contrast-enhanced ultrasound detects type II endoleaks during follow-up for endovascular aneurysm repair. J Vasc Surg 2020;72:1952–9. https://doi.org/10.1016/j.jvs.2020.02.020
1165. George J, Tadros RO, Rao A, Png CYM, Han DK, Ilonzo N, et al. Duplex ultrasound can successfully identify endoleaks and renovisceral stent patency in patients undergoing complex endovascular aneurysm repair. Vasc Endovascular Surg 2021;55:234–8. https://doi.org/10.1177/1538574420980605
1166. Smith L, Thomas N, Arnold A, Bell R, Zayed H, Tyrrell M, et al. Editor’s choice—a comparison of computed tomography angiography and colour duplex ultrasound surveillance post infrarenal endovascular aortic aneurysm repair: financial implications and impact of different international surveillance guidelines. Eur J Vasc Endovasc Surg 2021;62:193–201. https://doi.org/10.1016/j.ejvs.2021.04.005
1167. Iscan HZ, Unal EU, Akkaya B, Daglı M, Karahan M, Civelek I, et al. Color Doppler ultrasound for surveillance following EVAR as the primary tool. J Card Surg 2021; 36:111–7. https://doi.org/10.1111/jocs.15194
1168. Antoniou GA, Kontopodis N, Rogers SK, Golledge J, Forbes TL, Torella F, et al. Editor’s choice—meta-analysis of compliance with endovascular aneurysm repair surveillance: the EVAR surveillance paradox. Eur J Vasc Endovasc Surg 2023;65: 244–54. https://doi.org/10.1016/j.ejvs.2022.10.033
1169. Baderkhan H, Haller O, Wanhainen A, Björck M, Mani K. Follow-up after endovascular aortic aneurysm repair can be stratified based on first postoperative imaging. Br J Surg 2018;105:709–18. https://doi.org/10.1002/bjs.10766
1170. Png CY, Tadros RO, Faries PL, Torres MR, Kim SY, Lookstein R, et al. The effect of age on post-EVAR outcomes. Ann Vasc Surg 2016;35:156–62. https://doi.org/10.1016/j.avsg.2016.01.022
1171. Xiong X, Wu Z, Qin X, Huang Q, Wang X, Qin J, et al. Meta-analysis suggests statins reduce mortality after abdominal aortic aneurysm repair. J Vasc Surg 2022;75: 356–62.e4. https://doi.org/10.1016/j.jvs.2021.06.033
1172. Schrimpf C, Teebken OE, Wilhelmi M. Thoracic endovascular aortic repair after iatrogenic aortic dissection and false lumen stent grafting. Ann Thorac Surg 2015;99: 1447–9. https://doi.org/10.1016/j.athoracsur.2014.05.101
1173. Sampson UK, Norman PE, Fowkes FG, Aboyans V, Song Y, Harrell FE, Jr, et al. Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010. Glob Heart 2014;9:171–80.e110. https://doi.org/10.1016/j.gheart.2013.12.010
1174. Clough RE, Nienaber CA. Management of acute aortic syndrome. Nat Rev Cardiol 2015;12:103–14. https://doi.org/10.1038/nrcardio.2014.203
1175. Evangelista A, Isselbacher EM, Bossone E, Gleason TG, Eusanio MD, Sechtem U, et al. Insights from the international registry of acute aortic dissection: a 20-year experience of collaborative clinical research. Circulation 2018;137:1846–60. https://doi.org/10.1161/circulationaha.117.031264
1176. Booher AM, Isselbacher EM, Nienaber CA, Trimarchi S, Evangelista A, Montgomery DG, et al. The IRAD classification system for characterizing survival after aortic dissection. Am J Med 2013;126:730.e19–24. https://doi.org/10.1016/j.amjmed.2013.01. 020
1177. Howard C, Ponnapalli A, Shaikh S, Idhrees M, Bashir M. Non-A non-B aortic dissection: a literature review. J Card Surg 2021;36:1806–13. https://doi.org/10.1111/jocs. 15349
1178. Urbanski PP, Wagner M. Acute non-A-non-B aortic dissection: surgical or conservative approach? Eur J Cardiothorac Surg 2016;49:1249–54. https://doi.org/10.1093/ejcts/ezv301
1179. Carino D, Singh M, Molardi A, Agostinelli A, Goldoni M, Pacini D, et al. Non-A non-B aortic dissection: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2019; 55:653–9. https://doi.org/10.1093/ejcts/ezy337
1180. Sievers HH, Rylski B, Czerny M, Baier ALM, Kreibich M, Siepe M, et al. Aortic dissection reconsidered: type, entry site, malperfusion classification adding clarity and enabling outcome prediction. Interact Cardiovasc Thorac Surg 2020;30:451–7. https://doi.org/10.1093/icvts/ivz281
1181. Aboyans V, Boukhris M. Dissecting the epidemiology of aortic dissection. Eur Heart J Acute Cardiovasc Care 2021;10:710–1. https://doi.org/10.1093/ehjacc/zuab065
1182. Pape LA, Awais M, Woznicki EM, Suzuki T, Trimarchi S, Evangelista A, et al. Presentation, diagnosis, and outcomes of acute aortic dissection: 17-year trends from the international registry of acute aortic dissection. J Am Coll Cardiol 2015;66: 350–8. https://doi.org/10.1016/j.jacc.2015.05.029
1183. Januzzi JL, Isselbacher EM, Fattori R, Cooper JV, Smith DE, Fang J, et al. Characterizing the young patient with aortic dissection: results from the international registry of aortic dissection (IRAD). J Am Coll Cardiol 2004;43:665–9. https://doi.org/10.1016/j.jacc.2003.08.054
1184. Dalen JE, Alpert JS, Goldberg RJ, Weinstein RS. The epidemic of the 20(th) century: coronary heart disease. Am J Med 2014;127:807–12. https://doi.org/10.1016/j.amjmed.2014.04.015
1185. Bossone E, Pyeritz RE, O’Gara P, Harris KM, Braverman AC, Pape L, et al. Acute aortic dissection in blacks: insights from the international registry of acute aortic dissection. Am J Med 2013;126:909–15. https://doi.org/10.1016/j.amjmed.2013.04.020
1186. Rylski B, Hoffmann I, Beyersdorf F, Suedkamp M, Siepe M, Nitsch B, et al. Iatrogenic acute aortic dissection type A: insight from the German registry for acute aortic dissection type A (GERAADA). Eur J Cardiothorac Surg 2013;44:353–9; discussion 359. https://doi.org/10.1093/ejcts/ezt055
1187. Núñez-Gil IJ, Bautista D, Cerrato E, Salinas P, Varbella F, Omedè P, et al. Incidence, management, and immediate- and long-term outcomes after iatrogenic aortic dissection during diagnostic or interventional coronary procedures. Circulation 2015;131: 2114–9. https://doi.org/10.1161/circulationaha.115.015334
1188. Carbone A, Ranieri B, Castaldo R, Franzese M, Rega S, Cittadini A, et al. Sex differences in type A acute aortic dissection: a systematic review and meta-analysis. Eur J Prev Cardiol 2023;30:1074–89. https://doi.org/10.1093/eurjpc/zwad009
1189. Nienaber CA, Fattori R, Mehta RH, Richartz BM, Evangelista A, Petzsch M, et al. Gender-related differences in acute aortic dissection. Circulation 2004;109: 3014–21. https://doi.org/10.1161/01.Cir.0000130644.78677.2c
1190. Manalo-Estrella P, Barker AE. Histopathologic findings in human aortic media associated with pregnancy. Arch Pathol 1967;83:336–41.
1191. Lempel JK, Frazier AA, Jeudy J, Kligerman SJ, Schultz R, Ninalowo HA, et al. Aortic arch dissection: a controversy of classification. Radiology 2014;271:848–55. https://doi.org/10.1148/radiol.14131457
1192. Mussa FF, Horton JD, Moridzadeh R, Nicholson J, Trimarchi S, Eagle KA. Acute aortic dissection and intramural hematoma: a systematic review. JAMA 2016;316:754–63. https://doi.org/10.1001/jama.2016.10026
1193. Tsai TT, Trimarchi S, Nienaber CA. Acute aortic dissection: perspectives from the international registry of acute aortic dissection (IRAD). Eur J Vasc Endovasc Surg 2009;37:149–59. https://doi.org/10.1016/j.ejvs.2008.11.032
1194. Neri E, Toscano T, Papalia U, Frati G, Massetti M, Capannini G, et al. Proximal aortic dissection with coronary malperfusion: presentation, management, and outcome. J Thorac Cardiovasc Surg 2001;121:552–60. https://doi.org/10.1067/mtc.2001.112534
1195. Trimarchi S, Tsai T, Eagle KA, Isselbacher EM, Froehlich J, et al. Acute abdominal aortic dissection: insight from the International Registry of Acute Aortic Dissection (IRAD). J Vasc Surg 2007;46:913–9. https://doi.org/10.1016/j.jvs.2007.07.030
1196. Gorla R, Erbel R, Kahlert P, Tsagakis K, Jakob H, Mahabadi A-A, et al. Accuracy of a diagnostic strategy combining aortic dissection detection risk score and D-dimer levels in patients with suspected acute aortic syndrome. Eur Heart J Acute Cardiovasc Care 2017;6:371–8. https://doi.org/10.1177/2048872615594497
1197. Strayer RJ, Shearer PL, Hermann LK. Screening, evaluation, and early management of acute aortic dissection in the ED. Curr Cardiol Rev 2012;8:152–7. https://doi.org/10.2174/157340312801784970
1198. Nazerian P, Mueller C, Soeiro AM, Leidel BA, Salvadeo SAT, Giachino F, et al. Diagnostic accuracy of the aortic dissection detection risk score plus D-dimer for acute aortic syndromes: the ADvISED prospective multicenter study. Circulation 2018;137:250–8. https://doi.org/10.1161/circulationaha.117.029457
1199. Bima P, Pivetta E, Nazerian P, Toyofuku M, Gorla R, Bossone E, et al. Systematic review of aortic dissection detection risk score plus d-dimer for diagnostic rule-out of suspected acute aortic syndromes. Acad Emerg Med 2020;27:1013–27. https://doi.org/10.1111/acem.13969
1200. Rogers AM, Hermann LK, Booher AM, Nienaber CA, Williams DM, Kazerooni EA, et al. Sensitivity of the aortic dissection detection risk score, a novel guideline-based tool for identification of acute aortic dissection at initial presentation: results from the international registry of acute aortic dissection. Circulation 2011;123:2213–8. https://doi.org/10.1161/CIRCULATIONAHA.110.988568
1201. Suzuki T, Distante A, Zizza A, Trimarchi S, Villani M, Salerno Uriarte JA, et al. Diagnosis of acute aortic dissection by D-dimer: the international registry of acute aortic dissection substudy on biomarkers (IRAD-bio) experience. Circulation 2009; 119:2702–7. https://doi.org/10.1161/circulationaha.108.833004
1202. Baliga RR, Nienaber CA, Bossone E, Oh JK, Isselbacher EM, Sechtem U, et al. The role of imaging in aortic dissection and related syndromes. JACC Cardiovasc Imaging 2014;7: 406–24. https://doi.org/10.1016/j.jcmg.2013.10.015
1203. Nazerian P, Mueller C, Vanni S, Soeiro AM, Leidel BA, Cerini G, et al. Integration of transthoracic focused cardiac ultrasound in the diagnostic algorithm for suspected acute aortic syndromes. Eur Heart J 2019;40:1952–60. https://doi.org/10.1093/eurheartj/ehz207
1204. Shiga T, Wajima Z, Apfel CC, Inoue T, Ohe Y. Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis. Arch Intern Med 2006;166:1350–6. https://doi.org/10.1001/archinte.166.13.1350
1205. Nienaber CA, Clough RE. Management of acute aortic dissection. Lancet 2015;385: 800–11. https://doi.org/10.1016/s0140-6736(14)61005-9
1206. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023; 44:3720–826. https://doi.org/10.1093/eurheartj/ehad191
1207. Rogers IS, Banerji D, Siegel EL, Truong QA, Ghoshhajra BB, Irlbeck T, et al. Usefulness of comprehensive cardiothoracic computed tomography in the evaluation of acute undifferentiated chest discomfort in the emergency department (CAPTURE). Am J Cardiol 2011;107:643–50. https://doi.org/10.1016/j.amjcard.2010.10.039
1208. Evangelista A, Maldonado G, Gruosso D, Gutiérrez L, Granato C, Villalva N, et al. The current role of echocardiography in acute aortic syndrome. Echo Res Pract 2019;6: R53–r63. https://doi.org/10.1530/erp-18-0058
1209. Vignon P, Guéret P, Vedrinne JM, Lagrange P, Cornu E, Abrieu O, et al. Role of transesophageal echocardiography in the diagnosis and management of traumatic aortic disruption. Circulation 1995;92:2959–68. https://doi.org/10.1161/01.cir.92.10.2959
1210. Moral S, Avegliano G, Cuéllar H, Ballesteros E, Rodríguez-Palomares J, Teixidó G, et al. Usefulness of transesophageal echocardiography in the evaluation of celiac trunk and superior mesenteric artery involvement in acute aortic dissection. J Am Soc Echocardiogr 2021;34:327–35. https://doi.org/10.1016/j.echo.2020.12.019
1211. Nienaber CA, Clough RE, Sakalihasan N, Suzuki T, Gibbs R, Mussa F, et al. Aortic dissection. Nat Rev Dis Primers 2016;2:16053. https://doi.org/10.1038/nrdp.2016.53
1212. Vilacosta I, San Román JA, di Bartolomeo R, Eagle K, Estrera AL, Ferrera C, et al. Acute aortic syndrome revisited: JACC state-of-the-art review. J Am Coll Cardiol 2021;78:2106–25. https://doi.org/10.1016/j.jacc.2021.09.022
1213. Tadros RO, Tang GHL, Barnes HJ, Mousavi I, Kovacic JC, Faries P, et al. Optimal treatment of uncomplicated type B aortic dissection: JACC review topic of the week. J Am Coll Cardiol 2019;74:1494–504. https://doi.org/10.1016/j.jacc.2019.07.063
1214. Kodama K, Nishigami K, Sakamoto T, Sawamura T, Hirayama T, Misumi H, et al. Tight heart rate control reduces secondary adverse events in patients with type B acute aortic dissection. Circulation 2008;118:S167–70. https://doi.org/10.1161/circulationaha.107.755801
1215. Estrera AL, Miller CC, III, Safi HJ, Goodrick JS, Keyhani A, Porat EE, et al. Outcomes of medical management of acute type B aortic dissection. Circulation 2006;114: I384–389. https://doi.org/10.1161/circulationaha.105.001479
1216. Nejim B, Mathlouthi A, Naazie I, Malas MB. The effect of intravenous and oral beta-blocker use in patients with type B thoracic aortic dissection. Ann Vasc Surg 2022;80: 170–9. https://doi.org/10.1016/j.avsg.2021.07.056
1217. Hameed I, Cifu AS, Vallabhajosyula P. Management of thoracic aortic dissection. JAMA 2023;329:756–7. https://doi.org/10.1001/jama.2023.0265
1218. Fukui T. Management of acute aortic dissection and thoracic aortic rupture. J Intensive Care 2018;6:15. https://doi.org/10.1186/s40560-018-0287-7
1219. Suzuki T, Mehta RH, Ince H, Nagai R, Sakomura Y, Weber F, et al. Clinical profiles and outcomes of acute type B aortic dissection in the current era: lessons from the international registry of aortic dissection (IRAD). Circulation 2003;108:Ii312–7. https://doi.org/10.1161/01.cir.0000087386.07204.09
1220. Mehta RH, Suzuki T, Hagan PG, Bossone E, Gilon D, Llovet A, et al. Predicting death in patients with acute type a aortic dissection. Circulation 2002;105:200–6. https://doi.org/10.1161/hc0202.102246
1221. Mészáros I, Mórocz J, Szlávi J, Schmidt J, Tornóci L, Nagy L, et al. Epidemiology and clinicopathology of aortic dissection. Chest 2000;117:1271–8. https://doi.org/10.1378/chest.117.5.1271
1222. Glower DD, Speier RH, White WD, Smith LR, Rankin JS, Wolfe WG. Management and long-term outcome of aortic dissection. Ann Surg 1991;214:31–41. https://doi.org/10.1097/00000658-199107000-00006
1223. Nallamothu BK, Mehta RH, Saint S, Llovet A, Bossone E, Cooper JV, et al. Syncope in acute aortic dissection: diagnostic, prognostic, and clinical implications. Am J Med 2002;113:468–71. https://doi.org/10.1016/s0002-9343(02)01254-8
1224. Suzuki T, Isselbacher EM, Nienaber CA, Pyeritz RE, Eagle KA, Tsai TT, et al. Type-selective benefits of medications in treatment of acute aortic dissection (from the international registry of acute aortic dissection [IRAD]). Am J Cardiol 2012;109:122–7. https://doi.org/10.1016/j.amjcard.2011.08.012
1225. Palmer J, Gelmann D, Engelbrecht-Wiggans E, Hollis G, Hart E, Ali A, et al. Invasive arterial blood pressure monitoring may aid in the medical management of hypertensive patients with acute aortic disease. Am J Emerg Med 2022;59:85–93. https://doi.org/10.1016/j.ajem.2022.06.054
1226. Nienaber CA, Kische S, Rousseau H, Eggebrecht H, Rehders TC, Kundt G, et al. Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv 2013;6: 407–16. https://doi.org/10.1161/circinterventions.113.000463
1227. Fattori R, Montgomery D, Lovato L, Kische S, Di Eusanio M, Ince H, et al. Survival after endovascular therapy in patients with type B aortic dissection: a report from the international registry of acute aortic dissection (IRAD). JACC Cardiovasc Interv 2013;6:876–82. https://doi.org/10.1016/j.jcin.2013.05.003
1228. Durham CA, Cambria RP, Wang LJ, Ergul EA, Aranson NJ, Patel VI, et al. The natural history of medically managed acute type B aortic dissection. J Vasc Surg 2015;61: 1192–8. https://doi.org/10.1016/j.jvs.2014.12.038
1229. Lou X, Chen EP, Duwayri YM, Veeraswamy RK, Jordan WD, Zehner CA, et al. The impact of thoracic endovascular aortic repair on long-term survival in type B aortic dissection. Ann Thorac Surg 2018;105:31–8. https://doi.org/10.1016/j.athoracsur.2017.06.016
1230. Lou X, Duwayri YM, Chen EP, Jordan WD, Forcillo J, Zehner CA, et al. Predictors of failure of medical management in uncomplicated type B aortic dissection. Ann Thorac Surg 2019;107:493–8. https://doi.org/10.1016/j.athoracsur.2018.08.012
1231. Lou X, Duwayri YM, Jordan WD, Jr, Chen EP, Veeraswamy RK, Leshnower BG. The safety and efficacy of extended TEVAR in acute type B aortic dissection. Ann Thorac Surg 2020;110:799–806. https://doi.org/10.1016/j.athoracsur.2019.12.036
1232. Hirst AE, Jr, Johns VJ, Jr, Kime SW, Jr. Dissecting aneurysm of the aorta: a review of 505 cases. Medicine 1958;37:217–79. https://doi.org/10.1097/00005792-195809000-00003
1233. Chiappini B, Schepens M, Tan E, Amore AD, Morshuis W, Dossche K, et al. Early and late outcomes of acute type A aortic dissection: analysis of risk factors in 487 consecutive patients. Eur Heart J 2005;26:180–6. https://doi.org/10.1093/eurheartj/ ehi024
1234. Harris KM, Nienaber CA, Peterson MD, Woznicki EM, Braverman AC, Trimarchi S, et al. Early mortality in type A acute aortic dissection: insights from the international registry of acute aortic dissection. JAMA Cardiol 2022;7:1009–15. https://doi.org/10.1001/jamacardio.2022.2718
1235. Zhu Y, Lingala B, Baiocchi M, Tao JJ, Toro Arana V, Khoo JW, et al. Type A aortic dissection-experience over 5 decades: JACC historical breakthroughs in perspective. J Am Coll Cardiol 2020;76:1703–13. https://doi.org/10.1016/j.jacc.2020.07.061
1236. Czerny M, Siepe M, Beyersdorf F, Feisst M, Gabel M, Pilz M, et al. Prediction of mortality rate in acute type A dissection: the German registry for acute type A aortic dissection score. Eur J Cardiothorac Surg 2020;58:700–6. https://doi.org/10.1093/ejcts/ ezaa156
1237. Perko MJ, Nørgaard M, Herzog TM, Olsen PS, Schroeder TV, Pettersson G. Unoperated aortic aneurysm: a survey of 170 patients. Ann Thorac Surg 1995;59: 1204–9. https://doi.org/10.1016/0003-4975(95)00132-5
1238. Wolfe SB, Sundt TM, III, Isselbacher EM, Cameron DE, Trimarchi S, Bekeredjian R, et al. Survival after operative repair of acute type A aortic dissection varies according to the presence and type of preoperative malperfusion. J Thorac Cardiovasc Surg 2024; 168:37–49.e6. https://doi.org/10.1016/j.jtcvs.2022.09.034
1239. Trimarchi S, Eagle KA, Nienaber CA, Rampoldi V, Jonker FHW, De Vincentiis C, et al. Role of age in acute type A aortic dissection outcome: report from the international registry of acute aortic dissection (IRAD). J Thorac Cardiovasc Surg 2010;140:784–9. https://doi.org/10.1016/j.jtcvs.2009.11.014
1240. Shrestha M, Khaladj N, Haverich A, Hagl C. Is treatment of acute type A aortic dissection in septuagenarians justifiable? Asian Cardiovasc Thorac Ann 2008;16:33–6. https://doi.org/10.1177/021849230801600109
1241. Bonser RS, Ranasinghe AM, Loubani M, Evans JD, Thalji NMA, Bachet JE, et al. Evidence, lack of evidence, controversy, and debate in the provision and performance of the surgery of acute type A aortic dissection. J Am Coll Cardiol 2011;58:2455–74. https://doi.org/10.1016/j.jacc.2011.06.067
1242. Subramanian S, Leontyev S, Borger MA, Trommer C, Misfeld M, Mohr FW. Valve-sparing root reconstruction does not compromise survival in acute type A aortic dissection. Ann Thorac Surg 2012;94:1230–4. https://doi.org/10.1016/j.athoracsur.2012.04.094
1243. Urbanski PP, Hijazi H, Dinstak W, Diegeler A. Valve-sparing aortic root repair in acute type A dissection: how many sinuses have to be repaired for curative surgery? Eur J Cardiothorac Surg 2013;44:439–43; discussion 443–4. https://doi.org/10.1093/ejcts/ezt042
1244. Shrestha M, Baraki H, Maeding I, Fitzner S, Sarikouch S, Khaladj N, et al. Long-term results after aortic valve-sparing operation (David I). Eur J Cardiothorac Surg 2012; 41:56–61; discussion 61–2. https://doi.org/10.1016/j.ejcts.2011.04.012
1245. Tsagakis K, Pacini D, Di Bartolomeo R, Gorlitzer M, Weiss G, Grabenwoger M, et al. Multicenter early experience with extended aortic repair in acute aortic dissection: is simultaneous descending stent grafting justified? J Thorac Cardiovasc Surg 2010;140: S116–20; discussion S142–S146. https://doi.org/10.1016/j.jtcvs.2010.07.066
1246. Tsagakis K, Pacini D, Grabenwöger M, Borger MA, Goebel N, Hemmer W, et al. Results of frozen elephant trunk from the international E-vita Open registry. Ann Cardiothorac Surg 2020;9:178–88. https://doi.org/10.21037/acs-2020-fet-25
1247. Beckmann E, Martens A, Kaufeld T, Natanov R, Krueger H, Rudolph L, et al. Frozen elephant trunk in acute aortic type a dissection: risk analysis of concomitant root replacement. Eur J Cardiothorac Surg 2022;62:ezac051. https://doi.org/10.1093/ejcts/ ezac051
1248. Cruz I, Stuart B, Caldeira D, Morgado G, Gomes AC, Almeida AR, et al. Controlled pericardiocentesis in patients with cardiac tamponade complicating aortic dissection: experience of a centre without cardiothoracic surgery. Eur Heart J Acute Cardiovasc Care 2015;4:124–8. https://doi.org/10.1177/2048872614549737
1249. Hayashi T, Tsukube T, Yamashita T, Haraguchi T, Matsukawa R, Kozawa S, et al. Impact of controlled pericardial drainage on critical cardiac tamponade with acute type A aortic dissection. Circulation 2012;126:S97–101. https://doi.org/10.1161/CIRCULATIONAHA.111.082685
1250. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The international registry of acute aortic dissection (IRAD): new insights into an old disease. JAMA 2000;283:897–903. https://doi.org/10.1001/jama.283.7.897
1251. Saczkowski R, Malas T, Mesana T, de Kerchove L, El Khoury G, Boodhwani M. Aortic valve preservation and repair in acute type A aortic dissection. Eur J Cardiothorac Surg 2014;45:e220–226. https://doi.org/10.1093/ejcts/ezu099
1252. Hysi I, Juthier F, Fabre O, Fouquet O, Rousse N, Banfi C, et al. Aortic root surgery improves long-term survival after acute type A aortic dissection. Int J Cardiol 2015; 184:285–90. https://doi.org/10.1016/j.ijcard.2015.02.020
1253. Peterss S, Dumfarth J, Rizzo JA, Bonaros N, Fang H, Tranquilli M, et al. Sparing the aortic root in acute aortic dissection type A: risk reduction and restored integrity of the untouched root. Eur J Cardiothorac Surg 2016;50:232–9. https://doi.org/10.1093/ejcts/ezw012
1254. Chen SK, Qiu ZH, Fang GH, Wu XJ, Chen LW. Reported outcomes after aortic valve resuspension for acute type A aortic dissection: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 2019;29:331–8. https://doi.org/10.1093/icvts/ivz080
1255. Qiu J, Wu J, Xie E, Luo X, Chen JF, Gao W, et al. Surgical management and outcomes of the aortic root in acute type A aortic dissection. Ann Thorac Surg 2020;110: 136–43. https://doi.org/10.1016/j.athoracsur.2019.10.014
1256. Umana-Pizano JB, Nissen AP, Sandhu HK, Miller CC, Loghin A, Safi HJ, et al. Acute type A dissection repair by high-volume vs low-volume surgeons at a high-volume aortic center. Ann Thorac Surg 2019;108:1330–6. https://doi.org/10.1016/j.athoracsur.2019.04.040
1257. Goldstone AB, Chiu P, Baiocchi M, Lingala B, Lee J, Rigdon J, et al. Interfacility transfer of medicare beneficiaries with acute type A aortic dissection and regionalization of care in the United States. Circulation 2019;140:1239–50. https://doi.org/10.1161/circulationaha.118.038867
1258. Mosbahi S, Stak D, Gravestock I, Burgstaller JM, Steurer J, Eckstein F, et al. A systemic review and meta-analysis: Bentall versus David procedure in acute type A aortic dissection. Eur J Cardiothorac Surg 2019;55:201–9. https://doi.org/10.1093/ejcts/ezy266
1259. Beckmann E, Martens A, Pertz J, Kaufeld T, Umminger J, Hanke JS, et al. Valve-sparing David I procedure in acute aortic type A dissection: a 20-year experience with more than 100 patients. Eur J Cardiothorac Surg 2017;52:319–24. https://doi.org/10.1093/ejcts/ezx170
1260. Weiss G, Tsagakis K, Jakob H, Di Bartolomeo R, Pacini D, Barberio G, et al. The frozen elephant trunk technique for the treatment of complicated type B aortic dissection with involvement of the aortic arch: multicentre early experience. Eur J Cardiothorac Surg 2015;47:106–14; discussion 114. https://doi.org/10.1093/ejcts/ ezu067
1261. Iafrancesco M, Goebel N, Mascaro J, Franke UFW, Pacini D, Di Bartolomeo R, et al. Aortic diameter remodelling after the frozen elephant trunk technique in aortic dissection: results from an international multicentre registry. Eur J Cardiothorac Surg 2017;52:310–8. https://doi.org/10.1093/ejcts/ezx131
1262. Tsagakis K, Wendt D, Dimitriou AM, Thielmann M, Shehada S-D, El Gabry M, et al. The frozen elephant trunk treatment is the operation of choice for all kinds of arch disease. J Cardiovasc Surg (Torino) 2018;59:540–6. https://doi.org/10.23736/s00219509.18.10597-0
1263. Widenka KJ, Kosiorowska M, Jakob H, Pacini D, Hemmer W, Grabenwoeger M, et al. Early and midterm results of frozen elephant trunk operation with Evita open stent-graft in patients with Marfan syndrome: results of a multicentre study. BMC Cardiovasc Disord 2022;22:333. https://doi.org/10.1186/s12872-022-02777-5
1264. Jakob H, Shehada SE, Dohle D, Wendt D, El Gabry M, Schlosser T, et al. New 3-zone hybrid graft: first-in-man experience in acute type I dissection. J Thorac Cardiovasc Surg 2022;163:568–74.e1. https://doi.org/10.1016/j.jtcvs.2020.04.113
1265. Tsagakis K, Osswald A, Weymann A, Demircioglu A, Schmack B, Wendt D, et al. The frozen elephant trunk technique: impact of proximalization and the four-sites perfusion technique. Eur J Cardiothorac Surg 2021;61:195–203. https://doi.org/10.1093/ejcts/ezab295
1266. Rampoldi V, Trimarchi S, Eagle KA, Nienaber CA, Oh JK, Bossone E, et al. Simple risk models to predict surgical mortality in acute type A aortic dissection: the international registry of acute aortic dissection score. Ann Thorac Surg 2007;83:55–61. https://doi.org/10.1016/j.athoracsur.2006.08.007
1267. Lawton JS, Liu J, Kulshrestha K, Moon MR, Damiano RJ, Maniar H, et al. The impact of surgical strategy on survival after repair of type A aortic dissection. J Thorac Cardiovasc Surg 2015;150:294–301.e1. https://doi.org/10.1016/j.jtcvs.2015.03.023
1268. Malvindi PG, Modi A, Miskolczi S, Kaarne M, Velissaris T, Barlow C, et al. Open and closed distal anastomosis for acute type A aortic dissection repair. Interact Cardiovasc Thorac Surg 2016;22:776–83. https://doi.org/10.1093/icvts/ivw044
1269. Geirsson A, Shioda K, Olsson C, Ahlsson A, Gunn J, Hansson EC, et al. Differential outcomes of open and clamp-on distal anastomosis techniques in acute type A aortic dissection. J Thorac Cardiovasc Surg 2019;157:1750–8. https://doi.org/10.1016/j.jtcvs.2018.09.020
1270. Yan Y, Xu L, Zhang H, Xu Z-Y, Ding X-Y, Wang S-W, et al. Proximal aortic repair versus extensive aortic repair in the treatment of acute type A aortic dissection: a meta-analysis. Eur J Cardiothorac Surg 2016;49:1392–401. https://doi.org/10.1093/ejcts/ezv351
1271. Poon SS, Theologou T, Harrington D, Kuduvalli M, Oo A, Field M. Hemiarch versus total aortic arch replacement in acute type A dissection: a systematic review and meta-analysis. Ann Cardiothorac Surg 2016;5:156–73. https://doi.org/10.21037/acs.2016.05.06
1272. Hsieh WC, Kan CD, Yu HC, Aboud A, Lindner J, Henry BM, et al. Ascending aorta replacement vs. total aortic arch replacement in the treatment of acute type A dissection: a meta-analysis. Eur Rev Med Pharmacol Sci 2019;23:9590–611. https://doi.org/10.26355/eurrev_201911_19454
1273. Preventza O, Cervera R, Cooley DA, Bakaeen FG, Mohamed AS, Cheong BYC, et al. Acute type I aortic dissection: traditional versus hybrid repair with antegrade stent delivery to the descending thoracic aorta. J Thorac Cardiovasc Surg 2014;148: 119–25. https://doi.org/10.1016/j.jtcvs.2013.07.055
1274. Roselli EE, Idrees JJ, Bakaeen FG, Tong MZ, Soltesz EG, Mick S, et al. Evolution of simplified frozen elephant trunk repair for acute DeBakey type I dissection: midterm outcomes. Ann Thorac Surg 2018;105:749–55. https://doi.org/10.1016/j.athoracsur.2017.08.037
1275. Berretta P, Trimarchi S, Patel HJ, Gleason TG, Eagle KA, Di Eusanio M. Malperfusion syndromes in type A aortic dissection: what we have learned from IRAD. J Vis Surg 2018;4:65. https://doi.org/10.21037/jovs.2018.03.13
1276. Benedetto U, Mohamed H, Vitulli P, Petrou M. Axillary versus femoral arterial cannulation in type A acute aortic dissection: evidence from a meta-analysis of comparative studies and adjusted risk estimates. Eur J Cardiothorac Surg 2015;48:953–9. https://doi.org/10.1093/ejcts/ezv035
1277. Geirsson A, Szeto WY, Pochettino A, McGarvey ML, Keane MG, Woo YJ, et al. Significance of malperfusion syndromes prior to contemporary surgical repair for acute type A dissection: outcomes and need for additional revascularizations. Eur J Cardiothorac Surg 2007;32:255–62. https://doi.org/10.1016/j.ejcts.2007.04.012
1278. Yang B, Norton EL, Rosati CM, Wu X, Kim KM, Khaja MS, et al. Managing patients with acute type A aortic dissection and mesenteric malperfusion syndrome: a 20-year experience. J Thorac Cardiovasc Surg 2019;158:675–87.e4. https://doi.org/10.1016/j.jtcvs.2018.11.127
1279. Yang B, Rosati CM, Norton EL, Kim KM, Khaja MS, Dasika N, et al. Endovascular fenestration/stenting first followed by delayed open aortic repair for acute type A aortic dissection with malperfusion syndrome. Circulation 2018;138:2091–103. https://doi.org/10.1161/circulationaha.118.036328
1280. Leshnower BG, Keeling WB, Duwayri YM, Jordan WD, Jr, Chen EP. The “thoracic endovascular aortic repair-first” strategy for acute type A dissection with mesenteric malperfusion: initial results compared with conventional algorithms. J Thorac Cardiovasc Surg 2019;158:1516–24. https://doi.org/10.1016/j.jtcvs.2019.01.116
1281. Rylski B, Szeto WY, Bavaria JE, Branchetti E, Moser W, Milewski RK. Development of a single endovascular device for aortic valve replacement and ascending aortic repair. J Card Surg 2014;29:371–6. https://doi.org/10.1111/jocs.12348
1282. Kreibich M, Rylski B, Kondov S, Morlock J, Scheumann J, Kari FA, et al. Endovascular treatment of acute type A aortic dissection-the Endo Bentall approach. J Vis Surg 2018;4:69. https://doi.org/10.21037/jovs.2018.03.14
1283. Brown CR, Chen Z, Khurshan F, Kreibich M, Bavaria J, Groeneveld P, et al. Outcomes after thoracic endovascular aortic repair in patients with chronic kidney disease in the Medicare population. J Thorac Cardiovasc Surg 2020;159:402–13. https://doi.org/10.1016/j.jtcvs.2019.01.118
1284. Trimarchi S, Nienaber CA, Rampoldi V, Myrmel T, Suzuki T, Bossone E, et al. Role and results of surgery in acute type B aortic dissection: insights from the international registry of acute aortic dissection (IRAD). Circulation 2006;114:I357–64. https://doi.org/10.1161/circulationaha.105.000620
1285. Tolenaar JL, Froehlich W, Jonker FH, Upchurch GR, Rampoldi V, Tsai TT, et al. Predicting in-hospital mortality in acute type B aortic dissection: evidence from international registry of acute aortic dissection. Circulation 2014;130:S45–50. https://doi.org/10.1161/circulationaha.113.007117
1286. Martin G, Patel N, Grant Y, Jenkins M, Gibbs R, Bicknell C. Antihypertensive medication adherence in chronic type B aortic dissection is an important consideration in the management debate. J Vasc Surg 2018;68:693–9.e2. https://doi.org/10.1016/j.jvs.2017.12.063
1287. Brooke BS, Griffin CL, Glotzbach JP, Horns JJ, Patel S, Kraiss LW, et al. Predictors of adherence to anti-impulse therapy among patients treated for acute type-B aortic dissections. Ann Vasc Surg 2021;76:95–103. https://doi.org/10.1016/j.avsg.2021.04. 011
1288. Zeeshan A, Woo EY, Bavaria JE, Fairman RM, Desai ND, Pochettino A, et al. Thoracic endovascular aortic repair for acute complicated type B aortic dissection: superiority relative to conventional open surgical and medical therapy. J Thorac Cardiovasc Surg 2010;140:S109–115; discussion S142–S146. https://doi.org/10.1016/j.jtcvs.2010.06. 024
1289. Steuer J, Eriksson MO, Nyman R, Björck M, Wanhainen A. Early and long-term outcome after thoracic endovascular aortic repair (TEVAR) for acute complicated type B aortic dissection. Eur J Vasc Endovasc Surg 2011;41:318–23. https://doi.org/10.1016/j.ejvs.2010.11.024
1290. Zipfel B, Czerny M, Funovics M, Coppi G, Ferro C, Rousseau H, et al. Endovascular treatment of patients with types A and B thoracic aortic dissection using Relay thoracic stent-grafts: results from the RESTORE patient registry. J Endovasc Ther 2011;18: 131–43. https://doi.org/10.1583/10-3233mr.1
1291. Hanna JM, Andersen ND, Ganapathi AM, McCann RL, Hughes GC. Five-year results for endovascular repair of acute complicated type B aortic dissection. J Vasc Surg 2014;59:96–106. https://doi.org/10.1016/j.jvs.2013.07.001
1292. Stelzmueller ME, Nolz R, Mahr S, Beitzke D, Wolf F, Funovics M, et al. Thoracic endovascular repair for acute complicated type B aortic dissections. J Vasc Surg 2019;69: 318–26. https://doi.org/10.1016/j.jvs.2018.05.234
1293. Wilson-Smith AR, Muston B, Kamalanathan H, Yung A, Chen C-HJ, Sahai P, et al. Endovascular repair of acute complicated type B aortic dissection-systematic review and meta-analysis of long-term survival and reintervention. Ann Cardiothorac Surg 2021;10:723–30. https://doi.org/10.21037/acs-2021-taes-17
1294. MacGillivray TE, Gleason TG, Patel HJ, Aldea GS, Bavaria JE, Beaver TM, et al. The Society of Thoracic Surgeons/American Association for Thoracic Surgery clinical practice guidelines on the management of type B aortic dissection. J Thorac Cardiovasc Surg 2022;163:1231–49. https://doi.org/10.1016/j.jtcvs.2021.11.091
1295. Brunkwall J, Kasprzak P, Verhoeven E, Heijmen R, Taylor P, Alric P, et al. Endovascular repair of acute uncomplicated aortic type B dissection promotes aortic remodelling: 1 year results of the ADSORB trial. Eur J Vasc Endovasc Surg 2014;48:285–91. https://doi.org/10.1016/j.ejvs.2014.05.012
1296. Hossack M, Patel S, Gambardella I, Neequaye S, Antoniou GA, Torella F. Endovascular vs. medical management for uncomplicated acute and sub-acute type B aortic dissection: a meta-analysis. Eur J Vasc Endovasc Surg 2020;59:794–807. https://doi.org/10.1016/j.ejvs.2019.08.003
1297. Sa MP, Jacquemyn X, Van den Eynde J, Chu D, Serna-Gallegos D, Singh MJ, et al. Midterm outcomes of endovascular vs. medical therapy for uncomplicated type B aortic dissection: meta-analysis of reconstructed time to event data. Eur J Vasc Endovasc Surg 2023;66:609–19. https://doi.org/10.1016/j.ejvs.2023.07.004
1298. Sa MP, Jacquemyn X, Brown JA, Ahmad D, Serna-Gallegos D, Arnaoutakis GJ, et al. Thoracic endovascular aortic repair for hyperacute, acute, subacute and chronic type B aortic dissection: meta-analysis of reconstructed time-to-event data. Trends Cardiovasc Med 2023:S1050-1738(23)00113-5. https://doi.org/10.1016/j.tcm.2023.12.005
1299. Jubouri M, Al-Tawil M, Yip HCA, Bashir A, Tan SZCP, Bashir M, et al. Mid- and long-term outcomes of thoracic endovascular aortic repair in acute and subacute uncomplicated type B aortic dissection. J Card Surg 2022;37:1328–39. https://doi.org/10.1111/jocs.16349
1300. Torrent DJ, McFarland GE, Wang G, Malas M, Pearce BJ, Aucoin V, et al. Timing of thoracic endovascular aortic repair for uncomplicated acute type B aortic dissection and the association with complications. J Vasc Surg 2021;73:826–35. https://doi.org/10.1016/j.jvs.2020.05.073
1301. Schwartz SI, Durham C, Clouse WD, Patel VI, Lancaster RT, Cambria RP, et al. Predictors of late aortic intervention in patients with medically treated type B aortic dissection. J Vasc Surg 2018;67:78–84. https://doi.org/10.1016/j.jvs.2017.05.128
1302. Onitsuka S, Akashi H, Tayama K, Okazaki T, Ishihara K, Hiromatsu S, et al. Long-term outcome and prognostic predictors of medically treated acute type B aortic dissections. Ann Thorac Surg 2004;78:1268–73. https://doi.org/10.1016/j.athoracsur.2004.02.031
1303. Hughes GC, Ganapathi AM, Keenan JE, Englum BR, Hanna JM, Schechter MA, et al. Thoracic endovascular aortic repair for chronic DeBakey IIIb aortic dissection. Ann Thorac Surg 2014;98:2092–7; discussion 2098. https://doi.org/10.1016/j.athoracsur.2014.06.066
1304. Jánosi RA, Tsagakis K, Bettin M, Kahlert P, Horacek M, Al-Rashid F, et al. Thoracic aortic aneurysm expansion due to late distal stent graft-induced new entry. Catheter Cardiovasc Interv 2015;85:E43–53. https://doi.org/10.1002/ccd.25614
1305. Cheng L, Xiang D, Zhang S, Zheng C, Wu X. Reintervention after thoracic endovascular aortic repair of uncomplicated type B aortic dissection. J Clin Med 2023;12: 1418. https://doi.org/10.3390/jcm12041418
1306. Akutsu K, Nejima J, Kiuchi K, Sasaki K, Ochi M, Tanaka K, et al. Effects of the patent false lumen on the long-term outcome of type B acute aortic dissection. Eur J Cardiothorac Surg 2004;26:359–66. https://doi.org/10.1016/j.ejcts.2004.03.026
1307. Tsai TT, Evangelista A, Nienaber CA, Myrmel T, Meinhardt G, Cooper JV, et al. Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med 2007;357:349–59. https://doi.org/10.1056/NEJMoa063232
1308. Dake MD, Thompson M, van Sambeek M, Vermassen F, Morales JP. DISSECT: a new mnemonic-based approach to the categorization of aortic dissection. Eur J Vasc Endovasc Surg 2013;46:175–90. https://doi.org/10.1016/j.ejvs.2013.04.029
1309. Wang J, Jin T, Chen B, Pan Y, Shao C. Systematic review and meta-analysis of current evidence in endograft therapy vs medical treatment for uncomplicated type B aortic dissection. J Vasc Surg 2022;76:1099–108.e3. https://doi.org/10.1016/j.jvs.2022.03. 876
1310. Umaña JP, Lai DT, Mitchell RS, Moore KA, Rodriguez F, Robbins RC, et al. Is medical therapy still the optimal treatment strategy for patients with acute type B aortic dissections? J Thorac Cardiovasc Surg 2002;124:896–910. https://doi.org/10.1067/mtc.2002.123131
1311. Umaña JP, Miller DC, Mitchell RS. What is the best treatment for patients with acute type B aortic dissections—medical, surgical, or endovascular stent-grafting? Ann Thorac Surg 2002;74:S1840–3; discussion S1857–63. https://doi.org/10.1016/s0003-4975(02)04140-1
1312. Morello F, Santoro M, Fargion AT, Grifoni S, Nazerian P. Diagnosis and management of acute aortic syndromes in the emergency department. Intern Emerg Med 2021;16: 171–81. https://doi.org/10.1007/s11739-020-02354-8
1313. Marui A, Mochizuki T, Mitsui N, Koyama T, Kimura F, Horibe M. Toward the best treatment for uncomplicated patients with type B acute aortic dissection: a consideration for sound surgical indication. Circulation 1999;100:II275–80. https://doi.org/10.1161/01.cir.100.suppl_2.ii-275
1314. Crawford ES. The diagnosis and management of aortic dissection. JAMA 1990;264: 2537–41.
1315. Hata M, Shiono M, Inoue T, Sezai A, Niino T, Negishi N, et al. Optimal treatment of type B acute aortic dissection: long-term medical follow-up results. Ann Thorac Surg 2003;75:1781–4. https://doi.org/10.1016/s0003-4975(03)00113-9
1316. Oda T, Minatoya K, Sasaki H, Tanaka H, Seike Y, Itonaga T, et al. Surgical indication for chronic aortic dissection in descending thoracic and thoracoabdominal aorta. Circ Cardiovasc Interv 2017;10:e004292. https://doi.org/10.1161/circinterventions.116. 004292
1317. Conrad MF, Chung TK, Cambria MR, Paruchuri V, Brady TJ, Cambria RP. Effect of chronic dissection on early and late outcomes after descending thoracic and thoracoabdominal aneurysm repair. J Vasc Surg 2011;53:600–7; discussion 607. https://doi.org/10.1016/j.jvs.2010.09.053
1318. Crawford ES, Crawford JL, Safi HJ, Coselli JS, Hess KR, Brooks B, et al. Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients. J Vasc Surg 1986;3:389–404. https://doi.org/10.1067/mva.1986.avs0030389
1319. Zoli S, Etz CD, Roder F, Mueller CS, Brenner RM, Bodian CA, et al. Long-term survival after open repair of chronic distal aortic dissection. Ann Thorac Surg 2010;89: 1458–66. https://doi.org/10.1016/j.athoracsur.2010.02.014
1320. Etz CD, Zoli S, Mueller CS, Bodian CA, Di Luozzo G, Lazala R, et al. Staged repair significantly reduces paraplegia rate after extensive thoracoabdominal aortic aneurysm repair. J Thorac Cardiovasc Surg 2010;139:1464–72. https://doi.org/10.1016/j.jtcvs.2010.02.037
1321. Conrad MF, Ergul EA, Patel VI, Paruchuri V, Kwolek CJ, Cambria RP. Management of diseases of the descending thoracic aorta in the endovascular era: a Medicare population study. Ann Surg 2010;252:603–10. https://doi.org/10.1097/SLA. 0b013e3181f4eaef
1322. Sobocinski J, Dias NV, Berger L, Midulla M, Hertault A, Sonesson B, et al. Endograft repair of complicated acute type B aortic dissections. Eur J Vasc Endovasc Surg 2013; 45:468–74. https://doi.org/10.1016/j.ejvs.2013.01.031
1323. Conrad MF, Carvalho S, Ergul E, Kwolek CJ, Lancaster RT, Patel VI, et al. Late aortic remodeling persists in the stented segment after endovascular repair of acute complicated type B aortic dissection. J Vasc Surg 2015;62:600–5. https://doi.org/10.1016/j.jvs.2015.03.064
1324. Thrumurthy SG, Karthikesalingam A, Patterson BO, Holt PJE, Hinchliffe RJ, Loftus IM, et al. A systematic review of mid-term outcomes of thoracic endovascular repair (TEVAR) of chronic type B aortic dissection. Eur J Vasc Endovasc Surg 2011;42: 632–47. https://doi.org/10.1016/j.ejvs.2011.08.009
1325. Boufi M, Patterson BO, Loundou AD, Boyer L, Grima MJ, Loftus IM, et al. Endovascular versus open repair for chronic type B dissection treatment: a meta-analysis. Ann Thorac Surg 2019;107:1559–70. https://doi.org/10.1016/j.athoracsur.2018.10.045
1326. Conway AM, Qato K, Mondry LR, Stoffels GJ, Giangola G, Carroccio A. Outcomes of thoracic endovascular aortic repair for chronic aortic dissections. J Vasc Surg 2018;67: 1345–52. https://doi.org/10.1016/j.jvs.2017.08.098
1327. Tenorio ER, Oderich GS, Farber MA, Schneider DB, Timaran CH, Schanzer A, et al. Outcomes of endovascular repair of chronic postdissection compared with degenerative thoracoabdominal aortic aneurysms using fenestrated-branched stent grafts. J Vasc Surg 2020;72:822–36.e9. https://doi.org/10.1016/j.jvs.2019.10.091
1328. Marques De Marino P, Ibraheem A, Gafur N, Verhoeven EL, Katsargyris A. Outcomes of fenestrated and branched endovascular aortic repair for chronic postdissection thoracoabdominal aortic aneurysms. J Cardiovasc Surg 2020;61:427–34. https://doi.org/10.23736/s0021-9509.20.11367-3
1329. Gallitto E, Faggioli G, Melissano G, Fargion A, Isernia G, Bertoglio L, et al. Fenestrated and branched endografts for post-dissection thoraco-abdominal aneurysms: results of a national multicentre study and literature review. Eur J Vasc Endovasc Surg 2022;64:630–8. https://doi.org/10.1016/j.ejvs.2022.06.019
1330. Geisbüsch S, Kuehnl A, Salvermoser M, Reutersberg B, Trenner M, Eckstein H-H. Editor’s choice—hospital incidence, treatment, and in hospital mortality following open and endovascular surgery for thoraco-abdominal aortic aneurysms in Germany from 2005 to 2014: secondary data analysis of the Nationwide German DRG microdata. Eur J Vasc Endovasc Surg 2019;57:488–98. https://doi.org/10.1016/j.ejvs.2018.10.030
1331. Genoni M, Paul M, Jenni R, Graves K, Seifert B, Turina M. Chronic beta-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection. Eur J Cardiothorac Surg 2001;19:606–10. https://doi.org/10.1016/s1010-7940(01) 00662-5
1332. Chen SW, Chan YH, Lin CP, Wu VC-C, Cheng Y-T, Chen D-Y, et al. Association of long-term use of antihypertensive medications with late outcomes among patients with aortic dissection. JAMA Netw Open 2021;4:e210469. https://doi.org/10.1001/jamanetworkopen.2021.0469
1333. Smedberg C, Hultgren R, Leander K, Steuer J. Pharmacological treatment in patients with aortic dissection. Open Heart 2022;9:e002082. https://doi.org/10.1136/openhrt-2022-002082
1334. Xiong J, Jiang B, Guo W, Wang SM, Tong XY. Endovascular stent graft placement in patients with type B aortic dissection: a meta-analysis in China. J Thorac Cardiovasc Surg 2009;138:865–72.e1. https://doi.org/10.1016/j.jtcvs.2009.02.005
1335. Zhu JM, Ma WG, Peterss S, Wang L-F, Qiao Z-Y, Ziganshin BA, et al. Aortic dissection in pregnancy: management strategy and outcomes. Ann Thorac Surg 2017;103: 1199–206. https://doi.org/10.1016/j.athoracsur.2016.08.089
1336. Yates MT, Soppa G, Smelt J, Fletcher N, van Besouw J-P, Thilaganathan B, et al. Perioperative management and outcomes of aortic surgery during pregnancy. J Thorac Cardiovasc Surg 2015;149:607–10. https://doi.org/10.1016/j.jtcvs.2014.10.038
1337. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39:3165–241. https:// doi.org/10.1093/eurheartj/ehy340
1338. DeMartino RR, Sen I, Huang Y, Bower TC, Oderich GS, Pochettino A, et al. Population-based assessment of the incidence of aortic dissection, intramural hematoma, and penetrating ulcer, and its associated mortality from 1995 to 2015. Circ Cardiovasc Qual Outcomes 2018;11:e004689. https://doi.org/10.1161/circoutcomes.118.004689
1339. Evangelista A, Dominguez R, Sebastia C, Salas A, Permanyer-Miralda G, Avegliano G, et al. Long-term follow-up of aortic intramural hematoma: predictors of outcome. Circulation 2003;108:583–9. https://doi.org/10.1161/01.Cir.0000081776.49923.5a
1340. Moral S, Ballesteros E, Roque M, Carrato C, Vilardell P, Brugada R, et al. Intimal disruption in type B aortic intramural hematoma. Does size matter? A systematic review and meta-analysis. Int J Cardiol 2018;269:298–303. https://doi.org/10.1016/j.ijcard.2018.07.111
1341. Moral S, Ballesteros E, Evangelista A. Conservative vs surgical treatment in type A intramural hematoma. What is new? J Card Surg 2020;35:1758–60. https://doi.org/10.1111/jocs.14739
1342. Ishizu K, Kaji S, Nakashima M, Kitai T, Kim K, Ehara N, et al. Focal intimal disruption size at multidetector CT and disease progression in type B aortic intramural hematoma. Radiology 2021;301:311–9. https://doi.org/10.1148/radiol.2021204385
1343. Chou AS, Ziganshin BA, Charilaou P, Tranquilli M, Rizzo JA, Elefteriades JA. Long-term behavior of aortic intramural hematomas and penetrating ulcers. J Thorac Cardiovasc Surg 2016;151:361–72, 373.e1. https://doi.org/10.1016/j.jtcvs.2015.09.012
1344. Evangelista A, Mukherjee D, Mehta RH, O’Gara PT, Fattori R, Cooper JV, et al. Acute intramural hematoma of the aorta: a mystery in evolution. Circulation 2005;111: 1063–70. https://doi.org/10.1161/01.Cir.0000156444.26393.80
1345. Song JK. Update in acute aortic syndrome: intramural hematoma and incomplete dissection as new disease entities. J Cardiol 2014;64:153–61. https://doi.org/10.1016/j.jjcc.2014.05.005
1346. Song JK, Kim HS, Kang DH, Lim T-H, Song M-G, Park S-W, et al. Different clinical features of aortic intramural hematoma versus dissection involving the ascending aorta. J Am Coll Cardiol 2001;37:1604–10. https://doi.org/10.1016/s0735-1097(01)01184-6
1347. Evangelista A, Maldonado G, Moral S, Teixido-Tura G, Lopez A, Cuellar H, et al. Intramural hematoma and penetrating ulcer in the descending aorta: differences and similarities. Ann Cardiothorac Surg 2019;8:456–70. https://doi.org/10.21037/acs.2019.07.05
1348. Wee I, Varughese RS, Syn N, Choong A. Non-operative management of type A acute aortic syndromes: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2019;58:41–51. https://doi.org/10.1016/j.ejvs.2018.10.015
1349. Chow SCY, Wong RHL, Lakhani I, Wong MV, Tse G, Yu PSY, et al. Management of acute type A intramural hematoma: upfront surgery or individualized approach? A retrospective analysis and meta-analysis. J Thorac Dis 2020;12:680–9. https://doi.org/10.21037/jtd.2019.12.109
1350. Evangelista A, Czerny M, Nienaber C, Schepens M, Rousseau H, Cao P, et al. Interdisciplinary expert consensus on management of type B intramural haematoma and penetrating aortic ulcer. Eur J Cardiothorac Surg 2015;47:209–17. https://doi.org/10.1093/ejcts/ezu386
1351. Sa MP, Jacquemyn X, Tasoudis P, Dufendach K, Singh MJ, de la Cruz KI, et al. Five year results of endovascular versus medical therapy in acute type B aortic intramural haematoma: meta-analysis of reconstructed time to event data. Eur J Vasc Endovasc Surg 2024;67:584–92. https://doi.org/10.1016/j.ejvs.2023.12.024
1352. Moral S, Cuéllar H, Avegliano G, Ballesteros E, Salcedo MT, Ferreira-González I, et al. Clinical implications of focal intimal disruption in patients with type B intramural hematoma. J Am Coll Cardiol 2017;69:28–39. https://doi.org/10.1016/j.jacc.2016.10. 045
1353. Chakos A, Twindyawardhani T, Evangelista A, Maldonado G, Piffaretti G, Yan TD, et al. Endovascular versus medical management of type B intramural hematoma: a meta-analysis. Ann Cardiothorac Surg 2019;8:447–55. https://doi.org/10.21037/acs.2019.06.11
1354. Song JK, Yim JH, Ahn JM, Kim D-H, Kang JW, Lee TY, et al. Outcomes of patients with acute type a aortic intramural hematoma. Circulation 2009;120:2046–52. https://doi.org/10.1161/circulationaha.109.879783
1355. Ahn JM, Kim H, Kwon O, Om SY, Heo R, Lee S, et al. Differential clinical features and long-term prognosis of acute aortic syndrome according to disease entity. Eur Heart J 2019;40:2727–36. https://doi.org/10.1093/eurheartj/ehz153
1356. Kitamura T, Torii S, Miyamoto T, Mishima T, Ohkubo H, Fujioka S, et al. Watch-and-wait strategy for type A intramural haematoma and acute aortic dissection with thrombosed false lumen of the ascending aorta: a Japanese single-centre experience. Eur J Cardiothorac Surg 2020;58:590–7. https://doi.org/10.1093/ejcts/ ezaa080
1357. Jánosi RA, Gorla R, Tsagakis K, Kahlert P, Horacek M, Bruckschen F, et al. Thoracic endovascular repair of complicated penetrating aortic ulcer: an 11-year single-center experience. J Endovasc Ther 2016;23:150–9. https://doi.org/10.1177/ 1526602815613790
1358. Nguyen VX, Nguyen BD. PET/CT imaging of abdominal aorta with intramural hematomas, penetrating ulcer, and saccular pseudoaneurysm. Clin Nucl Med 2014;39: 467–9. https://doi.org/10.1097/RLU.0b013e318292f152
1359. Gorla R, Erbel R, Kuehl H, Kahlert P, Tsagakis K, Jakob H, et al. Prognostic value of (18)F-fluorodeoxyglucose PET-CT imaging in acute aortic syndromes: comparison with serological biomarkers of inflammation. Int J Cardiovasc Imaging 2015;31: 1677–85. https://doi.org/10.1007/s10554-015-0725-8
1360. Eggebrecht H, Plicht B, Kahlert P, Erbel R. Intramural hematoma and penetrating ulcers: indications to endovascular treatment. Eur J Vasc Endovasc Surg 2009;38:659–65. https://doi.org/10.1016/j.ejvs.2009.09.001
1361. Salim S, Locci R, Martin G, Gibbs R, Jenkins M, Hamady M, et al. Short- and long-term outcomes in isolated penetrating aortic ulcer disease. J Vasc Surg 2020;72:84–91. https://doi.org/10.1016/j.jvs.2019.09.039
1362. Überall MA, Elling C, Eibl C, Müller-Schwefe GHH, Lefeber C, Heine M, et al. Tapentadol prolonged release in patients with chronic low back pain: real-world data from the German Pain eRegistry. Pain Manag 2022;12:211–27. https://doi.org/10.2217/pmt-2021-0058
1363. Ganaha F, Miller DC, Sugimoto K, Do YS, Minamiguchi H, Saito H, et al. Prognosis of aortic intramural hematoma with and without penetrating atherosclerotic ulcer: a clinical and radiological analysis. Circulation 2002;106:342–8. https://doi.org/10.1161/01.cir.0000022164.26075.5a
1364. DeCarlo C, Latz CA, Boitano LT, Waller HD, Kim Y, Sumpio BJ, et al. Natural history of penetrating atherosclerotic ulcers in aortic branch vessels. J Vasc Surg 2021;74: 1904–9. https://doi.org/10.1016/j.jvs.2021.06.035
1365. Piazza M, Squizzato F, Porcellato L, Casali E, Grego F, Antonello M. Predictors of intervention in acute type B aortic penetrating ulcer and intramural hematoma. Semin Thorac Cardiovasc Surg 2022;36:1–10. https://doi.org/10.1053/j.semtcvs.2022.07.009
1366. Kotsis T, Spyropoulos BG, Asaloumidis N, Christoforou P, Katseni K, Papaconstantinou I. Penetrating atherosclerotic ulcers of the abdominal aorta: a case report and review of the literature. Vasc Specialist Int 2019;35:152–9. https://doi.org/10.5758/vsi.2019.35.3.152
1367. DeCarlo C, Latz CA, Boitano LT, Kim Y, Tanious A, Schwartz SI, et al. Prognostication of asymptomatic penetrating aortic ulcers: a modern approach. Circulation 2021;144: 1091–101. https://doi.org/10.1161/circulationaha.121.054710
1368. Demetriades D, Velmahos GC, Scalea TM, Jurkovich GJ, Karmy-Jones R, Teixeira PG, et al. Operative repair or endovascular stent graft in blunt traumatic thoracic aortic injuries: results of an American Association for the Surgery of Trauma Multicenter Study. J Trauma 2008;64:561–70; discussion 570–1. https://doi.org/10.1097/TA. 0b013e3181641bb3
1369. Katzenschlager R, Ugurluoglu A, Ahmadi A, Hülsmann M, Koppensteiner R, Larch E, et al. Incidence of pseudoaneurysm after diagnostic and therapeutic angiography. Radiology 1995;195:463–6. https://doi.org/10.1148/radiology.195.2.7724767
1370. Mulder EJ, van Bockel JH, Maas J, van den Akker PJ, Hermans J. Morbidity and mortality of reconstructive surgery of noninfected false aneurysms detected long after aortic prosthetic reconstruction. Arch Surg 1998;133:45–9. https://doi.org/10.1001/archsurg.133.1.45
1371. Chaud GJ, Mohammadi S, Cervetti MR, Guimaron S, Sebestyen A, Dagenais F, et al. Aortic pseudoaneurysm after type A aortic dissection: results of conservative management. Semin Thorac Cardiovasc Surg 2022;35:457–64. https://doi.org/10.1053/j.semtcvs.2022.04.004
1372. Richens D, Kotidis K, Neale M, Oakley C, Fails A. Rupture of the aorta following road traffic accidents in the United Kingdom 1992–1999. The results of the co-operative crash injury study. Eur J Cardiothorac Surg 2003;23:143–8. https://doi.org/10.1016/ s1010-7940(02)00720-0
1373. Harky A, Bleetman D, Chan JSK, Eriksen P, Chaplin G, MacCarthy-Ofosu B, et al. A systematic review and meta-analysis of endovascular versus open surgical repair for the traumatic ruptured thoracic aorta. J Vasc Surg 2020;71:270–82. https://doi.org/10.1016/j.jvs.2019.05.011
1374. Heneghan RE, Aarabi S, Quiroga E, Gunn ML, Singh N, Starnes BW. Call for a new classification system and treatment strategy in blunt aortic injury. J Vasc Surg 2016; 64:171–6. https://doi.org/10.1016/j.jvs.2016.02.047
1375. Januzzi JL, Sabatine MS, Eagle KA, Evangelista A, Bruckman D, Fattori R, et al. Iatrogenic aortic dissection. Am J Cardiol 2002;89:623–6. https://doi.org/10.1016/ s0002-9149(01)02312-8
1376. Gómez-Moreno S, Sabaté M, Jiménez-Quevedo P, Vázquez P, Alfonso F, Angiolillo DJ, et al. Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcome. EuroIntervention 2006;2:197–202.
1377. Dunning DW, Kahn JK, Hawkins ET, O’Neill W. Iatrogenic coronary artery dissections extending into and involving the aortic root. Catheter Cardiovasc Interv 2000; 51:387–93. https://doi.org/10.1002/1522-726x(200012)51:4<387::aid-ccd3>3.0. co;2-b
1378. Bekkers JA, te Riele RJ, Takkenberg JJ, Bol Raap G, Hofland J, Roos-Hesselink JW, et al. Thoracic aortic surgery: an overview of 40 years clinical practice. J Thorac Cardiovasc Surg 2014;147:332–43. https://doi.org/10.1016/j.jtcvs.2012.11.036
1379. Meena RA, Benarroch-Gampel J, Leshnower BG, Escobar GA, Duwayri Y, Jordan WD, et al. Surveillance recommendations after thoracic endovascular aortic repair should be based on initial indication for repair. Ann Vasc Surg 2019;57:51–9. https://doi.org/10.1016/j.avsg.2018.11.001
1380. Giles KA, Beck AW, Lala S, Patterson S, Back M, Fatima J, et al. Implications of secondary aortic intervention after thoracic endovascular aortic repair for acute and chronic type B dissection. J Vasc Surg 2019;69:1367–78. https://doi.org/10.1016/j.jvs.2018.07. 080
1381. Kimura N, Itoh S, Yuri K, Adachi K, Matsumoto H, Yamaguchi A, et al. Reoperation for enlargement of the distal aorta after initial surgery for acute type A aortic dissection. J Thorac Cardiovasc Surg 2015;149:S91–8.e1. https://doi.org/10.1016/j.jtcvs.2014.08.008
1382. Ameli-Renani S, Das R, Morgan RA. Thoracic endovascular aortic repair for the treatment of aortic dissection: post-operative imaging, complications and secondary interventions. Cardiovasc Intervent Radiol 2015;38:1391–404. https://doi.org/10.1007/ s00270-015-1072-9
1383. Fleischmann D, Afifi RO, Casanegra AI, Elefteriades JA, Gleason TG, Hanneman K, et al. Imaging and surveillance of chronic aortic dissection: a scientific statement from the American Heart Association. Circ Cardiovasc Imaging 2022;15:e000075. https://doi.org/10.1161/hci.0000000000000075
1384. Colacchio EC, Squizzato F, Piazza M, Menegolo M, Grego F, Antonello M. Clinical and imaging predictors of disease progression in type B aortic intramural hematomas and penetrating aortic ulcers: a systematic review. Diagnostics (Basel) 2022;12:2727. https://doi.org/10.3390/diagnostics12112727
1385. Vapnik JS, Kim JB, Isselbacher EM, Ghoshhajra BB, Cheng Y, Sundt TM, et al. Characteristics and outcomes of ascending versus descending thoracic aortic aneurysms. Am J Cardiol 2016;117:1683–90. https://doi.org/10.1016/j.amjcard.2016.02.048
1386. Gökalp AL, Takkenberg JJM. Decision-making in thoracic aortic aneurysm surgery-clinician and patient view. Semin Thorac Cardiovasc Surg 2019;31:638–42. https://doi.org/10.1053/j.semtcvs.2019.05.032
1387. Treasure T, King A, Hidalgo Lemp L, Golesworthy T, Pepper J, Takkenberg JJM. Developing a shared decision support framework for aortic root surgery in Marfan syndrome. Heart 2018;104:480–6. https://doi.org/10.1136/heartjnl-2017-311598
1388. Jondeau G, Ropers J, Regalado E, Braverman A, Evangelista A, Teixedo G, et al. International registry of patients carrying TGFBR1 or TGFBR2 mutations: results of the MAC (Montalcino Aortic Consortium). Circ Cardiovasc Genet 2016;9: 548–58. https://doi.org/10.1161/circgenetics.116.001485
1389. Thakker PD, Braverman AC. Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease. Heart 2021;107:619–26. https://doi.org/10.1136/heartjnl-2020-317036
1390. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006;355:788–98. https://doi.org/10.1056/NEJMoa055695
1391. Regalado ES, Morris SA, Braverman AC, Hostetler EM, De Backer J, Li R, et al. Comparative risks of initial aortic events associated with genetic thoracic aortic disease. J Am Coll Cardiol 2022;80:857–69. https://doi.org/10.1016/j.jacc.2022.05.054
1392. Huguenard AL, Johnson GW, Desai RR, Osbun JW, Dacey RG, Braverman AC. Relationship between phenotypic features in Loeys-Dietz syndrome and the presence of intracranial aneurysms. J Neurosurg 2022;138:1385–92. https://doi.org/10.3171/2022.9.Jns221373
1393. Lopez-Sainz A, Mila L, Rodriguez-Palomares J, Limeres J, Granato C, La Mura L, et al. Aortic branch aneurysms and vascular risk in patients with Marfan syndrome. J Am Coll Cardiol 2021;77:3005–12. https://doi.org/10.1016/j.jacc.2021.04.054
1394. Kaw A, Kaw K, Hostetler EM, Beleza-Meireles A, Smith-Collins A, Armstrong C, et al. Expanding ACTA2 genotypes with corresponding phenotypes overlapping with smooth muscle dysfunction syndrome. Am J Med Genet A 2022;188:2389–96. https://doi.org/10.1002/ajmg.a.62775
1395. Velvin G, Wilhelmsen JE, Johansen H, Bathen T, Geirdal AO. Systematic review of quality of life in persons with hereditary thoracic aortic aneurysm and dissection diagnoses. Clin Genet 2019;95:661–76. https://doi.org/10.1111/cge.13522
1396. Mariscalco G, Debiec R, Elefteriades JA, Samani NJ, Murphy GJ. Systematic review of studies that have evaluated screening tests in relatives of patients affected by nonsyndromic thoracic aortic disease. J Am Heart Assoc 2018;7:e009302. https://doi.org/10.1161/jaha.118.009302
1397. Cecchi AC, Boerio ML, Marin I, Pinard A, Milewicz DM. Preventing acute aortic dissections: the power of familial screening and risk assessment. J Am Heart Assoc 2022; 11:e025441. https://doi.org/10.1161/jaha.122.025441
1398. Abbasciano RG, Mariscalco G, Barwell J, Owens G, Zakkar M, Joel-David L, et al. Evaluating the feasibility of screening relatives of patients affected by nonsyndromic thoracic aortic diseases: the REST study. J Am Heart Assoc 2022;11:e023741. https://doi.org/10.1161/jaha.121.023741
1399. Musunuru K, Hershberger RE, Day SM, Klinedinst NJ, Landstrom AP, Parikh VN, et al. Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association. Circ Genom Precis Med 2020;13:e000067. https://doi.org/10.1161/hcg.0000000000000067
1400. Albornoz G, Coady MA, Roberts M, Davies RR, Tranquilli M, Rizzo JA, et al. Familial thoracic aortic aneurysms and dissections—incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg 2006;82:1400–5. https://doi.org/10.1016/j.athoracsur.2006.04.098
1401. Biddinger A, Rocklin M, Coselli J, Milewicz DM. Familial thoracic aortic dilatations and dissections: a case control study. J Vasc Surg 1997;25:506–11. https://doi.org/10.1016/ s0741-5214(97)70261-1
1402. Robertson EN, van der Linde D, Sherrah AG, Vallely MP, Wilson M, Bannon PG, et al. Familial non-syndromal thoracic aortic aneurysms and dissections—incidence and family screening outcomes. Int J Cardiol 2016;220:43–51. https://doi.org/10.1016/j.ijcard.2016.06.086
1403. De Backer J, Bondue A, Budts W, Evangelista A, Gallego P, Jondeau G, et al. Genetic counselling and testing in adults with congenital heart disease: a consensus document of the ESC Working Group of Grown-Up Congenital Heart Disease, the ESC Working Group on Aorta and Peripheral Vascular Disease and the European Society of Human Genetics. Eur J Prev Cardiol 2020;27:1423–35. https://doi.org/10.1177/2047487319854552
1404. Wolford BN, Hornsby WE, Guo D, Zhou W, Lin M, Farhat L, et al. Clinical implications of identifying pathogenic variants in individuals with thoracic aortic dissection. Circ Genom Precis Med 2019;12:e002476. https://doi.org/10.1161/circgen.118.002476
1405. Renard M, Francis C, Ghosh R, Scott AF, Witmer PD, Adès LC, et al. Clinical validity of genes for heritable thoracic aortic aneurysm and dissection. J Am Coll Cardiol 2018; 72:605–15. https://doi.org/10.1016/j.jacc.2018.04.089
1406. De Backer J, Jondeau G, Boileau C. Genetic testing for aortopathies: primer for the nongeneticist. Curr Opin Cardiol 2019;34:585–93. https://doi.org/10.1097/hco. 0000000000000669
1407. Milewicz DM, Guo D, Hostetler E, Marin I, Pinard AC, Cecchi AC, et al. Update on the genetic risk for thoracic aortic aneurysms and acute aortic dissections: implications for clinical care. J Cardiovasc Surg 2021;62:203–10. https://doi.org/10.23736/s0021-9509.21.11816-6
1408. Chou EL, Lindsay ME. The genetics of aortopathies: hereditary thoracic aortic aneurysms and dissections. Am J Med Genet C Semin Med Genet 2020;184:136–48. https://doi.org/10.1002/ajmg.c.31771
1409. Harris SL, Lindsay ME. Role of clinical genetic testing in the management of aortopathies. Curr Cardiol Rep 2021;23:10. https://doi.org/10.1007/s11886-020-01435-6
1410. Regalado ES, Guo DC, Prakash S, Bensend TA, Flynn K, Estrera A, et al. Aortic disease presentation and outcome associated with ACTA2 mutations. Circ Cardiovasc Genet 2015;8:457–64. https://doi.org/10.1161/circgenetics.114.000943
1411. Teixidó-Tura G, Franken R, Galuppo V, Gutiérrez García-Moreno L, Borregan M, Mulder BJM, et al. Heterogeneity of aortic disease severity in patients with Loeys-Dietz syndrome. Heart 2016;102:626–32. https://doi.org/10.1136/heartjnl-2015-308535
1412. Baudhuin LM, Kotzer KE, Lagerstedt SA. Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. Genet Med 2015;17: 177–87. https://doi.org/10.1038/gim.2014.91
1413. Franken R, Teixido-Tura G, Brion M, Forteza A, Rodriguez-Palomares J, Gutierrez L, et al. Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome. Heart 2017;103:1795–9. https://doi.org/10.1136/heartjnl-2016-310631
1414. Wallace SE, Regalado ES, Gong L, Janda AL, Guo D, Russo CF, et al. MYLK pathogenic variants aortic disease presentation, pregnancy risk, and characterization of pathogenic missense variants. Genet Med 2019;21:144–51. https://doi.org/10.1038/ s41436-018-0038-0
1415. Seike Y, Matsuda H, Ishibashi-Ueda H, Morisaki H, Morisaki T, Minatoya K, et al. Surgical outcome and histological differences between individuals with TGFBR1 and TGFBR2 mutations in Loeys-Dietz syndrome. Ann Thorac Cardiovasc Surg 2021; 27:56–63. https://doi.org/10.5761/atcs.oa.20-00223
1416. Arnaud P, Milleron O, Hanna N, Ropers J, Ould Ouali N, Affoune A, et al. Clinical relevance of genotype-phenotype correlations beyond vascular events in a cohort study of 1500 Marfan syndrome patients with FBN1 pathogenic variants. Genet Med 2021;23:1296–304. https://doi.org/10.1038/s41436-021-01132-x
1417. Silberbach M, Roos-Hesselink JW, Andersen NH, Braverman AC, Brown N, Collins RT, et al. Cardiovascular health in Turner syndrome: a scientific statement from the American Heart Association. Circ Genom Precis Med 2018;11:e000048. https://doi.org/10.1161/hcg.0000000000000048
1418. Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol 2017;177:G1–70. https://doi.org/10.1530/eje-17-0430
1419. van den Hoven AT, Chelu RG, Duijnhouwer AL, Demulier L, Devos D, Nieman K, et al. Partial anomalous pulmonary venous return in Turner syndrome. Eur J Radiol 2017;95:141–6. https://doi.org/10.1016/j.ejrad.2017.07.024
1420. Carlson M, Airhart N, Lopez L, Silberbach M. Moderate aortic enlargement and bicuspid aortic valve are associated with aortic dissection in Turner syndrome: report of the international Turner syndrome aortic dissection registry. Circulation 2012;126: 2220–6. https://doi.org/10.1161/circulationaha.111.088633
1421. Matura LA, Ho VB, Rosing DR, Bondy CA. Aortic dilatation and dissection in Turner syndrome. Circulation 2007;116:1663–70. https://doi.org/10.1161/circulationaha.106. 685487
1422. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 2008;93:4735–42. https://doi.org/10.1210/jc.2008-1049
1423. Duijnhouwer AL, Bons LR, Timmers H, van Kimmenade RRL, Snoeren M, Timmermans J, et al. Aortic dilatation and outcome in women with Turner syndrome. Heart 2019;105:693–700. https://doi.org/10.1136/heartjnl-2018-313716
1424. Donadille B, Tuffet S, Cholet C, Nedelcu M, Bourcigaux N, Iserin L, et al. Prevalence and progression of aortic dilatation in adult patients with Turner syndrome: a cohort study. Eur J Endocrinol 2020;183:463–70. https://doi.org/10.1530/eje-20-0284
1425. Meccanici F, Schotte MH, Snoeren M, Bons LR, van den Hoven AT, Kardys I, et al. Aortic dilation and growth in women with Turner syndrome. Heart 2023;109: 102–10. https://doi.org/10.1136/heartjnl-2022-320922
1426. Galian-Gay L, Rodriguez-Palomares JF. Turner syndrome and aortic complications: more benign than previously thought. Heart 2022;109:82–3. https://doi.org/10.1136/heartjnl-2022-321330
1427. Silberbach M, Braverman AC, Prakash SK, Roos-Hesselink JW, Quezada E, Scurlock C. Preventing aortic dissection in Turner syndrome: who faces the risk? Int J Cardiol 2023;377:44. https://doi.org/10.1016/j.ijcard.2023.01.075
1428. Prakash S, Gen TACRI, Milewicz D. Turner syndrome-specific and general population Z-scores are equivalent for most adults with Turner syndrome. Am J Med Genet A 2017;173:1094–6. https://doi.org/10.1002/ajmg.a.38100
1429. Corbitt H, Maslen C, Prakash S, Morris SA, Silberbach M. Allometric considerations when assessing aortic aneurysms in Turner syndrome: implications for activity recommendations and medical decision-making. Am J Med Genet A 2018;176:277–82. https://doi.org/10.1002/ajmg.a.38584
1430. Quigley CA, Fechner PY, Geffner ME, Eugster EA, Ross JL, Habiby RL, et al. Prevention of growth failure in Turner syndrome: long-term results of early growth hormone treatment in the “Toddler Turner” Cohort. Horm Res Paediatr 2021;94: 18–35. https://doi.org/10.1159/000513788
1431. Klein KO, Rosenfield RL, Santen RJ, Gawlik AM, Backeljauw PF, Gravholt CH, et al. Estrogen replacement in Turner syndrome: literature review and practical considerations. J Clin Endocrinol Metab 2018;103:1790–803. https://doi.org/10.1210/jc.2017-02183
1432. Quigley CA, Wan X, Garg S, Kowal K, Cutler GB, Ross JL. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 2014;99:E1754–1764. https://doi.org/10.1210/jc.2013-4518
1433. Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, et al. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J Clin Endocrinol Metab 2007;92:3406–16. https://doi.org/10.1210/jc.2006-2874
1434. Stephure DK; Canadian Growth Hormone Advisory Committee. Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 2005;90:3360–6. https://doi.org/10.1210/jc.2004-2187
1435. Campens L, Baris L, Scott NS, Broberg CS, Bondue A, Jondeau G, et al. Pregnancy outcome in thoracic aortic disease data from the registry of pregnancy and cardiac disease. Heart 2021;107:1704–9. https://doi.org/10.1136/heartjnl-2020-318183
1436. Grewal J, Valente AM, Egbe AC, Wu FM, Krieger EV, Sybert VP, et al. Cardiovascular outcomes of pregnancy in Turner syndrome. Heart 2021;107:61–6. https://doi.org/10.1136/heartjnl-2020-316719
1437. Thompson T, Zieba B, Howell S, Karakash W, Davis S. A mixed methods study of physical activity and quality of life in adolescents with Turner syndrome. Am J Med Genet A 2020;182:386–96. https://doi.org/10.1002/ajmg.a.61439
1438. Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000;342: 673–80. https://doi.org/10.1056/nejm200003093421001
1439. Byers PH, Belmont J, Black J, De Backer J, Frank M, Jeunemaitre X, et al. Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet 2017;175:40–7. https://doi.org/10.1002/ajmg.c.31553
1440. Oderich GS, Panneton JM, Bower TC, Lindor NM, Cherry KJ, Noel AA, et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg 2005;42:98–106. https://doi.org/10.1016/j.jvs.2005.03.053
1441. Frank M, Adham S, Seigle S, Legrand A, Mirault T, Henneton P, et al. Vascular Ehlers-Danlos syndrome: long-term observational study. J Am Coll Cardiol 2019;73: 1948–57. https://doi.org/10.1016/j.jacc.2019.01.058
1442. Pepin MG, Schwarze U, Rice KM, Liu M, Leistritz D, Byers PH. Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV). Genet Med 2014;16:881–8. https://doi.org/10.1038/gim.2014.72
1443. van de Laar I, Baas AF, De Backer J, Blankenstein JD, Dulfer E, Helderman-van den Enden ATJM, et al. Surveillance and monitoring in vascular Ehlers-Danlos syndrome in European reference network for rare vascular diseases (VASCERN). Eur J Med Genet 2022;65:104557. https://doi.org/10.1016/j.ejmg.2022.104557
1444. Baderkhan H, Wanhainen A, Stenborg A, Stattin EL, Bjorck M. Celiprolol treatment in patients with vascular Ehlers-Danlos syndrome. Eur J Vasc Endovasc Surg 2021;61: 326–31. https://doi.org/10.1016/j.ejvs.2020.10.020
1445. Ong KT, Perdu J, De Backer J, Bozec E, Collignon P, Emmerich J, et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet 2010;376:1476–84. https://doi.org/10.1016/s0140-6736(10)60960-9
1446. Murray ML, Pepin M, Peterson S, Byers PH. Pregnancy-related deaths and complications in women with vascular Ehlers-Danlos syndrome. Genet Med 2014;16:874–80. https://doi.org/10.1038/gim.2014.53
1447. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010;47:476–85. https://doi.org/10.1136/jmg.2009.072785
1448. Yildiz M, Nucera M, Jungi S, Heinisch PP, Mosbahi S, Becker D, et al. Outcome of Stanford type B dissection in patients with Marfan syndrome. Eur J Cardiothorac Surg 2023;64:ezad178. https://doi.org/10.1093/ejcts/ezad178
1449. Narula N, Devereux RB, Arbustini E, Ma X, Weinsaft JW, Girardi L, et al. Risk of type B dissection in Marfan syndrome: the Cornell aortic aneurysm registry. J Am Coll Cardiol 2023;82:2009–17. https://doi.org/10.1016/j.jacc.2023.08.055
1450. Senemaud J, Gaudry M, Jouve E, Blanchard A, Milleron O, Dulac Y, et al. Primary non-aortic lesions are not rare in Marfan syndrome and are associated with aortic dissection independently of age. J Clin Med 2023;12:2902. https://doi.org/10.3390/ jcm12082902
1451. Judge DP, Rouf R, Habashi J, Dietz HC. Mitral valve disease in Marfan syndrome and related disorders. J Cardiovasc Transl Res 2011;4:741–7. https://doi.org/10.1007/ s12265-011-9314-y
1452. Demolder A, Bianco L, Caruana M, Cervi E, Evangelista A, Jondeau G, et al. Arrhythmia and impaired myocardial function in heritable thoracic aortic disease: an international retrospective cohort study. Eur J Med Genet 2022;65:104503. https://doi.org/10.1016/j.ejmg.2022.104503
1453. Pyeritz RE. Marfan syndrome: improved clinical history results in expanded natural history. Genet Med 2019;21:1683–90. https://doi.org/10.1038/s41436-018-0399-4
1454. Jondeau G, Detaint D, Tubach F, Arnoult F, Milleron O, Raoux F, et al. Aortic event rate in the Marfan population: a cohort study. Circulation 2012;125:226–32. https://doi.org/10.1161/circulationaha.111.054676
1455. Requejo-Garcia L, Martinez-Lopez R, Plana-Andani E, Medina-Badenes P, Hernándiz-Martínez A, Torres-Blanco A, et al. Extrathoracic aneurysms in Marfan syndrome: a systematic review of the literature. Ann Vasc Surg 2022;87:548–59. https://doi.org/10.1016/j.avsg.2022.08.005
1456. Guala A, Teixidó-Tura G, Rodríguez-Palomares J, Ruiz-Muñoz A, Dux-Santoy L, Villalva N, et al. Proximal aorta longitudinal strain predicts aortic root dilation rate and aortic events in Marfan syndrome. Eur Heart J 2019;40:2047–55. https://doi.org/10.1093/eurheartj/ehz191
1457. Teixido-Tura G, Redheuil A, Rodríguez-Palomares J, Gutiérrez L, Sánchez V, Forteza A, et al. Aortic biomechanics by magnetic resonance: early markers of aortic disease in Marfan syndrome regardless of aortic dilatation? Int J Cardiol 2014;171:56–61. https://doi.org/10.1016/j.ijcard.2013.11.044
1458. Kuijpers JM, Mulder BJ. Aortopathies in adult congenital heart disease and genetic aortopathy syndromes: management strategies and indications for surgery. Heart 2017;103:952–66. https://doi.org/10.1136/heartjnl-2015-308626
1459. Milewicz DM, Braverman AC, De Backer J, Morris SA, Boileau C, Maumenee IH, et al. Marfan syndrome. Nat Rev Dis Primers 2021;7:64. https://doi.org/10.1038/s41572-021-00298-7
1460. Doyle JJ, Doyle AJ, Wilson NK, Habashi JP, Bedja D, Whitworth RE, et al. A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome. Elife 2015;4:e08648. https://doi.org/10.7554/eLife.08648
1461. Lacro RV, Dietz HC, Sleeper LA, Yetman AT, Bradley TJ, Colan SD, et al. Atenolol versus losartan in children and young adults with Marfan’s syndrome. N Engl J Med 2014;371:2061–71. https://doi.org/10.1056/NEJMoa1404731
1462. Teixido-Tura G, Forteza A, Rodríguez-Palomares J, González Mirelis J, Gutiérrez L, Sánchez V, et al. Losartan versus atenolol for prevention of aortic dilation in patients with Marfan syndrome. J Am Coll Cardiol 2018;72:1613–8. https://doi.org/10.1016/j.jacc.2018.07.052
1463. Pitcher A, Spata E, Emberson J, Davies K, Halls H, Holland L, et al. Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials. Lancet 2022;400:822–31. https://doi.org/10.1016/s0140-6736(22)01534-3
1464. Groenink M, den Hartog AW, Franken R, Radonic T, de Waard V, Timmermans J, et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J 2013;34:3491–500. https://doi.org/10.1093/eurheartj/eht334
1465. Nucera M, Kreibich M, Yildiz M, Berger T, Kolb RK, Kondov S, et al. Endovascular aortic repair in patients with Marfan and Loeys-Dietz syndrome is safe and durable when employed by a multi-disciplinary aortic team. Eur J Cardiothorac Surg 2024;65: ezae069. https://doi.org/10.1093/ejcts/ezae069
1466. Czerny M, Grabenwoger M, Berger T, Aboyans V, Della Corte A, Chen EP, et al. EACTS/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ. Eur J Cardiothorac Surg 2024;65:ezad426. https://doi.org/10.1093/ejcts/ezad426
1467. Milleron O, Arnoult F, Delorme G, Detaint D, Pellenc Q, Raffoul R, et al. Pathogenic FBN1 genetic variation and aortic dissection in patients with Marfan syndrome. J Am Coll Cardiol 2020;75:843–53. https://doi.org/10.1016/j.jacc.2019.12.043
1468. Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller G-P, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021;42:563–645. https://doi.org/10.1093/eurheartj/ehaa554
1469. Martín C, Evangelista A, Serrano-Fiz S, Villar S, Ospina V, Martínez D, et al. Aortic complications in Marfan syndrome: should we anticipate preventive aortic root surgery? Ann Thorac Surg 2020;109:1850–7. https://doi.org/10.1016/j.athoracsur.2019.08.096
1470. Roman MJ, Pugh NL, Hendershot TP, Devereux RB, Dietz H, Holmes K, et al. Aortic complications associated with pregnancy in Marfan syndrome: the NHLBI national registry of genetically triggered thoracic aortic aneurysms and cardiovascular conditions (GenTAC). J Am Heart Assoc 2016;5:e004052. https://doi.org/10.1161/jaha.116. 004052
1471. Braverman AC, Mittauer E, Harris KM, Evangelista A, Pyeritz RE, Brinster D, et al. Clinical features and outcomes of pregnancy-related acute aortic dissection. JAMA Cardiol 2021;6:58–66. https://doi.org/10.1001/jamacardio.2020.4876
1472. Narula N, Devereux RB, Malonga GP, Hriljac I, Roman MJ. Pregnancy-related aortic complications in women with Marfan syndrome. J Am Coll Cardiol 2021;78:870–9. https://doi.org/10.1016/j.jacc.2021.06.034
1473. Davis MB, Arendt K, Bello NA, Brown H, Briller J, Epps K, et al. Team-based care of women with cardiovascular disease from pre-conception through pregnancy and postpartum: JACC focus seminar 1/5. J Am Coll Cardiol 2021;77:1763–77. https://doi.org/10.1016/j.jacc.2021.02.033
1474. Meijboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman AH, Mulder BJM. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J 2005;26:914–20. https://doi.org/10.1093/eurheartj/ehi103
1475. Kuperstein R, Cahan T, Yoeli-Ullman R, Ben Zekry S, Shinfeld A, Simchen MJ. Risk of aortic dissection in pregnant patients with the Marfan syndrome. Am J Cardiol 2017; 119:132–7. https://doi.org/10.1016/j.amjcard.2016.09.024
1476. Roberts EA, Pistner A, Osobamiro O, Banning S, Shalhub S, Albright C, et al. Beta-blocker use during pregnancy correlates with less aortic root dilatation in patients with Marfan’s syndrome. Aorta (Stamford) 2023;11:63–70. https://doi.org/10.1055/a-2072-0469
1477. Roman MJ, Devereux RB. Aortic dissection risk in Marfan syndrome. J Am Coll Cardiol 2020;75:854–6. https://doi.org/10.1016/j.jacc.2019.12.042
1478. Quan A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 2006;82:23–8. https://doi.org/10.1016/j.earlhumdev.2005.11.001
1479. Walfisch A, Al-maawali A, Moretti ME, Nickel C, Koren G. Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers. J Obstet Gynaecol 2011;31: 465–72. https://doi.org/10.3109/01443615.2011.579197
1480. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443–51. https://doi.org/10.1056/NEJMoa055202
1481. Mas-Stachurska A, Siegert AM, Batlle M, Gorbenko del Blanco D, Meirelles T, Rubies C, et al. Cardiovascular benefits of moderate exercise training in Marfan syndrome: insights from an animal model. J Am Heart Assoc 2017;6:e006438. https://doi.org/10.1161/jaha.117.006438
1482. Gibson C, Nielsen C, Alex R, Cooper K, Farney M, Gaufin D, et al. Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm. J Appl Physiol 2017;123:147–60. https://doi.org/10.1152/japplphysiol.00132.2017
1483. Selamet Tierney ES, Chung S, Stauffer KJ, Brabender J, Collins RT, Folk R, et al. Can 10 000 healthy steps a day slow aortic root dilation in pediatric patients with Marfan syndrome? J Am Heart Assoc 2022;11:e027598. https://doi.org/10.1161/jaha.122.027598
1484. Jouini S, Milleron O, Eliahou L, Jondeau G, Vitiello D. Effects of a personalized home-based training program among patients suffering from Marfan syndrome: a pilot randomized and controlled study. Intractable Rare Dis Res 2021;10:263–8. https://doi.org/10.5582/irdr.2021.01080
1485. Benninghoven D, Hamann D, von Kodolitsch Y, Rybczynski M, Lechinger J, Schroeder F, et al. Inpatient rehabilitation for adult patients with Marfan syndrome: an observational pilot study. Orphanet J Rare Dis 2017;12:127. https://doi.org/10.1186/s13023-017-0679-0
1486. Fuglsang S, Heiberg J, Hjortdal VE, Laustsen S. Exercise-based cardiac rehabilitation in surgically treated type-A aortic dissection patients. Scand Cardiovasc J 2017;51: 99–105. https://doi.org/10.1080/14017431.2016.1257149
1487. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005;37:275–81. https://doi.org/10. 1038/ng1511
1488. MacCarrick G, Black JH, III, Bowdin S, El-Hamamsy I, Frischmeyer-Guerrerio PA, Guerrerio AL, et al. Loeys-Dietz syndrome: a primer for diagnosis and management. Genet Med 2014;16:576–87. https://doi.org/10.1038/gim.2014.11
1489. Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, Fert-Bober J, et al. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet 2012;44:922–7. https://doi.org/10.1038/ng.2349
1490. Boileau C, Guo DC, Hanna N, Regalado ES, Detaint D, Gong L, et al. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet 2012;44:916–21. https://doi.org/10.1038/ng.2348
1491. van der Linde D, van de Laar IM, Bertoli-Avella AM, Oldenburg RA, Bekkers JA, Mattace-Raso FUS, et al. Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. J Am Coll Cardiol 2012;60:397–403. https://doi.org/10.1016/j.jacc.2011.12.052
1492. Hostetler EM, Regalado ES, Guo DC, Hanna N, Arnaud P, Muiño-Mosquera L, et al. SMAD3 pathogenic variants: risk for thoracic aortic disease and associated complications from the Montalcino Aortic Consortium. J Med Genet 2019;56:252–60. https://doi.org/10.1136/jmedgenet-2018-105583
1493. Renard M, Callewaert B, Malfait F, Campens L, Sharif S, del Campo M, et al. Thoracic aortic-aneurysm and dissection in association with significant mitral valve disease caused by mutations in TGFB2. Int J Cardiol 2013;165:584–7. https://doi.org/10.1016/j.ijcard.2012.09.029
1494. Bertoli-Avella AM, Gillis E, Morisaki H, Verhagen JMA, de Graaf BM, van de Beek G, et al. Mutations in a TGF-beta ligand, TGFB3, cause syndromic aortic aneurysms and dissections. J Am Coll Cardiol 2015;65:1324–36. https://doi.org/10.1016/j.jacc.2015.01. 040
1495. Marsili L, Overwater E, Hanna N, Baujat G, Baars MJH, Boileau C, et al. Phenotypic spectrum of TGFB3 disease-causing variants in a Dutch-French cohort and first report of a homozygous patient. Clin Genet 2020;97:723–30. https://doi.org/10.1111/cge.13700
1496. Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 2007;39:1488–93. https://doi.org/10.1038/ng.2007.6
1497. Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 2009;84:617–27. https://doi.org/10.1016/j.ajhg.2009.04.007
1498. van de Laar I, Arbustini E, Loeys B, Björck E, Murphy L, Groenink M, et al. European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants. Orphanet J Rare Dis 2019;14:264. https://doi.org/10.1186/s13023-019-1186-2
1499. Brownstein AJ, Ziganshin BA, Kuivaniemi H, Body Simon, Bale A, Elefteriades J. Genes associated with thoracic aortic aneurysm and dissection: an update and clinical implications. Aorta (Stamford) 2017;5:11–20. https://doi.org/10.12945/j.aorta.2017.17.003
1500. Bray JJH, Freer R, Pitcher A, Kharbanda R. Family screening for bicuspid aortic valve and aortic dilatation: a meta-analysis. Eur Heart J 2023;44:3152–64. https://doi.org/10.1093/eurheartj/ehad320
1501. Michelena HI, Vallabhajosyula S, Prakash SK. Nosology spectrum of the bicuspid aortic valve condition: complex-presentation valvulo-aortopathy. Circulation 2020;142: 294–9. https://doi.org/10.1161/circulationaha.120.046892
1502. Prakash SK, Bosse Y, Muehlschlegel JD, Michelena HI, Limongelli G, Della Corte A, et al. A roadmap to investigate the genetic basis of bicuspid aortic valve and its complications: insights from the International BAVCon (Bicuspid Aortic Valve Consortium). J Am Coll Cardiol 2014;64:832–9. https://doi.org/10.1016/j.jacc.2014.04.073
1503. Fulmer D, Toomer K, Guo L, Moore K, Glover J, Moore R, et al. Defects in the exocyst-cilia machinery cause bicuspid aortic valve disease and aortic stenosis. Circulation 2019;140:1331–41. https://doi.org/10.1161/circulationaha.119.038376
1504. Luyckx I, Kumar AA, Reyniers E, Dekeyser E, Vanderstraeten K, Vandeweyer G, et al. Copy number variation analysis in bicuspid aortic valve-related aortopathy identifies TBX20 as a contributing gene. Eur J Hum Genet 2019;27:1033–43. https://doi.org/10.1038/s41431-019-0364-y
1505. Xu YJ, Di RM, Qiao Q, Li X-M, Huang R-T, Xue S, et al. GATA6 loss-of-function mutation contributes to congenital bicuspid aortic valve. Gene 2018;663:115–20. https://doi.org/10.1016/j.gene.2018.04.018
1506. Gehlen J, Stundl A, Debiec R, Fontana F, Krane M, Sharipova D, et al. Elucidation of the genetic causes of bicuspid aortic valve disease. Cardiovasc Res 2023;119:857–66. https://doi.org/10.1093/cvr/cvac099
1507. Gago-Díaz M, Brion M, Gallego P, Calvo F, Robledo-Carmona J, Saura D, et al. The genetic component of bicuspid aortic valve and aortic dilation. An exome-wide association study. J Mol Cell Cardiol 2017;102:3–9. https://doi.org/10.1016/j.yjmcc.2016.11.012
1508. Girdauskas E, Geist L, Disha K, Kazakbaev I, Groß T, Schulz S, et al. Genetic abnormalities in bicuspid aortic valve root phenotype: preliminary results. Eur J Cardiothorac Surg 2017;52:156–62. https://doi.org/10.1093/ejcts/ezx065
1509. Mansoorshahi S, Yetman AT, Bissell MM, Kim YY, Michelena H, Hui DS, et al. Whole exome sequencing uncovers the genetic complexity of bicuspid aortic valve in families with early onset complications. medRxiv 2024. https://doi.org/10.1101/2024.02.07. 24302406.
1510. Michelena HI, Della Corte A, Evangelista A, Maleszewski JJ, Edwards WD, Roman MJ, et al. International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. Eur J Cardiothorac Surg 2021;60:448–76. https://doi.org/10.1093/ejcts/ezab038
1511. Verma S, Siu SC. Aortic dilatation in patients with bicuspid aortic valve. N Engl J Med 2014;370:1920–9. https://doi.org/10.1056/NEJMra1207059
1512. Yang LT, Ye Z, Wajih Ullah M, Maleszewski JJ, Scott CG, Padang R, et al. Bicuspid aortic valve: long-term morbidity and mortality. Eur Heart J 2023;44:4549–62. https://doi.org/10.1093/eurheartj/ehad477
1513. Guo MH, Appoo JJ, Saczkowski R, Smith HN, Ouzounian M, Gregory AJ, et al. Association of mortality and acute aortic events with ascending aortic aneurysm: a systematic review and meta-analysis. JAMA Netw Open 2018;1:e181281. https://doi.org/10.1001/jamanetworkopen.2018.1281
1514. Dayan V, Zuasnabar A, Citro R, Bossone E, Michelena HI, Parma G, et al. Aortopathy and regurgitation in bicuspid valve patients increase the risk of aortopathy in relatives. Int J Cardiol 2019;286:117–20. https://doi.org/10.1016/j.ijcard.2019.03.031
1515. Galian-Gay L, Carro Hevia A, Teixido-Turà G, Rodríguez Palomares J, Gutiérrez-Moreno L, Maldonado G, et al. Familial clustering of bicuspid aortic valve and its relationship with aortic dilation in first-degree relatives. Heart 2019;105: 603–8. https://doi.org/10.1136/heartjnl-2018-313802
1516. Tessler I, Leshno M, Shmueli A, Shpitzen S, Durst R, Gilon D. Cost-effectiveness analysis of screening for first-degree relatives of patients with bicuspid aortic valve. Eur Heart J Qual Care Clin Outcomes 2021;7:447–57. https://doi.org/10.1093/ehjqcco/ qcab047
1517. Girdauskas E, Rouman M, Disha K, Espinoza A, Misfeld M, Borger MA, et al. Aortic dissection after previous aortic valve replacement for bicuspid aortic valve disease. J Am Coll Cardiol 2015;66:1409–11. https://doi.org/10.1016/j.jacc.2015.07.022
1518. Masri A, Kalahasti V, Svensson LG, Alashi A, Schoenhagen P, Roselli EE, et al. Aortic cross-sectional area/height ratio and outcomes in patients with bicuspid aortic valve and a dilated ascending aorta. Circ Cardiovasc Imaging 2017;10:e006249. https://doi.org/10.1161/circimaging.116.006249
1519. Della Corte A, Michelena HI, Citarella A, Votta E, Piatti F, Lo Presti F, et al. Risk stratification in bicuspid aortic valve aortopathy: emerging evidence and future perspectives. Curr Probl Cardiol 2021;46:100428. https://doi.org/10.1016/j.cpcardiol.2019.06. 002
1520. Ye Z, Lane C, Beachey JD. Clinical outcomes in patients with bicuspid aortic valves and ascending aorta ≥50 mm under surveillance. JACC: Advances 2023;2:100626. https://doi.org/10.1016/j.jacadv.2023.100626.
1521. Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM, et al. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA 2011;306:1104–12. https://doi.org/10.1001/jama.2011.1286
1522. Michelena HI, Desjardins VA, Avierinos JF, Russo A, Nkomo VT, Sundt TM, et al. Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation 2008;117:2776–84. https://doi.org/10.1161/CIRCULATIONAHA.107.740878
1523. Girdauskas E, Disha K, Secknus M, Borger M, Kuntze T. Increased risk of late aortic events after isolated aortic valve replacement in patients with bicuspid aortic valve insufficiency versus stenosis. J Cardiovasc Surg (Torino) 2013;54:653–9.
1524. Cortenbach KRG, Yosofi B, Rodwell L, Meek J, Patel R, Prakash SK, et al. Editor’s choice—therapeutic options and outcomes in midaortic syndrome: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2023;65:120–30. https://doi.org/10.1016/j.ejvs.2022.10.017
1525. Teo LL, Cannell T, Babu-Narayan SV, Hughes M, Mohiaddin RH. Prevalence of associated cardiovascular abnormalities in 500 patients with aortic coarctation referred for cardiovascular magnetic resonance imaging to a tertiary center. Pediatr Cardiol 2011;32:1120–7. https://doi.org/10.1007/s00246-011-9981-0
1526. Spaziani G, Girolami F, Arcieri L, Calabri GB, Porcedda G, Di Filippo C, et al. Bicuspid aortic valve in children and adolescents: a comprehensive review. Diagnostics (Basel) 2022;12:1751. https://doi.org/10.3390/diagnostics12071751
1527. Raissadati A, Nieminen H, Haukka J, Sairanen H, Jokinen E. Late causes of death after pediatric cardiac surgery: a 60-year population-based study. J Am Coll Cardiol 2016;68: 487–98. https://doi.org/10.1016/j.jacc.2016.05.038
1528. Panzer J, Bové T, Vandekerckhove K, De Wolf D. Hypertension after coarctation repair–a systematic review. Transl Pediatr 2022;11:270–9. https://doi.org/10.21037/tp-21-418
1529. Batlivala SP, Goldstein BH. Current transcatheter approaches for the treatment of aortic coarctation in children and adults. Interv Cardiol Clin 2019;8:47–58. https://doi.org/10.1016/j.iccl.2018.08.001
1530. Egbe AC, Miranda WR, Bonnichsen CR, Warnes CA, Connolly HM. Potential benefits of ambulatory blood pressure monitoring in coarctation of aorta. J Am Coll Cardiol 2020;75:2089–90. https://doi.org/10.1016/j.jacc.2020.02.053
1531. Luitingh TL, Lee MGY, Jones B, Kowalski R, Weskamp Aguero S, Koleff J, et al. A cross-sectional study of the prevalence of exercise-induced hypertension in childhood following repair of coarctation of the aorta. Heart Lung Circ 2019;28:792–9. https://doi.org/10.1016/j.hlc.2018.03.015
1532. Brown ML, Burkhart HM, Connolly HM, Dearani JA, Cetta F, Li Z, et al. Coarctation of the aorta: lifelong surveillance is mandatory following surgical repair. J Am Coll Cardiol 2013;62:1020–5. https://doi.org/10.1016/j.jacc.2013.06.016
1533. Somers T, Nies H, van Kimmenade RRJ, Bosboom DGH, Geuzebroek GSC, Morshuis WJ. Necessity of life-long follow-up after surgery for coarctation of the aorta: a case series of very late false aneurysm formation. Eur Heart J Case Rep 2022;6:ytac073. https://doi.org/10.1093/ehjcr/ytac073
1534. Padang R, Dennis M, Semsarian C, Bannon PG, Tanous DJ, Celermajer DS, et al. Detection of serious complications by MR imaging in asymptomatic young adults with repaired coarctation of the aorta. Heart Lung Circ 2014;23:332–8. https://doi.org/10.1016/j.hlc.2013.10.055
1535. Bhatt AB, Lantin-Hermoso MR, Daniels CJ, Jaquiss R, Landis BJ, Marino BS, et al. Isolated coarctation of the aorta: current concepts and perspectives. Front Cardiovasc Med 2022;9:817866. https://doi.org/10.3389/fcvm.2022.817866
1536. Erben Y, Oderich GS, Verhagen HJM, Witsenburg M, van den Hoven AT, Debus ES, et al. Multicenter experience with endovascular treatment of aortic coarctation in adults. J Vasc Surg 2019;69:671–9.e1. https://doi.org/10.1016/j.jvs.2018.06.209
1537. Meijs TA, Warmerdam EG, Slieker MG, Krings GJ, Molenschot MMC, Meijboom FJ, et al. Medium-term systemic blood pressure after stenting of aortic coarctation: a systematic review and meta-analysis. Heart 2019;105:1464–70. https://doi.org/10.1136/ heartjnl-2019-314965
1538. Layton KF, Kallmes DF, Cloft HJ, Lindell EP, Cox VS. Bovine aortic arch variant in humans: clarification of a common misnomer. AJNR Am J Neuroradiol 2006;27:1541–2.
1539. Berko NS, Jain VR, Godelman A, Stein EG, Ghosh S, Haramati LB. Variants and anomalies of thoracic vasculature on computed tomographic angiography in adults. J Comput Assist Tomogr 2009;33:523–8. https://doi.org/10.1097/RCT. 0b013e3181888343
1540. Dumfarth J, Peterss S, Kofler M, Plaikner M, Ziganshin BA, Schachner T, et al. In DeBakey type I aortic dissection, bovine aortic arch is associated with arch tears and stroke. Ann Thorac Surg 2017;104:2001–8. https://doi.org/10.1016/j.athoracsur.2017.05.026
1541. Hornick M, Moomiaie R, Mojibian H, Ziganshin B, Almuwaqqat Z, Lee ES, et al. ‘Bovine’ aortic arch—a marker for thoracic aortic disease. Cardiology 2012;123: 116–24. https://doi.org/10.1159/000342071
1542. Yousef S, Singh S, Alkukhun A, Alturkmani B, Mori M, Chen J, et al. Variants of the aortic arch in adult general population and their association with thoracic aortic aneurysm disease. J Card Surg 2021;36:2348–54. https://doi.org/10.1111/jocs.15563
1543. Tanaka A, Milner R, Ota T. Kommerell’s diverticulum in the current era: a comprehensive review. Gen Thorac Cardiovasc Surg 2015;63:245–59. https://doi.org/10.1007/ s11748-015-0521-3
1544. Upchurch GR, Jr, Escobar GA, Azizzadeh A, Beck AW, Conrad MF, Matsumura JS, et al. Society for Vascular Surgery clinical practice guidelines of thoracic endovascular aortic repair for descending thoracic aortic aneurysms. J Vasc Surg 2021;73:55s–83s. https://doi.org/10.1016/j.jvs.2020.05.076
1545. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317–24. https://doi.org/10.1001/jama.286.11.1317
1546. Suárez C, Zeymer U, Limbourg T, Baumgartner I, Cacoub P, Poldermans D, et al. Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH registry. Vasc Med 2010;15:259–65. https://doi.org/10.1177/1358863x 10373299
1547. Alberts MJ, Bhatt DL, Mas JL, Ohman EM, Hirsch AT, Rother J, et al. Three-year follow-up and event rates in the international REduction of atherothrombosis for continued health registry. Eur Heart J 2009;30:2318–26. https://doi.org/10.1093/eurheartj/ehp355
1548. van den Berg MJ, Bhatt DL, Kappelle LJ, de Borst GJ, Cramer MJ, van der Graaf Y, et al. Identification of vascular patients at very high risk for recurrent cardiovascular events: validation of the current ACC/AHA very high risk criteria. Eur Heart J 2017;38: 3211–8. https://doi.org/10.1093/eurheartj/ehx102
1549. Subherwal S, Bhatt DL, Li S, Wang TY, Thomas L, Alexander KP, et al. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes 2012;5:541–9. https://doi.org/10.1161/circoutcomes.111.964379
1550. van der Meer MG, Cramer MJ, van der Graaf Y, Appelman Y, Doevendans PA, Nathoe HM. The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients. Eur J Clin Invest 2014;44:231–9. https://doi.org/10.1111/eci.12222
1551. Steinvil A, Sadeh B, Arbel Y, Justo D, Belei A, Borenstein N, et al. Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. J Am Coll Cardiol 2011;57:779–83. https://doi.org/10.1016/j.jacc.2010.09.047
1552. Ahmed B, Al-Khaffaf H. Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: a meta-analysis. Eur J Vasc Endovasc Surg 2009;37:262–71. https://doi.org/10.1016/j.ejvs.2008.10.017
1553. Mukherjee D, Eagle KA, Kline-Rogers E, Feldman LJ, Juliard J-M, Agnelli G, et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the global registry of acute coronary events). Am J Cardiol 2007;100:1–6. https://doi.org/10.1016/j.amjcard.2007.02. 046
1554. Fowkes FG, Low LP, Tuta S, Kozak J. Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study. Eur Heart J 2006;27:1861–7. https://doi.org/10.1093/eurheartj/ehl114
1555. Durand DJ, Perler BA, Roseborough GS, Grega MA, Borowicz LM, Baumgartner WA, et al. Mandatory versus selective preoperative carotid screening: a retrospective analysis. Ann Thorac Surg 2004;78:159–66; discussion 159–66. https://doi.org/10.1016/j.athoracsur.2004.02.024
1556. Naylor AR, Mehta Z, Rothwell PM, Bell PR. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg 2002;23:283–94. https://doi.org/10.1053/ejvs.2002.1609
1557. Jens S, Koelemay MJ, Reekers JA, Bipat S. Diagnostic performance of computed tomography angiography and contrast-enhanced magnetic resonance angiography in patients with critical limb ischaemia and intermittent claudication: systematic review and meta-analysis. Eur Radiol 2013;23:3104–14. https://doi.org/10.1007/s00330-013-2933-8
1558. Illuminati G, Schneider F, Greco C, Mangieri E, Schiariti M, Tanzilli G, et al. Long-term results of a randomized controlled trial analyzing the role of systematic pre-operative coronary angiography before elective carotid endarterectomy in patients with asymptomatic coronary artery disease. Eur J Vasc Endovasc Surg 2015;49:366–74. https://doi.org/10.1016/j.ejvs.2014.12.030
1559. Eikelboom JW, Bhatt DL, Fox KAA, Bosch J, Connolly SJ, Anand SS, et al. Mortality benefit of rivaroxaban plus aspirin in patients with chronic coronary or peripheral artery disease. J Am Coll Cardiol 2021;78:14–23. https://doi.org/10.1016/j.jacc.2021.04. 083
1560. Aboyans V, Lacroix P, Postil A, Guilloux J, Rollé F, Cornu E, et al. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2005;46: 815–20. https://doi.org/10.1016/j.jacc.2005.05.066
1561. Rihal CS, Sutton-Tyrrell K, Guo P, Keller NM, Jandova R, Sellers MA, et al. Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation. Circulation 1999;100:171–7. https://doi.org/10.1161/01.cir.100.2.171
1562. Aboyans V, Lacroix P. Indications for carotid screening in patients with coronary artery disease. Presse Med 2009;38:977–86. https://doi.org/10.1016/j.lpm.2009.02.015
1563. Collet JP, Cayla G, Ennezat PV, Leclercq F, Cuisset T, Elhadad S, et al. Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: the randomized AMERICA study. Int J Cardiol 2018;254:36–42. https://doi.org/10.1016/j.ijcard.2017.11.081
1564. Neufang A, Dorweiler B, Espinola-Klein C, Savvidis S, Doemland M, Schotten S, et al. Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts. J Vasc Surg 2014;60:1543–53. https://doi.org/10.1016/j.jvs.2014.07.103
1565. Calvet D, Touzé E, Varenne O, Sablayrolles J-L, Weber S, Mas J-L. Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study. Circulation 2010;121:1623–9. https://doi.org/10.1161/circulationaha.109. 906958
1566. Hofmann R, Kypta A, Steinwender C, Kerschner K, Grund M, Leisch F. Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease. Heart 2005;91:1438–41. https://doi.org/10.1136/hrt.2004.050906
1567. Masabni K, Raza S, Blackstone EH, Gornik HL, Sabik JF, III. Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting? J Thorac Cardiovasc Surg 2015;149:1253–60. https://doi.org/10.1016/j.jtcvs.2015.02.003
1568. Klarin D, Patel VI, Zhang S, Xian Y, Kosinski A, Yerokun B, et al. Concomitant carotid endarterectomy and cardiac surgery does not decrease postoperative stroke rates. J Vasc Surg 2020;72:589–96.e3. https://doi.org/10.1016/j.jvs.2019.10.072
1569. D’Agostino RS, Svensson LG, Neumann DJ, Balkhy HH, Williamson WA, Shahian DM. Screening carotid ultrasonography and risk factors for stroke in coronary artery surgery patients. Ann Thorac Surg 1996;62:1714–23. https://doi.org/10.1016/s0003-4975(96)00885-5
1570. Weissler EH, Jones WS, Desormais I, Debus S, Mazzolai L, Espinola-Klein C, et al. Polyvascular disease: a narrative review of current evidence and a consideration of the role of antithrombotic therapy. Atherosclerosis 2020;315:10–7. https://doi.org/10. 1016/j.atherosclerosis.2020.11.001
1571. Alkhalil M, Kuzemczak M, Whitehead N, Kavvouras C, Džavík V. Meta-analysis of intensive lipid-lowering therapy in patients with polyvascular disease. J Am Heart Assoc 2021;10:e017948. https://doi.org/10.1161/jaha.120.017948
1572. Ward RP, Goonewardena SN, Lammertin G, Lang RM. Comparison of the frequency of abnormal cardiac findings by echocardiography in patients with and without peripheral arterial disease. Am J Cardiol 2007;99:499–503. https://doi.org/10.1016/j.amjcard.2006.09.102
1573. Kelly R, Staines A, MacWalter R, Stonebridge P, Tunstall-Pedoe H, Struthers AD. The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes: a case-control study. J Am Coll Cardiol 2002;39: 219–24. https://doi.org/10.1016/s0735-1097(01)01725-9
1574. Samsky MD, Hellkamp A, Hiatt WR, Fowkes FGR, Baumgartner I, Berger JS, et al. Association of heart failure with outcomes among patients with peripheral artery disease: insights from EUCLID. J Am Heart Assoc 2021;10:e018684. https://doi.org/10.1161/jaha.120.018684
1575. Kahan T. The importance of myocardial fibrosis in hypertensive heart disease. J Hypertens 2012;30:685–7. https://doi.org/10.1097/HJH.0b013e328350e5db
1576. O’Rourke MF, Safar ME, Dzau V. The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc Med 2010;15:461–8. https://doi.org/10.1177/1358863x10382946
1577. Duscha BD, Annex BH, Green HJ, Pippen AM, Kraus WE. Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure. J Am Coll Cardiol 2002;39:1170–4. https://doi.org/10.1016/s0735-1097(02)01740-0
1578. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992;85:1364–73. https://doi.org/10.1161/01.cir.85.4.1364
1579. Hedberg P, Hammar C, Selmeryd J, Viklund J, Leppert J, Hellberg A, et al. Left ventricular systolic dysfunction in outpatients with peripheral atherosclerotic vascular disease: prevalence and association with location of arterial disease. Eur J Heart Fail 2014;16:625–32. https://doi.org/10.1002/ejhf.95
1580. Sandesara PB, Hammadah M, Samman-Tahhan A, Kelli HM, O’Neal WT. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction. Clin Cardiol 2017;40:692–6. https://doi.org/10.1002/clc.22716
1581. Nakamura Y, Kunii H, Yoshihisa A, Takiguchi M, Shimizu T, Yamauchi H, et al. Impact of peripheral artery disease on prognosis in hospitalized heart failure patients. Circ J 2015;79:785–93. https://doi.org/10.1253/circj.CJ-14-1280
1582. Inglis SC, Bebchuk J, Al-Suhaim SA, Case J, Pfeffer MA, Solomon SD, et al. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. Int J Cardiol 2013;168:1094–101. https://doi.org/10.1016/j.ijcard.2012.11. 033
1583. Jones WS, Clare R, Ellis SJ, Mills JS, Fischman DL, Kraus WE, et al. Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION). Am J Cardiol 2011;108:380–4. https://doi.org/10.1016/j.amjcard.2011.03.057
1584. van Straten AH, Firanescu C, Soliman Hamad MA, Tan MESH, ter Woorst JFJ, Martens EJ, et al. Peripheral vascular disease as a predictor of survival after coronary artery bypass grafting: comparison with a matched general population. Ann Thorac Surg 2010;89:414–20. https://doi.org/10.1016/j.athoracsur.2009.11.036
1585. Goto S, Bhatt DL, Rother J, Alberts M, Hill MD, Ikeda Y, et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 2008;156:855–63, 863.e2. https://doi.org/10.1016/j.ahj.2008.06.029
1586. Olesen JB, Gislason GH, Torp-Pedersen C, Lip GY. Atrial fibrillation and vascular disease—a bad combination. Clin Cardiol 2012;35:15–20. https://doi.org/10.1002/clc. 20955
1587. Parvar SL, Thiyagarajah A, Nerlekar N, King P, Nicholls SJ. A systematic review and meta-analysis of gender differences in long-term mortality and cardiovascular events in peripheral artery disease. J Vasc Surg 2021;73:1456–65.e7. https://doi.org/10.1016/j.jvs.2020.09.039
1588. Depta JP, Bhatt DL. Atherothrombosis and atrial fibrillation: important and often overlapping clinical syndromes. Thromb Haemost 2010;104:657–63. https://doi.org/10.1160/th10-05-0332
1589. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2n–9n. https://doi.org/10.1016/s0002-9149(98)00583-9
1590. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study. JAMA 1994;271:840–4.
1591. Zhu J, Tan X, Zhou JZ. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis. Clin Cardiol 2021;44:1050–7. https://doi.org/10.1002/clc.23678
1592. Olesen JB, Lip GY, Lane DA, Køber L, Hansen ML, Karasoy D, et al. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study. Am J Med 2012;125: 826.e13–23. https://doi.org/10.1016/j.amjmed.2011.11.024
1593. Skelding KA, Yakubov SJ, Kleiman NS, Reardon MJ, Adams DH, Huang J, et al. Transcatheter aortic valve replacement versus surgery in women at high risk for surgical aortic valve replacement (from the CoreValve US High Risk Pivotal Trial). Am J Cardiol 2016;118:560–6. https://doi.org/10.1016/j.amjcard.2016.05.051
1594. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705–15. https://doi.org/10.1056/NEJMoa1114705
1595. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597–607. https://doi.org/10.1056/NEJMoa1008232
1596. Reindl M, Lechner I, Holzknecht M, Tiller C, Fink P, Oberhollenzer F, et al. Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement (TAVR-CMR): a randomized, open-label, non-inferiority trial. Circulation 2023;148:1220–30. https://doi.org/10.1161/CIRCULATIONAHA.123.066498
1597. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42:373–498. https://doi.org/10.1093/eurheartj/ehaa612
1598. Fanaroff AC, Manandhar P, Holmes DR, Cohen DJ, Harrison JK, Hughes GC, et al. Peripheral artery disease and transcatheter aortic valve replacement outcomes: a report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Therapy Registry. Circ Cardiovasc Interv 2017;10:e005456. https://doi.org/10.1161/CIRCINTERVENTIONS.117.005456